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INTRODUCTION
The human body is under constant siege of pathogens - bacteria, viruses, fungi and 
parasites. We can only survive because these attackers are continuously fought off 
by our immune system. Important tasks within the immune system of vertebrates are 
performed by T lymphocytes, the executors of specific, cellular immunity. 
The specificity of T lymphocytes lies in their T-cell receptor (TCR), through which 
they sense the presence of antigens in their environment. Each T cell expresses a 
TCR with a unique antigen-recognition site, so all T cells together can respond to an 
enormous variety of antigens. The highly diverse T-cell repertoire is generated by random 
recombination of discrete TCR gene segments. Via the TCR, T cells recognize peptide 
antigens that are displayed by antigen presenting cells (APCs), in the context of major 
histocompatibility complex (MHC) class I or class II molecules. Mature T cells carry out 
their function in cellular immunity as either CD8+ cytotoxic T cells or as CD4+ helper T 
cells. The humoral part of the specific immune system is supplied by B lymphocytes, 
which can secrete their antigen receptors in the form of antibodies.
T cells develop from multipotent precursors via a highly ordered, but complex 
differentiation pathway. A number of critical events occur during this T-cell development 
process. Cells proliferate, adopt a T-cell fate, and produce a TCR molecule via a strictly 
ordered process of gene rearrangements. Stringent selection processes make sure 
that the produced TCR molecule is self-MHC restricted but not reactive to self-antigens. 
Finally, the selected T cells are allowed to mature into functional effector T cells. 
To become highly differentiated and thoroughly ‘educated’ cells, T cells need a 
specialized microenvironment for their development. The organ which has evolved to 
fulfill this task and which also gave T cells their name, is the Thymus. The hematopoietic 
cells that undergo T-cell development in the thymus are called thymocytes.
The importance of the thymus as essential microenvironment for T-cell development 
is illustrated by children afflicted by the DiGeorge syndrome, who sometimes completely 
lack a thymus. These children have severely reduced T cell numbers and suffer from 
recurrent life-threatening infections. DiGeorge syndrome also illustrates the fact that 
T cells are the only hematopoietic cell type that absolutely require the thymus for their 
development. 
Although human T-cell development is the main theme of this thesis, most of the 
published knowledge about T-cell differentiation has been acquired by studies in the 
mouse. For that reason, this General introduction summarizes information about both 
human and murine thymocyte development. The main focus of this thesis is on the early 
‘double negative’ stages of T-cell development in the thymus. 
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T-CELL DEVELOPMENT IN THE THYMUS
The thymus
The thymus is a bilobate organ located behind the sternum, just above the heart. It is 
remarkably large in newborns and children (Figure 1), reaching its maximum size (~25 
cm3) within the first 12 months of life. Thereafter the volume of true thymic tissue reduces 
progressively, and by adulthood the thymus is composed largely of adipose tissue1. This 
decline in thymus size and function during ageing is called thymic involution2. 
Organogenesis of the thymus in man starts at the end of the fourth week of gestation 
and in the mouse at day 10.5 of embryonic development (E10.5)3,4. Bilateral endodermal 
proliferations of the third pharyngeal pouch invade the underlying mesenchyme to form 
the thymic primordium or anlage. Between four and seven weeks (mouse E12.5), the 
primordia separate from the pharynx and migrate to their definitive location, where they 
fuse to form a single organ. The epithelial cells of the thymic rudiment develop through 
interactions with mesenchymal cells5 and developing thymocytes6,7 to finally generate a 
three-dimensional network architecture8.
The bilobate structure of the thymus is surrounded by a thin fibrous capsule, 
invaginations of which form the septa that divide the lobes into many smaller 
pseudolobules and which carry blood vessels and nerves to the centre of the organ8. 
Every lobule comprises an outermost subcapsular region, a cortex, and an inner area, 
the medulla (Figure 1). Each of these regions contains several distinct types of thymic 
epithelial cells (TECs), creating a range of different microenvironmental niches, which 
provide signals for the developing thymocytes9. The cells that comprise the non-
lymphocytic component of the thymus are together called the thymic stroma. 
Origin of thymic progenitor cells
Shortly after the thymic anlage is formed, it is infiltrated by hematopoietic cells10-12. 
As the thymic rudiment is not yet vascularized, progenitor cells migrate into the anlage 
through the surrounding connective tissue11,13, probably guided by chemotactic factors 
secreted from the thymic epithelium14,15. 
Like all blood cells, T cells are generated from a small cohort of pluripotent 
hematopoietic stem cells (HSCs). By definition, HSCs have self-renewal capacity and 
Figure 1. Morphology of human and murine thymus. 
(A) The right thymic lobe of a 6 month-old child operated for congenital heart disease. At this age, the 
thymus contains over 2x1010 thymocytes. HE stainings of tissue sections in three different magnifications 
show the lobular structure, the cortex (C) with high cellularity and the less cell-dense medulla (M). 
Hassall’s corpuscles (H) are often found within the medulla. (B) The thymus of a 2.5 month-old (adult) 
mouse. A normal murine thymus can hold up to 2x108 thymocytes. In the tissue section, cortical stromal 
cells are specifically stained (ER-TR4 antibody), and closely surround the thymocytes.
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are pluripotent, i.e. they can give rise to cells of all hematopoietic lineages, including T 
and B cells, natural killer (NK) cells, dendritic cells (DCs), myeloid cells, erythrocytes 
and platelets16,17. The first adult-repopulating HSCs are generated in the aorta within the 
AGM (aorta-gonad-mesonephros) region at week four of gestation (mouse E10.5)18,19. 
However, umbilical and vitelline arteries, placental vasculature and the yolk sac may de 
novo generate HSCs as well. The mouse fetal liver is thought to be colonized by HSCs 
beginning at late E11 and serves as a reservoir for HSCs until the time of birth, when 
they migrate and settle in the bone marrow (BM)20.
The progenitors that colonize the thymic anlage are probably not true HSCs, but 
may have a more restricted lineage potential. T-cell committed precursors have been 
detected in the murine AGM21, fetal liver22,23 and fetal blood24. Other studies describe the 
presence in fetal blood of T/K and T/NK/DC restricted progenitors, which are assumed 
to seed the thymus25,26. In any case, B cell potential has never been detected in the fetal 
thymus27,28. 
In adults, the hematopoietic stem cells that eventually give rise to thymocytes are 
located in the BM. Progenitors within the thymus can maintain thymocyte production only 
for short periods and seeding of the thymus with BM progenitors is therefore required to 
maintain thymopoiesis throughout adult life29,30. The number of thymus-colonizing cells 
is very low, probably only a few per day29,31.
Also in the adult system, the identity of the thymus-seeding cell is unclear. In the 
mouse, several candidate thymus-colonizing progenitors have been proposed. These 
include lymphoid-restricted common lymphoid progenitors (CLPs)32, early lymphoid 
progenitors (ELPs) that have limited myeloid potential33 and multipotent Lin-Sca-1+c-
Kit+ (LSK) cells34. Even less is known about the identity of the thymus-seeding cell in 
man35.
During the early stages of T-cell development, the multipotent progenitors that 
have entered the thymus lose the ability to differentiate into multiple lineages and their 
developmental potential becomes restricted to a T-cell fate. This process is called T-cell 
commitment36. 
Stages of T-cell development 
Regardless of the identity of the seeding cell, it enters the thymus and starts T-cell 
development. The different events of T-cell development take place during a series 
of discrete phenotypic stages that can be recognized by expression of several key 
membrane molecules, mainly CD4 and CD8 (Figure 2). In both man and mouse, 
thymocytes are subsequently CD4-CD8- (double negative, DN), CD4+CD3- (human 
immature single positive, ISP) or CD8+CD3- (mouse ISP), CD4+CD8+ (double positive, 
DP) and finally CD4+CD3+ or CD8+CD3+ (single positive, SP). As CD3 is part of the 
TCR complex, its expression indicates the presence of a functional TCR on the surface 
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membrane. In the mouse, the DN subset can be further subdivided into four stages: 
CD44+CD25- (DN1), CD44+CD25+ (DN2), CD44-CD25+ (DN3) and CD44-CD25- (DN4)37. 
In man, DN thymocytes are subsequently CD34+CD1a- and CD34+CD1a+38, and finally 
they loose expression of CD34, a marker characterizing immature cells39.
The differentiation processes during T-cell development are in part guided by 
signals provided by the thymic stroma. The subsequent stages take place at defined 
anatomical sites within the thymus, which provide different external signals (Figure 2). 
Hematopoietic progenitor cells enter the thymus at the cortico-medullary junction40. 
As the numbers of progenitors that enter the thymus are very limited, a massive 
expansion takes place during the earliest stages of development. During these early 
DN stages, the thymocytes migrate to the outermost subcapsular region40. Here the 
first TCR gene rearrangements take place, which are described below. As thymocytes 
progress through the ISP and DP stages, they travel in opposite direction through the 
cortex, toward the medulla (Figure 2). Close to the cortico-medullary junction a series of 
selection processes ensues. The resulting immunocompetent medullary SP cells leave 
the thymus, at least in part via the blood41.
Movements through the thymus are mediated by chemokines secreted by and 
adhesion molecules expressed on the thymic epithelium. Migration of the earliest 
Figure 2. Schematic representation of three thymic lobules. 
(A) The stromal compartments of the thymus. Each compartment contains specialized epithelial cells 
(TECs), which provide growth and differentiation factors for developing thymocytes. (B) The different 
thymocyte subsets and their migration through the anatomic niches. The earliest (DN) thymocytes 
enter the thymus at the cortico-medullary junction and migrate to the sub-capsular zone. Thymocytes 
differentiate into DP and SP cells while passing through the cortex and the medulla. (C) The primary 
events during T-cell development. Proliferation (indicated by a curved arrow), differentiation, TCR gene 
rearrangements and selection processes take place in different microenvironments.
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progenitors toward the outer cortex is dependent on chemokine receptors CCR7 and 
CCR9 on the thymocytes42,43. CCR7 is also involved in the migration of selected SP 
cells through the medulla44. In addition, adhesion molecules such as VCAM1 on the 
thymic epithelium are likely to be involved in thymocyte migration45. 
The generation of a T-cell receptor 
The different steps of T-cell development all aim at the generation of mature T cells, 
each of which expresses a unique, self-MHC restricted and non-autoreactive TCR. This 
is achieved by random recombination of discrete TCR gene segments and subsequent 
shaping by intrathymic selection events.
TCR molecules consist of two disulfide-linked chains, either a TCRα and a TCRβ 
chain or a TCRγ and a TCRδ chain, each containing a constant and a variable domain46,47. 
The variable domain is responsible for the recognition of peptide/MHC complexes and 
is encoded by a combination of one of the many available V (variable), D (diversity, only 
for β and δ), and J (joining) gene segments. These gene segments are coupled via a 
tightly regulated series of TCR gene rearrangement steps, or V(D)J recombination, an 
example of which is depicted in Figure 3. Consequently, many different combinations 
Figure 3. Schematic diagram of sequential rearrangement steps, transcription, and translation of 
the TCRB gene during T-cell differentiation. 
In this example, first a Dβ2 to Jβ2.3 rearrangement occurs, followed by Vβ4 to Dβ2-Jβ2.3 rearrangement, 
resulting in the formation of a Vβ4Dβ2Jβ2.3 coding joint. The two extrachromosomal TCR excision 
circles (TRECs) that are formed during this recombination process are indicated as well; they contain 
the D-J signal joint and V-D signal joint, respectively. The rearranged TCRB gene is transcribed into 
precursor mRNA, spliced into mature mRNA, and finally translated into a TCRβ protein. The mature 
TCR, a dimer of a TCRα and a TCRβ chain, is expressed on the surface membrane together with the 
CD3 complex, consisting of CD3γ, CD3δ, CD3ε and CD3ζ proteins.
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of gene segments can be made, which together represent the so-called combinatorial 
repertoire of TCR molecules.
The TCR gene segments are flanked by recombination signal sequences (RSS) 
consisting of conserved palindromic heptamer and nonamer sequences, separated by 
a spacer (12 or 23 nucleotides). The two recombination activating gene (RAG) proteins 
recognize the RSS sequence and initiate the rearrangement by introducing a DNA 
double strand break between the RSS and the rearranging gene segment. This can 
then be religated to another gene segment, forming a coding joint (Figure 3). Between 
the coupled gene segments nucleotides can be deleted or randomly inserted, leading to 
imprecise coupling of gene segments. This results in the so-called junctional diversity, 
which together with the combinatorial diversity guarantees an enormous repertoire of 
over 1012 different TCR molecules.
Rearrangements of the different TCR genes occur in a fixed order. During the DN 
stages, the TCRD locus rearranges first, followed by the TCRG genes47,48 (Figure 2). 
Successful rearrangements may result in a functional γδ TCR and the development 
of a TCRγδ+ T cell. Alternatively, a cell may enter by the αβ lineage by synthesizing a 
functional β-chain, which locus starts rearranging shortly after TCRG. 
During the ISP stage, the functionality of the TCRβ chain is tested by expressing 
it on the cell surface together with the invariant pre-TCRα (pTα) chain (Figure 2), a 
process called β-selection49. Signaling by this pre-TCR complex induces the cells to 
enter the cell cycle and triggers differentiation into DP cells. Proliferation then ceases 
and TCRA gene rearrangements are initiated, starting with deletion of the TCRD gene, 
which is located between the Vα and Jα gene segments48,50. 
Productive rearrangements lead to the expression of a TCRαβ complex on the 
cell surface, which is then tested for the recognition of self-MHC molecules (positive 
selection) and absence of reactivity against self-antigens (negative selection)51. It has 
been estimated that 95% of developing thymocytes die by apoptosis52. The surviving 
cells become SP thymocytes that mature into either CD4+ T helper cells or CD8+ cytotoxic 
T cells, and migrate to the periphery as naïve recirculating T lymphocytes.
MOLECULAR REGULATION OF EARLY T-CELL DEVELOPMENT
β-selection and subsequent events are mediated by signals emanating from 
successively the pre-TCR and the TCR. The proliferation, commitment and 
rearrangement steps during early T-cell development are initiated and regulated by 
TCR-independent signals provided by the microenvironment. If a cell is receptive to a 
signal (by expressing the correct receptor), an intracellular signal transduction pathway 
is initiated and finally transcription factors will be activated. Transcription factors bind 
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to specific DNA sequences present in the core promoters or enhancers of genes, and 
thereby initiate gene-specific transcription. The coordinated expression of cohorts of 
genes will alter the phenotypical and the functional characteristics of the differentiating cell.
Regulatory signals provided by the thymic epithelium include chemokines and 
adhesion molecules, cytokines, Wnt proteins and Notch ligands. The molecular 
mechanisms of cytokines, Wnt proteins and Notch ligands, as well as their function 
during T-cell development, are described in the next paragraphs.
Cytokines
Cytokines are small soluble proteins secreted by one cell that can alter the behavior 
or properties of the same or another cell. A wide variety of soluble factors are produced 
by the thymic stroma53, but surprisingly few cytokine or cytokine receptor mutant mice 
display alterations in thymocyte development54. Three cytokines that are likely to play 
important roles during the early stages of thymic differentiation are Interleukin 7 (IL-7), 
stem cell factor (SCF, the ligand for c-Kit (CD117)), and Fms-related tyrosine kinase 3 
ligand (Flt3L, the ligand for fetal liver kinase 2 (Flk2, also called Flt3)). 
IL-7 engages a receptor complex that consists of two chains: the IL-7 receptor α (IL-
7Rα, CD127) and the common γ-chain (γc). The γc chain is also used by the receptors 
for IL-2, IL-4, IL-9, IL-15 and IL-21. Signals through the IL-7R are primarily transmitted 
by the Jak kinases Jak1 and Jak3 to the signal transduction and activator of transcription 
(STAT) 555. Mice lacking IL-7, IL-7Rα, γc chain or Jak3 all exhibit a profound reduction in 
thymic cellularity. Nevertheless, all major thymocyte subsets (except for TCRγδ+ cells) 
can be detected in such mice56,57. In remarkable contrast, human patients deficient for the 
same molecules completely lack T cells58,59. The principal function of IL-7 is supporting 
survival and proliferation of DN2 cells60. In addition, in vitro studies have suggested a 
(controversial) role for IL-7R signaling in promoting TCR rearrangements61.
c-Kit is expressed in HSCs and very early progenitors. In the thymus, expression 
is high in the earliest thymocytes and is absent from DN3 onward62. Mutations of c-Kit 
or SCF result in a ten fold decrease in HSCs and blood leukocytes, and an even more 
severe reduction in DN1 thymocytes63. Together with data from in vitro studies, this 
suggests that SCF is necessary for the expansion of the earliest thymocytes62. 
The significance of Flt3L for T-cell development is controversial, as mice deficient 
for Flk2 did not show any abnormalities in their thymus64, but adding Flt3L to cultures of 
developing thymocytes did increase thymocyte numbers65.
Wnt signaling pathway
Wnt genes encode a large family of secreted glycoproteins that regulate cell-to-cell 
interactions in many different cell types and various species66. The central player in 
the Wnt-signaling cascade (described in detail in Figure 4) is the cytoplasmic protein 
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Figure 4. The canonical Wnt signaling pathway.
Left: In the absence of Wnt binding, β-catenin is sequestered in the cytoplasm by the tumor suppressor 
proteins Axin and adenomous polyposis coli (APC)73. While present in this ‘destruction complex’, β-
catenin is phosphorylated by serine/threonine kinases casein kinase (CK) and glycogen-synthase 
kinase 3 (GSK3)74. Phosphorylated β-catenin is recognized by β-transducin-repeat-containing protein 
(β-TrCP), targeted for ubiquitination and degraded by the proteasome75. In the absence of β-catenin, 
members of the high mobility group (HMG) box containing T-cell factor/lymphocyte-enhancer-binding 
factor family (Tcf1, 3 and 4 and Lef1) are bound in the nucleus by transcriptional co-repressors (CoR) of 
the groucho family. Repression is mediated by recruitment of histon deacetylaces (HDAC)76. Right: Wnts 
bind to a receptor complex consisting of a member of the Frizzled (Fz) family of seven transmembrane 
proteins and the low-density lipoprotein receptor-related protein LRP5 or LRP6. How Wnt signals are 
transduced to the destruction complex is unclear. For sure, the Dishevelled (Dsh) protein is involved77. 
Dsh may directly interact with Fz78. In addition, LRP may directly interact with Axin79. Signaling results 
in inhibition of GSK3, which no longer can phosphorylate β-catenin, allowing accumulation of β-catenin 
and its translocation to the nucleus. Furthermore, various studies indicate that only dephosphorylated 
β-catenin is the transcriptionally active form80,81. β-catenin is targeted to the nucleus by Pygopus (pygo) 
and Legless (LGL, Bcl-9)82. Binding of β-catenin to Tcf recruits histon acetylace CBP/p30083 and Brg-
1, a component of the SWI/SNF chromatin remodeling complex84. Several factors can modulate Wnt 
signaling. For instance, interaction of Wnt with the receptor complex can be prevented by Dickkopf 
(Dkk), which binds to the LRP co-receptor85. Binding of β-catenin to Tcf/Lef can be inhibited by the 
nuclear protein Chibby86. Many other factors, known and yet unknown, may be involved in this pathway. 
Next to the canonical Wnt-signaling pathway, β-catenin independent mechanisms exist (reviewed in 
reference 87), but their implications for T-cell development have not been studied extensively.
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β-catenin. In the absence of Wnt signaling, β-catenin is present in a cytoplasmic 
‘destruction complex’ and is continuously phosphorylated and degraded. When a Wnt 
protein binds to the receptor complex consisting of a Frizzled (Fz) receptor67 and a 
low-density lipoprotein (LDL) receptor-related protein (LRP5 or LRP6)68, β-catenin is 
no longer phosphorylated and translocates to the nucleus, where it activates Tcf/Lef 
transcription factors69,70, in thymocytes predominantly Tcf171,72. 
In the thymus, Wnt proteins are mainly produced by the thymic epithelium, but to some 
extent also by the thymocytes88-90. Conversely, Fz receptors are expressed primarily by 
the thymocytes, but also by stromal cells88,89. Not much is known about which Wnts 
bind to which receptors. Biochemical studies are complicated by the fact that Wnts are 
palmitoylated and as a result hydrophobic and difficult to isolate91. Thus far, only Wnt3a 
has been produced as a recombinant protein91. This also complicates the direct analysis 
of the effects of Wnt proteins on developing T cells in vitro. Nevertheless, numerous 
studies have now revealed functional roles for several Wnt signaling components in 
T-cell development. 
Using a Tcf reporter construct, in which expression of a reporter gene is turned on 
when Wnt signaling occurs in a cell, it was demonstrated that developing thymocytes can 
respond to Wnt signals in in vitro cultures88. Retroviral transduction of fetal thymocytes 
with Wnt1 and Wnt4 increased their proliferation in culture. Furthermore, blocking Wnt 
binding using soluble Fz receptors completely inhibited T-cell development at the DN 
and ISP stages88. The requirement of Wnt proteins for thymocytes was confirmed in 
vivo, by showing that mice deficient for both Wnt1 and Wnt4 have about 50% of the 
normal thymic cell numbers92. This relatively mild reduction, combined with the fact that 
thymocyte subset distribution was normal in these mice, points out that different Wnt 
proteins are functionally redundant. The significance of Fz receptors in thymocytes was 
also indicated by the accelerated thymic atrophy observed in mice deficient for Fz993. 
But again the mild defect emphasizes the involvement of multiple Fz. 
Of the downstream Wnt signaling components, Tcf1 has been most extensively 
studied. Two different Tcf1 mutant mice have been described, targeting either exon 
5 (Tcf1(V)) or exon 7 (Tcf1(VII))94. In Tcf1(V) mutant mice, a low level of a truncated 
yet functional Tcf1 is still expressed, whereas the Tcf1(VII) mutation abolishes the 
DNA-binding activity of Tcf1 completely and is therefore regarded as a true Tcf1 null 
mutant. Young Tcf1 deficient mice have an incomplete block at the DN1, DN2 and 
ISP stages, while older mice display a complete block at the DN1 stage of thymocyte 
development94,95. 
Although Lef1 knock-outs have normal T-cell development96, Lef1/Tcf1(V) double 
deficient mice display a complete block in T-cell differentiation at the ISP stage97, 
showing the redundancy of these factors during thymocyte development. 
The critical role of Tcf1 in T-cell development may also lie in Wnt independent 
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functions, for instance as transcriptional repressor. However, β-catenin binding to Tcf1 is 
essential for thymocyte differentiation, as only Tcf isoforms which contain the N-terminal 
β-catenin binding domain could rescue the thymic defect in Tcf1(VII) mice88,98.
The importance of β-catenin for T-cell development is controversial. Presence of 
β-catenin mRNA was detected in all thymoycte subsets89. Mice with β-catenin deleted 
in all T-cells from DN3 onwards showed impaired T-cell development at the β-selection 
checkpoint99, but mice transplanted with hematopoietic stem cells in which β-catenin had 
been inducibly deleted, did not show in any thymic defect100. As possible explanation, 
redundancy between β-catenin and its homologue plakoglobin (γ-catenin) has been 
suggested. Irradiated mice reconstituted with plakoglobin-deficient fetal liver cells did 
not display marked defects in T-cell development, only a slightly reduced survival of 
DN3 and DN4 thymocytes101. Nevertheless, mice overexpressing Axin, one of the 
components of the β-catenin destruction complex, exhibited reduced cell numbers and 
increased apoptosis in their thymus102.
The question remains why the Wnt pathway is important for T-cell development. The 
above-described studies suggest that Wnt signaling affects those stages of thymocyte 
differentiation where proliferation occurs. A role for Wnt proteins in inducing proliferation 
would fit with the assumed function of Wnt signaling in stem cell self-renewal103. Wnt 
signaling does probably not directly induce a T-cell program, as transcription of T-cell 
specific genes and rearrangement of the TCRB genes is unaffected in Tcf/Lef deficient 
mice97. Furthermore, transplantation of irradiated mice with HSCs that overexpress a 
constitutively active form of β-catenin, lead to better reconstitution of all hematopoietic 
lineages, not preferentially T cells104. 
Additional roles for Wnt signaling have been reported in more mature stages of 
thymocyte development 98,99,101,105,106. In these subsets, Wnts probably block apoptosis 
rather than inducing proliferation. 
Wnt proteins are not only important for developing thymocytes, but also for thymic 
epithelial cells, in which expression of Fz receptors has been demonstrated as well89. 
Thus, Wnt proteins may provide part of the ‘cross-talk’ that exists between thymocytes 
and their microenvironment7. Interestingly, the expression in thymic epithelium of 
FoxN1, the transcription factor defective in a-thymic nude mice, is regulated by Wnt 
signaling90. 
Notch signaling pathway
The Notch signal transduction pathway is an evolutionary conserved mechanism 
that regulates cell fate determination during developmental processes107. The first 
indications that Notch might be involved in T-cell development, came from the finding 
that a part of the NOTCH gene (then termed TAN-1) is translocated to the TCRB locus in 
rare cases of human T-cell acute lymphoblastic leukemia (T-ALL)108. Later it was shown 
Chapter 1
22
that a large proportion of human T-ALLs have activating mutations in the NOTCH1 
gene109. The Notch family of transmembrane receptor consists of four members, Notch1 
to 4, which can bind to the ligands Delta1, 3 and 4 and Jagged1 and 2. Signaling occurs 
via a unique mechanism, in which part of the receptor (intracellular Notch; IC-Notch) 
functions as a transcriptional activator. The pathway is described in detail in Figure 5. 
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Figure 5. The Notch signaling pathway. 
The Notch receptor consists of a large extracellular part containing multiple EGF-like repeats110 and 
an intracellular part that includes several functional domains mediating Notch signal transduction. 
The glycosylation status of the Notch receptor can be modified by Fringe proteins (manic, lunatic and 
radical Fringe), thereby influencing ligand binding111. Ligands are of the Delta/Serrate/LAG-2 (DSL) 
family107. Interaction of Notch with a ligand can induce proteolytic cleavage of Notch, successively by 
metalloprotease and γ-secretase activities112,113, releasing the intracellular part of the protein (intracellular 
(IC-) Notch). IC-Notch then translocates to the nucleus and binds to the nuclear transcription factor CSL 
(CBF/Suppressor of Hairless/Lag-1; in human usually called CBF1, in mouse RBP-Jκ)114. Deltex1115 and 
Numb116 are cytoplasmic regulators of Notch signaling.
Binding of IC-Notch to CSL induces the dislocation of co-repressors (coR) such as Msx2-interacting 
nuclear target protein (Mint117) and Notch-regulated ankyrin-repeat protein (Nrarp118), and recruitment 
of co-activators (coA), such as Mastermind (Maml119), and stimulates the transcription of Notch target 
genes. The best known Notch-target gene is HES1 (Hairy-Enhancer of Split 1)120, but undoubtedly many 
others exist. Several reports suggest alternative Notch signaling pathways which are CSL-independent 
and may involve Deltex as an effector protein121.
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In contrast to cytokines and Wnt proteins, the ligands that induce Notch signaling 
are not secreted, but rather expressed on the membrane of thymic epithelial cells. High 
levels of Notch ligands Jagged1 and 2 and Delta1 and 4 are expressed in the fetal and 
adult murine thymus27,122-124. Expression of Notch ligands has been reported in murine 
and human BM stroma (Jagged 1125,126) and murine fetal liver (mainly Delta1 and 427) as 
well. Notch receptors are expressed by hematopoietic progenitor cells in the BM and 
fetal liver123,127-129 and by DN thymocytes (predominantly Notch1 and 3124,129,130).
When Notch-expressing hematopoietic progenitor cells enter the thymic micro-
environment and interact with Notch ligands on the thymic epithelium, they immediately 
start expressing Notch target genes123. This Notch signal is essential for the induction 
of a T-cell fate in these cells. This was first demonstrated in mice in which the NOTCH1 
gene was conditionally deleted, resulting in a complete block in T-cell development at the 
DN1 stage131 and the emergence of ectopic B-cell development in the thymus132. These 
effects are mediated by Notch1 signaling through CSL, since CSL deficient mice display 
a similar phenotype133. Conversely, BM reconstitution of mice with cells transduced with 
IC-Notch instructed a T-cell fate in BM progenitors and inhibited B-cell development134. 
Similar results were obtained when mice were transplanted with human hematopoietic 
progenitors overexpressing IC-Notch1 or 4127,135. 
The expression of the different Notch ligands and their receptors in a stage- and 
tissue-specific manner raises the possibility of a unique function for each ligand124. 
However, the mechanisms by which specific ligands induce different cellular fates 
remain unclear. 
Transplantation of mice with progenitors overexpressing Delta1 or 4 phenocopied 
the effect of overexpression of IC-Notch: DP cells emerged in the BM136,137. In vitro, this 
phenomenon can be mimicked using BM–derived stromal cell lines which otherwise 
promote myeloid and B-cell development of hematopoietic progenitor cells. Forced 
expression of Delta1 in these stromal cell lines induces murine and human progenitor 
cells to develop into T cells, in some studies up to DP and SP stages138-141. This co-
culture system will be described in detail in the next paragraph. The striking T-cell 
generating effect of Delta could not be reproduced by expression of Jagged in stroma 
cell lines138, although Jagged did inhibit development into B cells140. Furthermore, αβ T 
cell development was normal in Jagged2 deficient mice142. Signals induced by Jagged 
possibly promote NK cell or TCRγδ+ cell differentiation140,142,143.
To further complicate matters, stable induction of a T-cell fate by Delta is dependent 
on contact time144 and density of ligands, with lower doses of Delta also promoting B-cell 
development145. Furthermore, the interaction of Notch with the different ligands can be 
modulated by Fringe proteins111. Overexpression in the thymus of Lunatic Fringe, which 
is thought to inhibit Notch activation by Jagged and facilitate interaction with Delta146, 
blocked T-cell commitment147. This finding suggested that Notch signals activated by 
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Jagged might be functionally more important for thymocytes than signaling through 
Delta.
The downstream mechanisms by which a Notch signal is translated into a T-cell 
program are still largely unclear. The best known Notch target genes encode Hairy-
Enhancer of Split (Hes)1 and 5 and Hes-related repressor protein (Herp), basic-helix-
loop-helix (bHLH) proteins that function as transcriptional repressors120,148. Indeed, 
overexpression of Hes1 and Hes5 in the BM partly inhibits B-cell development149. But 
although proliferation of early thymocytes is severely affected by Hes1 deficiency150,151, 
thymocytes do develop in these mice. Hes1 can therefore not be the sole target of 
Notch signaling in the thymus.
Like Wnt signaling, the Notch pathway has also been implicated in later stages of T-
cell development, mostly in the DN to DP transition118,152-154. Furthermore, mice in which 
Notch1 was deleted after the T/B-fate choice (Lck-cre x Notch1lox/lox) show a complex 
phenotype which suggests that Notch1 contributes to both V to DJ rearrangement of the 
TCRB locus as well as to the physical elimination of cells which fail β-selection155. 
There are conflicting data on a function of Notch signalling in promoting αβ T cell 
development at the expense of γδ T cells155-157 and in the selection between CD4 and 
CD8 SP thymocytes153,154,158-160. 
Other transcription factors
Next to Tcf1 and CSL, numerous other transcription factors have been described 
to be involved in T-cell development (reviewed by Rothenberg and Taghon161). Among 
the transcription factors that are crucial for the early stages of T-cell differentiation are 
GATA3 and bHLH factors. 
GATA3 is a member of a transcription factor family that binds a GATA-consensus 
motif through a highly conserved zinc finger binding domain162. Within the hematopoietic 
system, GATA3 expression is confined to multipotent progenitors, T lymphocytes and 
NK cells163-165. Germline knock-out experiments show that GATA3 is critical for the 
generation of any identifiable T-cell precursors, even DN1 cells164. Furthermore GATA3 
is necessary for normal β-selection, proliferation in the DN to DP transition, development 
of CD4 SP cells and for survival and differentiation of peripheral T cells166-169.
The class I bHLH proteins, also known as E-box proteins, comprise E2A, HEB and 
E2-2, which bind DNA as homo- or heterodimers170. Of these transcription factors, E2A 
and HEB have been shown to be involved in T-cell differentiation. Overexpression of 
dominant negative mutants of HEB or any of the Id factors (HLH factors lacking the basic 
DNA-binding domain which heterodimerize with E-box proteins) completely blocks T-
cell development at the DN stage171-173.
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T-CELL DEVELOPMENT IN VITRO 
Studies of developmental processes, especially of human cells, call for the use of 
in vitro culture systems. B-cell development can be readily reproduced in vitro with the 
use of BM-derived stromal cell lines and the addition of defined sets of cytokines174. 
Myeloid and erythroid differentiation events can be studied in culture dishes that contain 
a mixture of defined cytokines in a semisolid medium (colony assays)175. However, 
until recently, the only way to induce T-cell development in vitro was to culture cells 
in a real thymic microenvironment by use of fetal thymic organ cultures (FTOCs)176. 
For this purpose, fetal thymic lobes of day 14 (E14) of gestation are isolated from 
mouse embryos. Around E14, the thymic anlage is colonized by progenitors from the 
hematopoietic tissues, implying that at this time-point the microenvironment is receptive 
for hematopoietic cells. E14 thymic rudiments are about one millimeter in diameter, 
demanding the use of a microscope. Lobes are depleted of endogenous thymocytes 
by treatment with deoxyguanosine177 or by γ-irradiation178 and the ‘empty’ lobes can be 
reconstituted with defined subsets of murine or human progenitor cells. This can be 
achieved using the ‘hanging drop’ method, although the inoculation of precursors via 
microinjection is more efficient179. The reconstituted lobes are maintained at an air/liquid 
interface by culturing them on polycarbonate filters.
FTOC is readily manipulable and allow analysis of the effects of reagents such 
as pharmacological inhibitors, neutralising antibodies and cytokines. Furthermore it 
facilitates study of the molecular regulation of T-cell development using retro- or lentiviral 
infection of precursors prior to their introduction into thymic lobes178,180. Finally, the roles 
of individual stromal cell components can be studied using a modified form of FTOC: 
reaggregate thymus organ cultures (RTOCs)5. For this purpose, the desired stromal 
cells are isolated and spun down together with thymocytes to form a pellet, which is 
cultured on a filter.
Disadvantages of the FTOC system are the cumbersome set up and the limited 
cellular yield. Recently, a culture system became available that demonstrated that a 
three-dimensional thymic architecture is not absolutely required for T-cell development. 
This culture system employs the OP9 stromal cell line that was originally derived from 
the BM of mice deficient in macrophage colony-stimulating factor (MCSF). The lack of 
MCSF expression contributed to the ability of OP9 cells to support B-cell differentiation 
from HSCs by limiting the clonal expansion of myeloid cells which interfere with 
lymphopoiesis181. By retrovirally introducing Notch ligand Delta1 in this cell line, the 
OP9 cells lost the ability to support B-cell development from HSCs and acquired the 
capacity to induce a normal program of T-cell differentiation from HSCs, including DP 
and CD8+ SP stages141. No CD4+ SP cells can be generated in this model because of 
the lack of MHC class II expression. Cultures are performed in the presence of IL-7 and 
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Flt3L. A range of different cell types has now been shown to be able to develop into T 
cells in this culture system, including mouse fetal liver and BM HSCs, embryonic stem 
cells and progenitors from human cord blood139,141,182. 
Comparable experiments have been performed with the BM stromal cell line S17138. 
However, although unmodified OP9 and S17 stromal cells appeared to function equally 
well in generating large numbers of B cells, OP9-Delta1 stromal cells were vastly 
superior in their ability to generate DP T cells compared to S17-Delta1141. This finding 
raises the important point that there is more to making T cells than the mere presence 
or absence of a Notch signal.
OUTLINE OF THE THESIS
The strictly controlled processes of T-cell development in the thymus are aimed 
at the generation of functionally mature T cells with a broad TCR repertoire, that can 
respond correctly and efficiently against invading pathogens. Errors occurring during 
certain events or stages of T-cell differentiation may lead to the development of diseases 
as diverse as leukemia, immunodeficiency or autoimmune disease. The objective of the 
research described in this thesis is to increase our knowledge of T-cell differentiation, 
with emphasis on human thymocyte development. 
Chapter 2 describes the relative and absolute contribution of the different thymocyte 
subsets to the human thymus and how these change as children age. In Chapter 3 
the thymocyte subsets are molecularly characterized in detail. Quantitative TCR gene 
rearrangement studies and gene expression profiling using microarrays are employed 
to obtain more insight into the initiation and regulation of TCR gene rearrangements. In 
Chapter 4, lineage potential and self-renewal capacity of two very immature thymocyte 
subsets are studied, with the goal of providing insight into the identity of progenitor cells 
that seed the thymus. 
Chapters 5 to 8 go into the molecular regulation of T-cell development. As explained 
above, the Wnt and Notch pathways are crucial for the proliferation and differentiation of 
immature thymocytes. Chapter 5 examines, both in the human and the murine thymus, 
which thymocyte populations undergo Wnt signaling and how this is molecularly 
determined. In Chapter 6, target genes of the Wnt signaling pathway in human 
thymocytes are identified, which appear to be involved in proliferation and adhesion. 
The effect of the absence of a specific Wnt gene is investigated in Chapter 7, using a 
mouse deficient for Wnt3a. Wnt3a is demonstrated to be important not only for T-cell 
development, but for other hematopoietic lineages and stem cells as well. Chapter 8 is 
about the Notch signaling pathway: target genes of Notch signaling are determined in 
human progenitor cells and their contribution to T-cell development is evaluated. 
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Finally, Chapter 9 discusses the significance of the results described in chapters 2-8, 
with emphasis on T-cell commitment, and provides directions for future investigations.
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ABSTRACT
Background: T-cell development in the thymus is an extensively studied subject, 
mainly in mice. Nevertheless, the normal composition and cell numbers of the non-
involuted human thymus are largely unknown. 
Objective: We aimed to gain insight into age related changes in different thymic 
subpopulations and to provide reference values for the distribution of thymocyte 
subsets. The composition of the normal thymus may serve as a reference for thymi in 
pathological conditions and may aid to diagnoses of immunodeficiency diseases.
Methods: Thymic lobes of 70 children (58 ‘immunologically normal’ and 12 ‘diseased’), 
ranging in age from 8 days to 8 years old, were studied by four-color flowcytometric 
analysis. Detailed staining and gating strategies allowed us to dissect small subsets, 
including immature CD4-CD8- populations and thymic B, NK and TCRγδ+ cells.
Results: We demonstrate that distribution of thymocyte subsets changes with age 
and correlates with age-related fluctuations of T-lymphocyte counts in peripheral blood. 
Thymi of children 3 to 6 months of age appear to be the most active: they have high 
numbers of total thymocytes, the highest percentage of double positive cells, and large 
numbers of CD34+ progenitors in their thymi. Furthermore, we show that the human 
thymus is a site for B-cell development, as all B-cell progenitor stages that can be found 
in the bone marrow are also present in the thymus. 
Conclusion: We conclude that T-cell development in children is a dynamic process, 
answering to the demands of a maturing and expanding immune system.
INTRODUCTION
The thymus is a primary lymphoid organ that provides a unique microenvironment for 
the development of bone marrow derived progenitors into mature T cells1. In the thymus, 
thymocytes proliferate and differentiate, passing through a series of discrete phenotypic 
stages, during which they undergo T-cell receptor (TCR) gene rearrangements and 
positive and negative selection events, which form the TCR repertoire. A TCR molecule 
consists of either an α- and a β-chain or a γ- and a δ-chain. TCRαβ+ cells are by far 
the most abundant T cells in the thymus and peripheral blood. The γδ lineage probably 
branches off early in the DN stage2.
In man, the thymus is fully developed before birth in terms of the presence of all 
major subpopulations, including the most mature cells3. The rate of T-cell production by 
the thymus is greatest during childhood, when the peripheral TCR repertoire is being 
established due to antigenic pressure. After puberty, thymocyte numbers drastically 
decrease, although the thymus remains functional until old age4-7. 
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Relatively little is known about the normal cell numbers and composition of the 
human thymus and how these parameters change during childhood. Apart from studies 
using TCR gene rearrangement excision circles (TRECs) to quantify recent thymic 
emigrants in peripheral blood both in adults and children7-9, correlations between T cell 
numbers in peripheral blood and the cellular composition of the thymus in children have 
not been investigated.
We studied thymic lobes of 58 immunologically healthy children, ranging in age from 
8 days to 8 years. Because of the considerable size of this group, we were able to give 
reference values, both for absolute numbers of thymocytes per lobe and for relative 
contributions of thymocyte subpopulations. These reference values may add to the 
diagnosis of complicated diseases, such as primary immunodeficiencies (e.g. SCID). 
A recent report10 shows that a thymic biopsy may be a realistic tool for the diagnosis of 
such pathologies. Furthermore, detailed four-color flowcytometric analysis enabled us 
to investigate the normal existence of small subpopulations of great biological interest, 
like immature single positive cells (ISPs), TCRγδ+ cells, immature T cell populations, 
and thymic B and NK cells. In addition to the description of healthy thymi, we show how 
the thymus differs in pathological conditions. 
RESULTS
Thymic cellularity changes with age 
We first investigated whether age dependent differences in thymic cellularity (here 
defined as total cell numbers) occurred. The absolute number of thymocytes per thymic 
lobe was plotted against the age of each child (Figure 1A) and the median and 10th 
and 90th percentiles were calculated for 6 age groups (Figure 1B). The number of cells 
per thymus appeared to be the lowest in the first two age groups, particularly in the 
neonates until 11 days, and increased gradually with age. The maximum cellularity was 
reached at 6 months of age, after which it again decreased. Significant differences were 
observed between the youngest age group and all other age groups over 3 months of 
age. Furthermore the 1 to 3 months age group had significantly lower cell numbers than 
the 6 to 9 month group (p<0.01). 
The thymus of the patient suffering from protracted Rotavirus infection had extremely 
low thymocyte numbers. Children with Down syndrome tended to have lower thymocyte 
numbers: 5 out of 10 Down syndrome patients were below the 10th percentile of their 
age group. 
No significant differences in cell numbers (nor in any subsequent flowcytometric 
assay) could be detected between boys and girls (data not shown).
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Distribution of major thymocyte subpopulations
To determine the relative distribution of thymocyte subsets and to investigate 
whether this changes with age, flowcytometric analysis of thymocyte populations was 
performed. Median values and ranges in six age groups for every subset described 
are listed in Table I. Thymocytes were stained for CD4, CD8 and CD3, to determine 
the 5 ‘classical’ subsets: during thymocyte development cells are successively double 
negative (DN), immature single positive (ISP), double positive (DP) and CD4 or CD8 
single positive (SP) (Figure 2A). 
The percentage of DN cells was highest in the youngest age group, especially in the 
youngest neonates (Figure 2B and C). It was lowest in the 3-6 months group (p=0.013 
versus 0-1 month group and p=0.001 versus 1.5-8 years group). The youngest children 
Figure 1. Thymic cellularity is age dependent. 
(A) Total thymocyte numbers per thymic lobe in ‘normal’ (black dots) and ‘diseased’ (open symbols) 
children, plotted against the log age of each child. (B) Median total thymocyte numbers of healthy 
children in 6 age groups. Grey bars show 10th and 90th percentiles. Kruskal-Wallis test: p=0.011.
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had the lowest percentage of DP cells (median 57.4%), subsequently increasing until 
76.3% in age group 3-6 months (Figure 2B). Variations in the percentage of DP cells 
were probably not stress-related, as in a different study no correlation was detected 
between the proportion of DP thymocytes and serum cortisol levels12.
SP cells represent the most mature T cell population in the thymus. Both CD4 and 
CD8 SP populations were significantly higher in the youngest age group (Figure 2B). 
The ratio of CD4 SP versus CD8 SP gradually decreased with age (Figure 3), starting at 
2.5 and reaching a ratio of 1.3 in the oldest age group. This decrease in CD4/CD8 ratio 
correlated remarkably well with that in peripheral blood of a different group of children 
(Figure 3, R=0.92). 
Finally we determined whether the distribution of the ‘classical’ thymocyte subsets 
was influenced by disease conditions. Although the thymic composition of Down and 
Figure 2. Distribution of ‘classical’ subsets is age dependent. 
(A) Contourplot of a representative thymus sample (age 6 months). In the left panel CD4-CD8- (DN) 
cells, CD4+CD8+ (DP) cells, and CD8+4- (CD8 SP) cells can be distinguished. The CD4+8- population can 
be further subdivided in CD4+3- (ISP) cells and CD4+3+ (CD4 SP) cells (right panel). (B) Median values 
of percentage DN, ISP, DP and SP within the total thymocyte population in each age group. Significant 
differences between groups exist for DN cells (p=0.002), CD4 SP (p=0.03) and CD8 SP (p=0.037). (C) 
Percentages of DN cells within the total thymocyte population in ‘normal’ (black dots) and ‘diseased’ 
(open symbols) children, versus the log age. 
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Williams syndrome children did not differ in these aspects (Figure 2C), the patient with 
Rotavirus infection appeared to have a very high percentage of DN cells, associated 
with a low percentage of DP cells. 
Early T-cell precursors
Since we found that the youngest children had the highest percentage of DN cells, 
the most immature ‘classical’ subset, we wanted to investigate whether the cells within 
this subset are also more immature in young children than at later ages. Therefore we 
stained thymocytes with CD34 and CD1a (Figure 4A). The most immature, ‘stem cell 
like’ cells in the thymus are CD34 positive and CD1a negative. One stage later, when 
the cells are committed to the T cell lineage, they become CD1a positive13,14. In the most 
Figure 4. Distribution of early progenitors is age dependent. 
(A) Contourplot of a representative thymus sample (age 6 months). CD34 and CD1a staining within 
the DN gate. (B) Median percentages of CD34+CD1a-, CD34+CD1a+ and total CD34- cells within the 
DN population in each age group. Significant differences between groups were found for CD34+CD1a- 
(p=0.039) and CD34+CD1a+ (p=0.001).
Figure 3. High correlation between CD4/CD8 ratios in thymus and blood. 
Ratios of CD4+ SP/CD8+ SP cells in thymus (left panel) and CD4+/CD8+ T cells in peripheral blood (right 
panel) in 6 age groups.
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mature DN stages, the cells lose expression of CD34, but they stay positive for CD1a.
Surprisingly, the percentage of CD34 positive cells within the DN population was 
not highest in the youngest age group, but instead significantly peaked at age 3-6 
months (p=0.003 versus age group 0-1 month) (Figure 4B). After 6 months of age, the 
percentage of CD34+ cells within the DN population tended to decline. 
Expression of αβ and γδ T-cell receptors
DP T cells undergo positive and negative selection and only the surviving cells will start 
expressing high levels of TCRαβ molecules. Therefore we determined the percentage of 
DP cells that are TCRαβ+ in thymi of different ages (Figure 5). No significant difference 
could be distinguished in expression of TCRαβ between the different age groups. 
As it has been described that individuals with Down syndrome have lower numbers 
of TCRαβ+ cells15, we investigated whether this could be confirmed in our subject group 
as well. Surprisingly, the children with Down syndrome appeared to have high numbers 
of DP cells positive for TCRαβ (Figure 5). The same was true when regarding all 
thymocytes (data not shown). 
The percentage of TCRγδ+ cells was around 0.3% in all age groups (Figure 6A) and 
not significantly higher in the youngest age group. This was an unexpected finding, 
since TCRγδ+ cells are the first T cells to appear during fetal development16. On the 
other hand, the relative contribution of TCRγδ+ cells from thymic and extra-thymic origin 
is unknown, although an extra-thymic origin is controversial17. In any case, our finding 
corresponded with TCRγδ+ cell numbers in blood, which were relatively low in the first 
age groups (Figure 6B).
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Figure 5. TCRαβ+ cells in the thymus. 
Percentages of TCRαβ+ cells within the DP population in ‘normal’ (black dots) and ‘diseased’ (open 
symbols) children versus the age of each child. 
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B and NK cells
To investigate whether B and NK cells are present in human pediatric thymus 
samples, thymocytes were stained with B cell marker CD19 and NK cell markers CD16 
and CD56. Among total thymocytes, about 0.4% comprised B cells and 0.1% NK cells 
(Figure 7A). The percentage of B cells was significantly higher in the two eldest age 
groups, while the percentage of NK cells was highest in the youngest age group and 
more or less stable in the later age groups. The latter finding reflects the situation in 
the blood, where NK cell numbers are also highest in the youngest children 11. In the 
thymus as well as in blood, the variation in NK cell numbers was very high in the first 
age group. The presence of thymic B cells was confirmed by immunohistochemistry of 
three different thymi. B cells were found to comprise about 25% of the thymic medullary 
cells, while the cortex contained only a few scattered B cells (Figure 7B).
The majority of the B and NK cells that are present in the thymus are not a result of 
blood contamination, as the estimated absolute number of blood derived B or NK cells 
(blood volume calculated by measuring the number of erythrocytes per thymic lobe), 
was always 50 to 100 times lower than the absolute number that we found. However, 
it does not indicate whether these cells have originated in the thymus or whether they 
have preferentially migrated to or expanded in the thymus. 
To determine whether B-cell precursors are present in the thymus, we stained 3 
thymi of different ages with markers for immature B cells. During B-cell development in 
the bone marrow, CD19 positive B cells are first CD10 positive, CD20 negative18. They 
then become positive for both CD20 and CD10 and finally they lose expression of CD10. 
Figure 6. TCRγδ+ cells in the thymus.
(A) Median percentage of TCRγδ+ cells within the total thymocyte population was determined for healthy 
children divided into 6 age groups. Black lines represent median values for each age group and dotted 
bars show 10th and 90th percentiles. Differences between groups were not significant. (B) Percentage 
of TCRγδ+ within the CD3+ population in peripheral blood. Median percentages and 10th and 90th 
percentiles are indicated. Kruskal-Wallis test: p<0.001.
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Figure 7. B and NK (precursor) cells in the thymus. 
(A) Median percentage and 10th and 90th percentiles of B and NK cells within the total thymocyte 
population. Differences between groups were significant for B cells (p=0.005), but not for NK cells. 
(B) Thymic tissue sections stained for CD20 (left panel) or isotype control (right panel). Similar results 
were obtained with a CD19 antibody (not shown). C: cortex, M: medulla, H: Hassall’s corpuscle. (C) 
Contourplots of a representative thymus sample stained with CD10 and CD20 within the CD19+ gate 
(lower left panel) and with CD34 within both the CD19+ gate (lower right panel) and the CD16/56+ gate 
(upper right panel). (D) Representative contour plot of a normal pediatric bone marrow. Expression of 
CD10 and CD20 within the CD19+ gate.
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In the thymus all these stages could be distinguished within the CD19 gate (Figure 7C), 
displaying populations phenotypically similar to those in normal bone marrow (Figure 
7D). By staining with CD34 and gating on CD19 or CD16/CD56 positive cells (Figure 
7C), we showed that the human thymus contains stem cell like cells expressing lineage 
markers for B and NK cells. Together these data demonstrate that the thymus is a site 
for B and NK cell development.
DISCUSSION
The normal composition of the human pediatric thymus is a neglected subject, 
despite the large scientific interest in T-cell development. In this paper, we studied the 
thymic cellularity and used four-color flowcytometry to determine subset distribution of 
thymic lobes of 58 ‘immunologically normal’ children, ranging in age from 8 days to 8 
years. The considerable size of our subject group allows us to give reference values for 
a number of thymic subsets and to make statements that are of value both for general 
knowledge about T-cell development as well as for clinical purposes, although caution 
should be taken as the children in our control group are not healthy but suffer from 
congenital heart disease. Nevertheless, none of their cardiac defects are likely to have 
influenced the immune system. A part of these children were cyanotic before surgery. 
However, no differences in thymic subset distribution were observed between cyanotic 
and normally saturated children (data not shown). 
Apart from studies examining post-mortem thymi19,20, we know of no reports that 
determine total thymocyte numbers in thymi from healthy individuals. Two studies 
employ the elegant approach of analyzing cellular density per gram of thymus material4,5, 
but this method does not take into account age related changes in total volume of the 
thymus, and therefore cannot determine total thymocyte numbers. Since we always 
received a complete thymic lobe after surgery, we were able to calculate the total cell 
number per thymic lobe.
In a few studies, thymic material from children was examined by flow cytometry4,5,12, 
although from different viewpoints. Varas et al. compared thymus material of 9 neonates 
(age 1 to 20 days) and 11 children (age 1 month to 10 years)12 and Marusic et al. 
included 11 children (age 1 to 14 years) in their study of 39, mostly adult, thymi4. Both 
these studies employed 2 or 3 color flow cytometry and mainly analyzed the large (e.g. 
DN, DP) thymocyte subsets.
Consistent with the study of Varas et al.12, we found that thymi of infants until one 
month of age (neonates) differed from the other age groups, especially with respect 
to lower total cell numbers and relatively low percentage of DP cells. In particular the 
8- to 11-day-old children were very similar to the neonates described by Varas et al. 
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However, these differences were not observed in all children below one month of age. 
Two children within this age group (25 and 26 days) fit more into the second age group, 
suggesting that the shift from a neonatal to a childhood thymic phenotype probably 
takes place around 3 weeks of age. 
Unlike Varas et al.12, we did not find increased numbers of very immature cells in 
neonates. In our study, the percentage CD34+ cells is relatively low in neonates and 
increases at 3 months of age. This difference in observation may be due to the fact that 
Varas et al. do not subdivide the children over one month into age groups, and to the 
higher average age of the children in their study (23.4 months versus 13.1 months in 
our study). 
Besides neonates, the age group of 3-6 months deviates most from all other groups. 
These children have high numbers of total thymocytes, the highest percentage of DP 
cells and the highest percentage of stem cells within the DN subset. Together these 
characteristics reflect a very active thymus of children encountering many antigens and 
establishing an extensive T cell receptor repertoire. This active thymus is mirrored by 
the high T cell numbers in peripheral blood of children of the same age11. 
Together, these results show that T-cell development during childhood is not merely 
a continuous process from a build up of T cells to the start of thymic involution, but 
rather a dynamic process, that fluctuates in response to the demands of the maturing 
and expanding peripheral immune system.
The bone marrow is the predominant site for B- and NK-cell development. However, 
data in mice have demonstrated that B cells can develop in the thymus21 and it is known 
that NK cells can develop in the fetal thymic microenvironment22,23. We could detect low 
percentages of NK cells and B cells in the thymus in all age groups. Presence of B cells 
in the human thymus has been reported24,25, but their origin remains controversial. 
In our study, we demonstrate that B cell precursors can be found in the human 
thymus. These cells were not derived from the blood, as CD10 positive B cells are 
virtually absent in peripheral blood, with the sole exception of leukemia patients after 
chemotherapy cessation26. Thus, our study extends the finding of B-cell development in 
the murine thymus to the human situation. The presence of NK cell precursors suggests 
that the origin of (a part of) the thymic NK cells lies in the thymus as well.
Analysis of a large group of healthy thymi allows us to draw conclusions about the 
thymus in disease states. The dramatic effects that infections can have on the thymus, 
are exemplified by the patient in our study suffering from a protracted Rotavirus infection. 
This child’s thymus had an extremely low cellularity and contained high percentages of 
DN and SP cells, reflecting very low numbers of DP cells. However, more samples from 
patients with ongoing infection would be needed to confirm this finding. In addition, 
we studied the thymus in children with Down and Williams syndrome, both mental 
retardation syndromes that often involve cardiac complications. Down syndrome 
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patients are known to have small and abnormal thymi27, which is probably due to 
increased apoptosis caused by overexpression of copper-zinc superoxide dismutase28. 
In accordance with these studies, we find lower numbers of total thymocytes in Down 
syndrome patients (p=0.052 for age group 3-6 months). Consistent with the findings of 
Murphy and Epstein15, we find no differences in subset distributions in thymi of children 
with Down syndrome. However we do not find the diminished percentage of TCRαβ+ 
cells that they report. No data about the thymus in Williams syndrome have been 
reported. For our single Williams syndrome patient we show that subset distribution is 
within the normal range, but that total thymocytes counts are lower than in age matched 
controls. 
Although unorthodox, a thymic biopsy is feasible as a recent paper demonstrates10, 
and may add greatly to the diagnosis of immunodeficiency diseases. Differential 
presence of specific subpopulations as compared to our reference values can indicate 
the defects in T-cell development and may even give clues as to which gene defect 
would be the cause of the immunodeficiency. 
In conclusion, our paper provides age dependent reference values for the normal 
composition of the human pediatric thymus. These are of value for in vitro studies of 
human T-cell development using fetal thymic organ culture and other stromal culture 
systems, as well as for clinical studies focusing on T-cell immunodeficiencies (SCID), 
HIV disease, development of allergies and lymphoid reconstitution after bone marrow 
transplantation.
MATERIALS AND METHODS
Thymus and blood samples
Thymic lobes were obtained from 70 children (90% Caucasian, 38 boys and 32 girls), operated 
for congenital heart disease. The thymus material was collected according to the informed consent 
guidelines of the Medical Ethics Committee of the Erasmus MC, Rotterdam. In all cases a complete 
thymic lobe was removed, for reasons of surgical approach. 57 children had septum defects, either 
isolated (30 children) or in combination with Fallot’s tetralogy or a persistent ductus arteriosus (11) or in 
combination with another defect (16) and 13 had other cardiac defects, such as stenosis or hypoplasia. 
No children were diagnosed with DiGeorge syndrome.
In 58 children no additional disease was present: the patients presented without immunological 
or hematological disorders, were free of infections, did not receive prostaglandin treatment, and had 
no apparent cytological abnormalities. These children are referred to as ‘immunologically normal’. 
In addition, we analyzed thymic lobes of 10 children with Down syndrome, one child with Williams 
syndrome and one child suffering from a protracted Rotavirus infection. All children below one year of 
age were born at term. The children ranged in age from 8 days to 8 years and were divided into 6 age 
groups (see Table II). 
Peripheral blood data were obtained from a group of healthy children, that has been described 
previously11. 
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Isolation and counting of thymocytes
Thymic lobes were stripped of the surrounding membrane and cut into small pieces. The fragments 
were subsequently disrupted by rubbing them gently through a stainless steel filter and washed with 
PBS containing 5% heat-inactivated fetal calf serum, until only stroma remained and all thymocytes 
were collected in the buffer. Thymocytes were spun down and resuspended in PBS containing 5% heat-
inactivated fetal calf serum and 50 U/ml DNAseI.
The absolute leukocyte counts were determined in duplicate with a Coulter Counter model Z1 
(Coulter Electronics), after lysis with ZAP-oglobin II (Beckman Coulter). Blood contamination of thymus 
samples was determined by measuring the number of erythrocytes per thymus. Therefore, a limited 
number of samples were counted both with and without lysing the cells.
Immunophenotyping
All monoclonal antibodies were directly conjugated and obtained from BD Biosciences, except for 
CD1a-RD1, which was from Beckman Coulter. All thymus samples were analyzed using a standard 
protocol of four tubes:
tube 1:  CD4-FITC CD1a-RD1 CD3-PerCP CD8-APC
tube 2:  CD4-FITC CD1a-RD1 CD8-PerCP CD34-APC
tube 3:  CD19-FITC CD16- and 56-PE CD3-PerCP CD4-APC
tube 4:  TCRαβ-FITC TCRγδ-PE CD8-PerCP CD4-APC
For characterization of B- and NK-cell subsets into further detail, a limited number of thymus samples 
was analyzed using the following antibodies: CD19-PerCP-Cy5.5, CD10-APC, CD20-PE, CD16-PE, 
CD56-PE and CD34-APC.
For the standard protocol, 100 μl aliquots with 106 thymocytes were incubated for 10 minutes at 
room temperature with combinations of antibodies. After washing, 105 cells were measured by flow 
cytometry. For the analysis of precursor B cells, 107 cells were stained and 1.5x105 cells were measured 
within a CD3-,CD4-,CD8- gate. All analyses were performed with a FACSCalibur flowcytometer (BD 
Biosciences) that had been calibrated with CaliBRITE beads and Cell Quest Pro software.
Immunohistochemistry
6 μm tissue sections of 3 frozen human thymi were fixed in acetone and incubated with antibodies 
against CD20 (Dako) or CD19 (BD Biosciences) or an isotype matched IgG (R&D), followed by a 
biotinylated rabbit anti mouse antibody (Dako) and finally with avidin-biotin complex-horseradish 
peroxidase (Dako). 
Statistical analysis
The Kruskal-Wallis test (a nonparametric alternative to one-way analysis of variance) was used to 
determine whether there were significant differences between groups. To test differences between two 
single groups, the nonparametric Mann-Whitney U test was used.
Table II. Composition of the 6 age groups. 
0-1 months 1-3 months 3-6 months 6-9 months 9-18 months 1.5-8 years
n mean n mean n mean n mean n mean n mean
thymus 6 15 10 61 23 127 12 205 7 389 12 1350
blood 6 7 31 73 66 148 61 193 71 366 91 1378
n:  number of children in each age group
mean: mean age (days)
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ABSTRACT
To gain more insight into initiation and regulation of T cell receptor (TCR) 
gene rearrangement during human T-cell development, we analyzed TCR gene 
rearrangements by quantitative PCR analysis in nine consecutive T-cell developmental 
stages, including CD34+ lin- cord blood cells as a reference. The same stages were 
used for gene expression profiling using DNA microarrays. We show that TCR loci 
rearrange in a highly ordered way (TCRD-TCRG-TCRB-TCRA) and that the initiating 
Dδ2-Dδ3 rearrangement occurs at the most immature CD34+CD38-CD1a- stage. 
TCRB rearrangement starts at the CD34+CD38+CD1a- stage and complete in-frame 
TCRB rearrangements were first detected in the ISP stage. TCRB rearrangement data 
together with the PTCRA (pTα) expression pattern show that human TCRβ-selection 
occurs at the CD34+CD38+CD1a+ stage. By combining the TCR rearrangement data 
with gene expression data, we identified candidate factors for the initiation/regulation 
of TCR recombination. Our data demonstrate that a number of key events occur earlier 
than previously assumed and that human T-cell development is therefore much more 
similar to murine T-cell development than reported before. 
INTRODUCTION
T cells develop from progenitors that migrate from the bone marrow into the thymus1. 
Thymocytes are roughly subdivided as either being double negative (DN), double positive 
(DP) or single positive (SP), based on the expression of the CD4 and CD8 co-receptors1. 
The DN stage is heterogeneous and can be subdivided into four distinct subsets in 
mice based on the expression of CD44 and CD25. In human, three clearly distinct DN 
stages can be recognized: a CD34+CD38-CD1a- stage, representing the most immature 
thymic subset and the consecutive CD34+CD38+CD1a- and CD34+CD38+CD1a+ stages. 
Human DN thymocytes mature via an immature single positive (ISP CD4+) and a DP 
stage into either CD4+ or CD8+ SP T cells that express functional T-cell receptors (TCR) 
and that exit the thymus1. 
A hallmark of T-cell development is the generation of T cells that express a functional 
TCR, either being TCRαβ or TCRγδ. During T-cell development, the variable domains 
of TCRA, TCRB, TCRG, and TCRD (located within TCRA) genes are assembled 
following rearrangement of variable (V), diversity (D), and joining (J) gene segments by 
a process called V(D)J recombination2. V(D)J recombination uses the RAG1 and RAG2 
enzymes that selectively target recombination signal sequences (RSS) that flank V, D 
and J segments2. 
Studies in T-cell acute lymphoblastic leukemias (T-ALL) suggest that recombinations 
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of TCR genes are sequential between the different genes (TCRD > TCRG > TCRB > 
TCRA) as well as within a particular gene (e.g. TCRD: Dδ2-Dδ3, Dδ2-Jδ1, Vδ-Jδ1)2,3, 
which is supported by limited data obtained from normal human T-cell subsets4. 
Therefore, the timing and efficiency of rearrangement of various TCR genes must be 
determined by the accessibility of gene segments to RAG enzymes. Evidence suggests 
that promoter and enhancer activity controlled by transcription factors regulate V(D)J 
recombination by modulating chromatin structures and rendering gene segments 
accessible to RAG cleavage5,6. 
T-cell development is for obvious reasons mainly studied in the mouse. Real-time 
quantitative PCR (RQ-PCR) and DNA microarray techniques allow careful analysis of 
small cell numbers. In this study we assessed the precise TCR gene configuration 
and the gene expression profiles of thymic subsets by RQ-PCR and Affymetrix DNA 
microarrays. By combining these two techniques we aimed for the identification of 
factors that play a role in regulating human TCR gene recombination. 
RESULTS AND DISCUSSION
Definition of T-cell populations
From umbilical cord blood (UCB) CD34+ lineage negative “stem cell-like” cells and 
from thymi CD34+CD38-CD1a-, CD34+CD38+CD1a-, CD34+CD38+CD1a+, ISP CD4+, DP 
CD3-, DP CD3+ and SP CD4+ and SP CD8+ subpopulations were obtained, representing 
consecutive stages of T-cell development (Figure 1). TCRαβ and TCRγδ expressing 
cells were obtained from thymic samples and peripheral blood. Cells from 5 donors 
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Figure 1. T-cell differentiation stages and gate settings for sorting. 
The differentiation stages of human T-cell development are depicted schematically. FACS plots show 
the gating strategy used for sorting various populations.
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were pooled to reduce intra-sample variation and all subsets were isolated twice from 
different donor pools. 
Determination of TCR gene rearrangements by RQ-PCR and GeneScan analysis 
TCR gene rearrangement analysis was performed in duplicate and on the two 
independently purified subsets (average is shown). The primers and TaqMan probes 
(listed at http://www.jem.org/cgi/content/full/jem.20042524/DC1) do not amplify germline 
DNA.
TCRD
The Dδ2-Dδ3 rearrangement was first detected in the earliest CD34+CD38-
CD1a- thymic subset, much earlier during development than found in our previous 
Southern blotting-based report4. Dδ2-Dδ3 rearrangements reached maximum levels 
in the subsequent CD34+CD38+CD1a- stage and thereafter declined to low levels in 
the following subsets (Figure 2B). The initial Dδ2-Dδ3 wave was followed by Dδ2-
Jδ1 rearrangements, which were detectable at low levels in CD34+CD38-CD1a- cells, 
increased in CD34+CD38+CD1a- and peaked in CD34+CD38+CD1a+ cells (Figure 2C). 
Complete Vδ1-Jδ1 or Vδ2-Jδ1 rearrangements were first detected in CD34+CD38+CD1a- 
cells, increasing to peak levels in CD4+ ISP cells after which they declined when the 
majority of thymocytes further differentiated into the TCRαβ lineage (Figure 2D). During 
TCRαβ T-cell lineage development, the TCRD gene is deleted from the TCRA/D gene 
complex2,7 which results in the formation of a T-cell receptor excision circle (TREC) 
that may contain Vδ-Jδ1 rearrangements. TRECs do not replicate on cell division; 
consequently, they are diluted out in proliferating, developing T-cells2. Ki67 staining 
demonstrated high percentages of proliferating cells within the human ISP and DP CD3- 
thymic subsets (data not shown). This proliferation likely accounts for the observed 
decline in Vδ-Jδ1 rearrangements after the ISP stage. The Vδ1 gene segment appeared 
to be used preferentially in postnatal TCRγδ+ thymocytes, which is in sharp contrast to 
the well-described preferential Vδ2 usage by peripheral TCRγδ+ T cells (Figure 2D)8. We 
detected very low Vδ-Dδ3 levels in the thymic subsets, indicating that this represents a 
minor pathway to initiate TCRD gene rearrangement in postnatal thymus (Figure 2E). 
 
TCRG 
The first TCRG rearrangements (Vγ-Jγ1.1/2.1) were detected in the 
CD34+CD38+CD1a- thymic subset, earlier than we previously reported4, and one 
stage after the initiation of TCRD rearrangement. These rearrangements peaked in 
CD34+CD38+CD1a+ thymocytes, after which levels decreased to a relative constant level 
in subsequent subsets (Figure 3B). Vγ-Jγ1.3/2.3 rearrangements were first observed 
in CD34+CD38+CD1a- cells after which they rapidly increased and by far exceeded Vγ-
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Jγ1.1/2.1 rearrangements from the ISP stage onwards (Figure 3C). Peripheral TCRγδ+ 
and TCRαβ+ T cells revealed lower Jγ1.3/2.3 usage than then their thymic counter parts 
(Figure 3C). In thymocytes Jγ1.2 was used at very low frequency, but massive positive 
selection for the Jγ1.2 segment occurred in peripheral TCRγδ+ T cells (Figure 3D)8.
TCRB 
Dβ1-Jβ1 rearrangements were first detected at low levels in the CD34+CD38+CD1a- 
population and increased thereafter from CD34+CD38+CD1a+ to CD4+ ISP cells (Figure 
4B). Dβ2-Jβ2 rearrangements were first detected at low levels in CD34+CD38+CD1a+ 
cells, one differentiation stage after Dβ1-Jβ1 rearrangements (Figure 4B). The seemingly 
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Figure 2. RQ-PCR analysis of TCRD gene rearrangements in human T-cell development and 
mature T cells. 
(A) Schematic diagram of the human TCRD gene complex. The six ‘classical’ Vδ gene segments 
are scattered between Vα gene segments. As Vδ4, Vδ5, and Vδ6 are also recognized as Vα gene 
segments, their Vα gene code is given in parentheses (adapted from reference 9). (B) Analysis of Dδ2-
Dδ3 rearrangement. (C) Analysis of Dδ2-Jδ1 rearrangement. (D) Analysis of Vδ1-Jδ1 and Vδ2-Jδ1 
rearrangements (E) Analysis of Vδ-Dδ3 rearrangements. 
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lower levels of Dβ-Jβ in DP CD3+ are probably caused by variation within the lower 
range of detection of our assay and likely do not represent a true decrease. 
Due to the complexity of the TCRB locus, Vβ-Jβ rearrangements were determined 
using non-quantitative GeneScan analysis9. The CD34+CD38+CD1a+ thymocytes 
contained low levels of the first Vβ-Jβ rearrangements in which exclusively Jβ2 gene 
segments were used (Figure 4D), much earlier than described before4. From the ISP 
subset onwards Vβ-Jβ rearrangements were in-frame as shown by the triplet peaks 
(Figure 4E) and were retained throughout all subsequent stages of development 
(Figure 4E-H). Previous reports suggested that TCRβ-selection in humans is initiated 
at the ISP/DP stages of T-cell development4,10,11, but the 3 nucleotide spacing of the 
peaks in our GeneScan analysis suggest that selection for in-frame TCRB already 
Figure 3. RQ-PCR analysis of TCRG gene rearrangements in human T-cell development and 
mature T cells. 
(A) Schematic diagram of the human TCRG gene complex. Only the rearrangeable Vγ gene segments 
are depicted in black (functional Vγ) or in gray (non-functional Vγ). For the Jγ gene segments both 
nomenclatures are used (adapted from reference 9). (B) Analysis of Vγ to Jγ1.1 and Jγ2.1 rearrangements 
(C) Analysis of Vγ to Jγ1.3 and Jγ2.3 rearrangements (D) Analysis of Vγ to Jγ1.2 rearrangement.
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occurs at the transition from CD34+CD38+CD1a+ to ISP. From the DP CD3- fraction 
Vβ-Jβ1 rearrangements were also present, although less abundant than Vβ-Jβ2 
rearrangements (Figure 4F; tube A). For Vβ-Jβ rearrangements usage of Jβ2 gene 
segments was preferred over Jβ1 (Figure 4D-H). TCRγδ+ thymocytes contained no Vβ-
Jβ1 rearrangements but did contain Vβ-Jβ2 rearrangements (Figure 4H). 
TCRA
Due to large numbers of rearrangable Vα (~54) and Jα (61) gene segments2, 
we could not design a multiplex RQ-PCR for reliable quantification of all Vα-Jα 
rearrangements. Instead, we aimed for an alternative approach in which we used 
different indirect measures to study TCRA recombination. TCRA recombination is 
initiated by the transcription of T-early alpha (TEA) in order to open the 5’ site of the 
Jα cluster, which is followed by TCRD deleting rearrangements, particularly the δREC- 
ψJα rearrangement. These initiating events are then followed by multiple, consecutive 
Vα-Jα rearrangements7,12. 
To study initiation of TCRA rearrangement we determined the level of TEA-Cα 
transcripts as well as the occurrence of δREC-ψJα α rearrangements. TEA-Cα transcripts 
started to increase in CD34+CD38+CD1a+ cells and reached peak levels in ISP and DP 
cells after which they declined again (Figure 5B). δREC-ψJα rearrangements were first 
detected in ISP cells and reached peak levels in SP and TCRαβ+ thymocytes (Figure 5C). 
These data show that TCRA rearrangement has already started in the ISP cell population, 
but that there are still cells within the CD3+ DP population that start rearrangement 
of the (most likely) second TCRA allele. Although TEA-Cα transcripts and δREC-ψJα 
rearrangements are good measures for initiation of TCRA rearrangement they cannot 
be used for quantification of the actual TCRA rearrangements. TEA-Cα is an mRNA 
product that cannot simply be extrapolated to the actual level of TCRA rearrangements. 
Quantification of δREC-ψJα is complex because it is strongly influenced by ongoing 
Vα- Jα rearrangements and the consequently produced TRECs (containing δREC-
ψJα), whereas the amount of TRECs (and their dilution) is heavily dependent on the 
fraction of proliferating cells within specific subsets. Therefore, extra accumulation of 
TRECs may explain the relatively high δREC-ψJα levels in non-proliferating SP cells as 
compared to the preceding proliferating stages. 
In an attempt to quantify TCRA recombination, we determined loss of germline 
Figure 4. RQ-PCR and GeneScan analysis of TCRB rearrangements in human T-cell development 
and in mature T cells. 
(A) Schematic diagram of the human TCRB gene complex. (B) Analysis of Dβ to Jβ rearrangements. 
(C) Schematic diagram of Vβ-Jβ rearrangements as determined by GeneScan analysis. The primers 
for the Jβ1 cluster were HEX-labeled (solid lines), while primers for the Jβ2 cluster were FAM-labeled 
(dotted lines). (D-H) Analysis of Vβ -Jβ rearrangements in CD34+CD38+CD1a+ cells (D), ISP cells (E), 
DP CD3- cells (F), TCRαβ+ thymocytes (G) and TCRγδ+ thymocytes (H). 
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TCRA DNA based on the disappearance of germline ψJα as indirect measure for TCRA 
rearrangements. For this approach we used DNA from CD34+lin- UCB cells as 100% 
germline reference. Germline TCRA clearly declined from the CD34+CD38+CD1a+ 
stage onwards with a major decline when ISP cells progress towards DP cells (Figure 
5D). The low levels of germline TCRA in DP CD3- cells indicate that extensive TCRA 
rearrangement has occurred at this stage. The seemingly inconsistence with the 
relatively low levels of δREC-ψJα in these DP CD3- cells can be explained by the fact that 
TRECs containing δREC-ψJα are rapidly diluted-out in these heavily proliferating cells 
and that other TCRD deleting rearrangements can occur as well, such as δREC-Jα58 
and Vδ-ψJα7. It should be noted that our approach is only suitable for quantification of 
major decreases in germline TCRA, which occur at early stages of T-cell development 
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Figure 5. RQ-PCR analysis of initiating events around TCRA rearrangement in human T-cell 
development and mature T cells. 
(A) Schematic diagram of the human TCRA gene complex. The TEA element forms a sterile mRNA with 
Cα sequences. The TCRD deleting elements δRec and ψJα are also indicated. (B) Analysis of TEA-Cα 
mRNA expression. Due to shortage of material, TEA expression was only determined once. (C) Analysis 
of the TCRD deleting rearrangement δRec-ψJα. (D) Analysis of “remaining” TCRA germline DNA. 
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(ISP/CD3- DP), but that it is much more difficult to accurately measure additional 
TCRA rearrangements at the later stages of T-cell development. The latter is because 
germline ψJα (for instance due to δREC-Jα58 rearrangements) remains detectable 
on TRECs and the difficulty of detecting further decreases within the 5-10% germline 
TCRA present in these stages. 
We conclude that TCRA rearrangements are initiated when thymocytes progress 
from CD34+CD38+CD1a+ towards the ISP stage, which is much earlier than previously 
reported11, and is apparently ongoing up until the CD3+ DP stage. 
Microarray analysis
A total of 3848 probe sets underwent a significant change between any two 
successive stages of differentiation. The expression levels of these probe sets were 
used to calculate a correlation coefficient between all possible pairs of microarrays and 
revealed high correlation between biological repeats (not shown). This allowed us to 
use the average expression values of the two arrays performed per subset (obtained 
from 5 pooled thymi) for further analysis. 
Expression data of the 3848 probe sets were used to perform hierarchical clustering 
using Genlab. Expression patterns of the 3848 probe sets were subdivided in k = 15 
different clusters (A to O; Figure 6). This hierarchical clustering immediately revealed 
that the thymocyte subsets isolated based on the expression of surface markers 
have distinct gene expression profiles, although both SP subsets show highly similar 
expression profiles. A table with the members of each cluster including the expression 
data is provided at http://www.jem.org/cgi/content/full/jem.20042524/DC1. A large group 
of probe sets (580 in cluster B) is specifically expressed in CD34+lin- UCB cells and 
shows a dramatic decrease in expression in the first thymic subset (e.g. KIT (CD117). 
Other non-T cell markers such as BTK and PLCG2 show a slower decrease starting 
in the second and third thymic population (cluster H and F, respectively). One of the 
first probe sets directly related to T-cell differentiation to show increased expression 
represents TCRD (cluster G), followed shortly thereafter by TCRB, TCRG and CD7 
(cluster J). Increased expression of RAG1, RAG2, DNTT (TdT) and PTCRA (pTα) was 
detected immediately after T-cell commitment (cluster C). This particular combination of 
genes is specific for the T-cell lineage. 
Of special interest for TCRβ-selection and initiation of TCRA rearrangement is the fact 
that PTCRA (pTα) expression increased in the CD34+CD38+CD1a- stage and peaked in 
the CD34+CD38+CD1a+ and ISP stages, after which it declined. Mouse microarray data13 
have shown a similar expression pattern of pTα, with a minor peak at DN3 and a larger 
peak at the DP CD3- stage. Experiments with pTα mutant mice indicate that TCRβ-
selection in the mouse occurs at DN314, and that TCRA recombination is initiated after 
TCRβ-selection has occurred14. Here we show that initiation of TCRA recombination 
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starts in CD34+CD38+CD1a+ cells. The analogous pTα expression between mice and 
men, together with our TCRB GeneScan and our TCRA recombination data, indicates 
that human TCRβ-selection occurs at the CD34+CD38+CD1a+ stage instead of the 
previously suggested ISP/DP stage4,10,11. 
Some probe sets that represent genes involved in double strand (ds)DNA break repair, 
such as G22P1 (KU70), XRCC5 (KU80), PRKDC (DNAPK), DCLRE1C (ARTEMIS), 
XRCC4 and LIG4 (DNA ligase IV), showed no significant change in expression between 
any of the subsequent developmental stages. Probe sets representing genes that 
take part in the TCR complex, such as CD3D, CD3E, CD3G and ZAP70 are relatively 
over-represented starting in the ISP CD4+ population (Figure 6; cluster O), although 
expression of CD3D, CD3E and ZAP70 mRNA is already detectable in the first thymic 
subset that we analyzed. Transcription of the TCRA locus (cluster L) is first seen in the 
DP CD3- stage, after TCRβ-selection has already occurred. Surface markers such as 
CD5, CD8α and β1, CD27 and CD28 (cluster L) that are generally seen on more mature 
T cells, were indeed found to be upregulated in the latest stages of T-cell development. 
Cclusters A and I, harboring genes involved in signaling, showed a peak in expression 
in the ISP stage of T-cell development.
Identification of factors regulating TCR gene rearrangements
To identify candidate transcription factors involved in regulating TCR recombination 
the list of 3848 probe sets was filtered based on Gene Ontology (GO) annotation 
(transcriptional activity and DNA binding) yielding a final list of 446 probe sets encoding 
a total of 361 genes (available at http://www.jem.org/cgi/content/full/jem.2004 2524/
DC1). Expression of genes associated with T-cell commitment/differentiation and/or 
V(D)J recombination, such as NOTCH1, HES1, GATA3, BCL11B, RAG1, RAG2, and 
DNTT (TdT) strongly increased in early T-cell differentiation. 
To determine which genes may have a role in regulating TCR rearrangement, 
hierarchical cluster analysis was performed (Figure 7A). The 446 probe sets were 
divided in 15 clusters, of which the prototypic expression patterns are depicted in 
Figure 7B. Clusters 3, 5, 6, 7, 14 and 15 (indicated by * in Figure 7B) contain genes 
Figure 6. Hierarchical clustering of the 3848 differentially expressed probe sets into 15 
clusters. 
(A) Probe sets shown in rows. Analyzed subsets are shown in columns (a: CD34+lin- UCB, b: CD34+CD38-
CD1a-, c: CD34+CD38+CD1a-, d: CD34+CD38+CD1a+, e: ISP, f: DP CD3-, g: DP CD3+, h: SP CD4+, i: SP 
CD8+). Grey values correlate with the value of the z-score. On the right side of the figure the 15 clusters 
are depicted (A-O). (B) z-score trend representation shown for each cluster. Clusters codes (A-O) are 
displayed in the top left corner of each graph. The z-score is shown on the y-axis, the thymic subsets 
(labels are the same as in A) on the x-axis. The gray area represents 1 SD. In the bottom left corner  of 
the graphs some representative cluster members are mentioned. n (bottom right corner) indicates the 
number of probe sets per cluster.
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of which expression levels increase concomitantly with episodes of active TCR gene 
rearrangement, as determined above, and which may therefore encode factors that 
initiate and/or regulate TCR rearrangements. Genes present in clusters 3, 5, 6, 7, 14 
and 15 are presented in Table I. 
We propose that clusters 3, 5 and 6 contain genes common for the rearrangement 
of all four TCR genes. Cluster 5 likely contains genes important for the regulation of 
TCRD, TCRG and TCRB rearrangements while cluster 3 likely contains genes that 
need to be expressed at a higher level when TCRA rearranges. These clusters include 
DNTT (cluster 6), RAG 1/RAG 2 (cluster 3) as well as genes encoding factors such as 
NOTCH1 (cluster 6), RORC (cluster 3), SMARCA4 (BRG1) (clusters 6 and 3), H2AFX 
(cluster 3) that have previously been linked to regulation of TCRG, TCRB or TCRA 
rearrangements15-18. 
Genes in cluster 7, 14 and 15 such as SPIB, ICSBP1, TCF4, CREB1, ETS1 and 
LEF1, with high expression in ISP and DP subsets, may encode factors involved in 
regulating TCRA rearrangements, as well as allelic exclusion of the TCRB locus. CREB1 
in conjunction with factors such as Ets1 and Lef1 activates the TCRA enhancer19. 
Recently, Ets1 has been identified as a critical factor for allelic exclusion at the TCRB 
locus20. Genes present in cluster 7 show a specific expression peak in the ISP stage. 
Among these genes ICSBP1 (IRF8) and SPIB are likely candidates for initiating TCRA 
rearrangements, as they encode factors that have been implicated in the regulation of Ig 
light-chain transcription and recombination in developing B cells21,22, while involvement 
of TCF4 (E2-2) is supported by the finding that E2-2 deficient mice exhibit reduced 
transition from the DN to the DP stage23. 
Novel insights into human T-cell development 
We confirm that TCR loci rearrange in a highly ordered way (TCRD-TCRG-TCRB-
TCRA) and defined sequential rearrangement steps of TCRD, TCRG, TCRB, and 
initiation of TCRA recombination to specific human thymic subsets. Importantly, our 
data show that recombination of the TCR genes occurs earlier during human T-cell 
development than previously reported4,11. Given that in mice TCRD rearrangement starts 
at DN1, followed by TCRG in DN2 and TCRB in DN2 but especially DN31,24, the human 
Figure 7. Analysis of probe sets related to transcriptional regulation. 
(A) Hierarchical clustering of 446 probe sets differentially expressed over the various stages and related 
to transcriptional regulation and DNA binding. Labels of the thymocyte subsets are the same as in 
Figure 6. (B) z-score trend representation for each cluster deduced from the 446 probe sets. Cluster 
codes (1-15) are shown in the top right corner, z-score on the y-axis, subsets on the x-axis. The gray 
area represents 1 SD. The asterisk in the upper right corner indicates clusters that contain genes that 
are potentially important in regulating TCR rearrangements. n indicates the number of probe sets in a 
cluster.
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CD34+CD38-CD1a-, CD34+CD38+CD1a- and CD34+CD38+CD1a+ subsets resemble 
murine early DN1 (CD44+CD25-CD117-), late DN1+DN2 (CD117+ DN1; CD44+CD25+), 
and DN3 (CD44-CD25+) stages, respectively. However, the relative frequency of DN1 
cells in mice is higher than that of the corresponding human subset (CD34+CD38-CD1a).
We also demonstrate that TCRβ-selection and initiation of TCRA rearrangements do 
not occur at the ISP/DP stages of human T-cell development4,10,11, but instead already 
at the CD34+CD38+CD1a+ stage. This is similar to the mouse, in which TCRβ-selection 
occurs in DN3 thymocytes14. 
Based on the TCR rearrangement data and the expression of key recombination 
and differentiation genes (e.g., RAG1, RAG2 and PTCRA), we show that human and 
mouse T-cell development are much more similar than previously assumed. In addition 
candidate factors for regulation of TCR recombination are identified. We propose an 
up-dated human T-cell differentiation model, as shown in the Discussion of this thesis. 
These novel data help to bridge gaps in our understanding of human T-cell development, 
and should provide insight into the development of T cell acute lymphoblastic leukemia 
and SCID.
MATERIALS AND METHODS
Isolation of cell samples from thymus, umbilical cord blood and peripheral blood
Thymi were obtained as surgical tissue discards from children aged 7 weeks to 3 years (median of 
6 month) undergoing cardiac surgery at the Erasmus MC Rotterdam, with informed consent from the 
parents. The children did not have immunological abnormalities. Thymocytes were isolated by cutting 
the thymic lobes into small pieces and squeezing them through a metal mesh, and stored at -80ºC until 
further analyses. Mononuclear cells were isolated by Ficoll-Paque (Amersham Biosciences) density 
centrifugation from human umbilical cord blood (UCB) obtained from full-term normal deliveries and 
from peripheral blood of healthy volunteers. All samples were obtained according to the guidelines of the 
Medical Ethical Committee of the Erasmus MC that also approved the human studies. 
Purification of subpopulations
Total mononuclear cells or thymocytes from 5 donors were pooled to reduce intra-sample variation. 
After thawing, pooling and Ficoll density separation, thymocytes were labeled with fluorochrome-
conjugated monoclonal antibodies. In order to isolate the CD34+ lineage (lin)- UCB cells, CD34+CD38-
CD1a-, CD34+CD38+CD1a- and CD34+CD38+CD1a+ thymocytes, magnetic beads (Myltenyi Biotech) were 
used to enrich for CD34+ cells. For isolation of the ISP population, thymocytes were depleted of CD3-
expressing cells using magnetic beads. For isolation of TCRγδ+ thymocytes, magnetic beads were used 
to enrich for TCRγδ+ cells. All magnetic beads were used according to the manufacturers protocol. After 
MACS isolation, the enriched cells were labeled with fluorochrome-conjugated monoclonal antibodies 
for further purification by high speed cell sorting. In order to isolate mature TCRαβ+ and TCRγδ+ T-cells, 
peripheral blood mononuclear cells were labeled with fluorochrome-conjugated monoclonal antibodies 
for cell sorting. All cell sorting was performed on a FACS DiVa cell sorter (BD Biosciences). Monoclonal 
antibodies used, with the clone in brackets: CD4-FITC (SK3), CD38-FITC (HB7), TCRαβ-FITC (WT31), 
CD1a-RDI (T6), CD3-PE (SK7), CD16-PE (B73.1), CD19-PE (4G7), CD56-PE (M431), TCRγδ-PE 
(11F2), CD3-PerCP (SK7), CD8-PerCP (SK1), CD19-PerCP (SJ25C1), CD3-APC ( SK7), CD8-APC 
Chapter 3
72
(SK1) and CD34-APC (8G12) (all from BD Biosciences), CD13-RDI (MY7) and CD33-RDI (906) (from 
Beckman Coulter). Purity of sorted population was determined on the FACS Calibur (BD Biosciences) 
and shown to be over 95% for all populations. All populations were sorted twice using different donors 
for each sort. 
 
DNA isolation, and RQ-PCR analyses of TCR gene rearrangements 
DNA from thymic subsets, CD34+ lin- UCB cells and peripheral TCRαβ+ and TCRγδ+ T cells was 
extracted with the GenElute Mammalian Genomic DNA miniprep kit (Sigma-Aldrich), according to 
the manufacturers protocol. DNA was extracted from control cell lines using the QIAamp Blood Midi 
kit (Qiagen) according to the manufactures protocol. RQ-PCR for quantification of different TCR 
recombinations was essentially performed as described previously using ABI Prism 7700 equipment 
(Applied Biosystems)25. The following TCRD recombinations were determined. Dδ2-Dδ3; using Dδ2 
and Dδ3 specific primers, Dδ2-Jδ1; using Dδ2 and Jδ1 specific primers, Vδ1-Jδ1 and Vδ2-Jδ1; were 
performed in two independent PCR reactions using either a Vδ1or a Vδ2 primer in combination with a 
Jδ1 primer, Vδ-Dδ3; using six specific Vδ primers (Vδ1-Vδ6) in combination with a Dδ3 primer. The cell 
lines/diagnostic samples that were selected as clonal control DNA for TCRD rearrangements are the 
following: Dδ2-Dδ3 (Nalm 16), Dδ2-Jδ1 (Loucy), Vδ1-Jδ1 (Peer), Vδ2-Jδ1 (T-ALL sample), all Vδ’s-
Dδ3 (Nalm 16 with Vδ2-Dδ3). TCRG rearrangements were determined as follows: Vγ to Jγ1.1 and 
Jγ2.1 rearrangements were determined in two independent PCR reactions using a Jγ1.1/2.1 consensus 
primer (recognizing Jγ1.1 and Jγ2.1) in combination with either a VγI family primer (VγIf; recognizing 
Vγ2, Vγ3, Vγ4, Vγ5, ψVγ7 and Vγ8) and a Vγ10 primer or in combination with a Vγ9 and a Vγ11 primer. 
Analysis of Vγ to Jγ1.3 and Jγ2.3 rearrangement which was performed using a Jγ1.3/2.3 consensus 
primer (recognizing Jγ1.3 and Jγ2.3) in combination with VγIf, Vγ9, Vγ10 and Vγ11 primers. Analysis 
of Vγ to Jγ1.2 rearrangement which was performed using a Jγ1.2 primer in combination with VγIf, Vγ9, 
Vγ10 and Vγ11 primers. The cell lines/diagnostic samples that were selected as clonal control DNA for 
TCRG rearrangements are the following: Vγ1f+Vγ10-Jγ1.1/2.1 (HUT 78 with Vγ8-Jγ1.1), Vγ9+Vγ11-
Jγ1.1/2.1 (ARR with Vγ9-Jγ1.1), all Vγ’s-Jγ1.3/2.3 (RPMI 8402 with Vγ10-Jγ2.3 and Vγ4-Jγ2.3), all 
Vγ’s-Jγ1.2 (T-ALL sample with Vγ9-Jγ1.2). TCRB Dβ to Jβ rearrangements were performed in two 
independent PCR reactions containing either a Dβ1 primer in combination with six primers for the Jβ1 
cluster (one specific primer for each Jβ1 gene segment) or a Dβ2 primer in combination with seven 
primers for the Jβ2 cluster (one specific primer for each Jβ2 gene segment). As a clonal control for Dβ1-
Jβ1 and Dβ2-Jβ2 gene rearrangements we used HUT78 which contains a Dβ1-Jβ1.2 and Dβ2-Jβ2.3 
rearrangement. Furthermore, in order to examine initiation of TCRA rearrangement, we determined 
the TCRD deleting δREC-ψJα rearrangement using a δRec primer in combination with a ψJα specific 
primer and for which we used H-SB2 as clonal control. In addition we determined the decrease of TCRA 
germline DNA in all thymic subsets and peripheral TCRαβ+ and TCRγδ+ T cells by using a primer located 
just upstream of ψJα in combination with a primer located just downstream of ψJα. For this purpose 
CD34+lin- UCB cells were used as a hundred percent TCRA germline control. All applied forward/reverse 
primers and TaqMan probes are available at http://www.jem.org/cgi/content/full/jem.2004 2524/DC1; 
most have been described previously5,9,26,27. 
Control cell lines and T-ALL controls were serially diluted in a background of un-rearranged (germline) 
DNA in order to generate a standard curve ranging from 100% to 0.1% of specific template DNA (specific 
rearrangement) in a non-template background. An albumin RQ-PCR was performed to normalize the 
amount of input DNA of non-diluted control DNA and DNA from thymocyte subsets, CD34+lin- UCB 
cells and peripheral T-cells, using serially diluted reference DNA. A typical RQ-PCR mixture of 25 μl 
contained TaqMan Universal MasterMix (Applied Biosystems), 540-900 nM of each primer, 100 nM 
of FAM-TAMRA labeled probe, 0.4 μg of bovine serum albumin and 50 ng of genomic DNA. Positive 
controls were considered to be clonal and to contain hundred percent of the specific rearrangement. 
CT values of thymic subsets, CD34
+lin- UCB cells and peripheral T cell DNA for a particular TCR RQ-
PCR were subsequently plotted on the corresponding standard curve, and expressed as relative 
rearrangement levels as compared to the corresponding clonal control DNA. The sensitivity of each 
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assay was at least 1%. All RQ-PCR experiments were performed in duplicate on two independently 
purified sets of all isolated subsets. 
GeneScan analysis for complete and in-frame Vβ-Jβ gene rearrangements 
In order to analyze Vβ-Jβ rearrangements and selection of the TCRβ chain (i.e. in-frame TCRB gene 
rearrangements) in the isolated populations, complete TCRB V-J rearrangements were amplified with 
HEX-labeled primers for the Jβ1 cluster and FAM-labeled primers for the Jβ2 cluster. This was done by 
two multiplex PCR reactions as described by the BIOMED-2 Concerted Action BMH4 CT98-3936: tube 
A containing primers for each Jβ1 segment as well as Jβ2.2, Jβ2.6, and Jβ2.7 primers in combination 
with Vβ primers and tube B containing Jβ2.1, Jβ2.3, Jβ2.4, and Jβ2.5 primers in combination with Vβ 
primers9. The obtained PCR products were subsequently subjected to GeneScan analysis as described 
before9. 
 
TEA expression by real time quantitative (RQ)-PCR analyses 
In order to determine the expression of the sterile T-early alpha (TEA) transcript in the isolated 
populations, RNA was reverse transcribed into cDNA as described previously28. Subsequently the cDNA 
was diluted by adding 80 μl of milli Q water yielding a final concentration of 10 ng/μl. As positive control 
for TEA expression the immature T-cell line SUPT3 was used and as a negative control the immature 
T-cell line H-SB2, which has both TCRD alleles deleted and therefore expected to be TEA negative, was 
used as well as the non-hematopoietic cell line HeLa. RQ-PCR was performed as previously29, and the 
expression of TEA was defined by calculating the ratio of TEA to the average value of the control genes 
Abelson (ABL) and beta-glucuronidase (GUSB)29. 
Microarray analysis 
Microarray analysis was essentially done as described previously30 and according to MIAME 
guidelines 31. RNA was isolated using RNeasy columns (Qiagen) according to the manufacturers protocol 
and RNA quality was assessed using the Agilent 2100 BioAnalyzer. Two to five μg of total RNA from the 
CD34+CD38+CD1a-, CD34+CD38+CD1a+, ISP, DP CD3-, DP CD3+, SP CD4+ and SP CD8+ populations 
was used to generate double-stranded cDNA using SuperScript reverse transcriptase and a T7-oligo(dT) 
primer. An ENZO kit (ENZO-Life Sciences Inc) was used to convert cDNA into biotinylated cRNA utilizing 
T7 RNA polymerase and biotinylated ribonucleotides. Biotinylated cRNA was separated from enzymes 
and unincorporated nucleotides using RNeasy ‘clean-up’ spin columns (Qiagen). For the smaller, 
earlier populations, CD34+lin- UCB cells, CD34+CD38-CD1a- thymocytes and for control purposes the 
CD34+CD38+CD1a+ thymocytes, the GeneChip Eukaryotic Small Sample Target Labeling Assay Version 
II (Affymetrix) was used to generate biotinylated cRNA. Eleven μg of cRNA was fragmented for 35 min 
at 95 ˚C. 10 μg of fragmented cRNA was then hybridized to HG-U133A human genome microarrays for 
16 hours at 45 ˚C followed by washing, staining and scanning at 570 nm (Affymetrix). All raw microarray 
data are freely available at http://franklin.et.tudelft.nl/.
Statistical analysis
Probe intensity background was removed using robust multichip analysis (RMA32). The intensity 
levels were then quantile normalised33. Array groups (two biologically independent arrays per group) 
corresponding to the development stages were compared based on the perfect match (PM) probe 
intensity levels only32, by performing a per-probe set two-way analysis of variance (ANOVA, with factors 
“probe” and “stage”). This resulted in average expression levels over the two biological repeats for each 
probe set in each stage, as well as a p-value for the significance of the difference between the stages. 
As data resulting from the standard protocol (“non-amplified”) are not directly comparable to those from 
the small sample protocol (“amplified”), the expression levels measured for probe sets under the small 
sample protocol were scaled, according to the results in the CD34+CD38+CD1a- population, which was 
analyzed by both protocols. For each individual probe set, the scaling factor used was the ratio between 
the average expression level measured for that probe set in the CD34+CD38+CD1a- population, under 
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the standard protocol and the small sample protocol. 
The p-values were adjusted for multiple testing using Šidák step-down adjustment34 and all 
differences with adjusted p-values <0.05 were considered significant. All probe sets that underwent a 
significant change between any two successive stages of differentiation (CD34+lin- UCB vs CD34+CD38-
CD1a-, CD34+CD38-CD1a- vs CD34+CD38+CD1a-, CD34+CD38+CD1a- vs CD34+CD38+CD1a+, 
CD34+CD38+CD1a+ vs ISP, ISP vs DP CD3-, DP CD3- vs DP CD3+, DP CD3+ vs SP CD4+ and DP CD3+ 
vs SP CD8+) were selected. 
The OmniViz software package was used to construct and display a Pearson correlation matrix 
between the individual microarrays, based on the expression values of significant probe sets. Before 
calculating correlations, all expression values lower than 30 were set to 30. Expression values were 
then log2-transformed and the per probe set geometric mean was subtracted. Further analysis was 
performed using the Genlab software toolbox, running in the Matlab programming environment (http://
www.genlab.tudelft.nl). After per-probe set normalization to zero mean and unit standard deviation 
(z-score), a hierarchical clustering (complete linkage) was calculated based on Pearson correlation. 
The number of clusters k was determined by looking for a local minimum of the Davies-Bouldin index 
calculated for k=1, …, 3035.
For further analysis the list of significant probe sets was filtered, using the annotation found in the 
Affymetrix NetAffx analysis database (http://www.affymetrix.com/), for probe sets related to transcriptional 
activity based on the following Gene Ontology (GO) Consortium designations: nucleic acid binding (GO: 
3676), DNA binding (GO: 3677), transcription factor activity (GO: 3700), transcription cofactor activity 
(GO: 3712), transcription co-activator activity (GO: 3713), transcription co-repressor activity (GO: 3714), 
transcription (GO: 6350), transcription, DNA dependent (GO: 6351), regulation of transcription, DNA 
dependent (GO: 6355), transcription from Pol II promoter (GO: 6366), transcription initiation from Pol 
II promoter (GO: 6367), transcription factor complex (GO: 5667), negative regulation of transcription 
(GO: 16481), transcriptional activator activity (GO: 16563), transcriptional repressor activity (GO: 
16564) and positive regulation of transcription (GO: 45941). Less relevant genes obtained from these 
categories (e.g., RNA editing enzymes/polymerases, nucleosome assembly proteins, histones, etc) 
where manually removed from this list. The resulting 446 probe sets were then hierarchically clustered 
as described above.
ACKNOWLEDGEMENTS
W.A. Dik, J.J.M. van Dongen, A.W. Langerak are supported by the Dutch Cancer Foundation 
(EMCR 2002-2707), A.W. Langerak is supported by the Haak Bastiaanse Kuneman Foundation, K. 
Pike-Overzet by EU 5th and 6th Framework grants (INHERINET, CONSERT), E.F.E. de Haas and E.E.L. 
Koster are supported by NWO/Stigon grants. We thank Dr. V.H.J. van der Velden for advice on RQ-PCR 
analysis. 
REFERENCES
1. Staal FJ, Weerkamp F, Langerak AW, Hendriks RW, Clevers HC. Transcriptional control of T 
lymphocyte differentiation. Stem Cells 2001; 19:165-79.
2. van Dongen JJM, Staal FJ, Langerak AW. Developmental and functional biology of T lymphocytes. In: 
Mauch PM, Armitage JO, Coiffier B, Dalla-Favera R, Harris NL, editors. Non-Hodgkin’s Lymphoma’s. 
Philadelphia: Lippincott, Williams & Wilkins; 2004. p. 787-808.
TCR rearrangements and gene expression in T-cell development
75
3. Asnafi V, Beldjord K, Boulanger E, Comba B, Le Tutour P, Estienne MH, et al. Analysis of TCR, pT 
alpha, and RAG-1 in T-acute lymphoblastic leukemias improves understanding of early human T-
lymphoid lineage commitment. Blood 2003; 101:2693-703.
4. Blom B, Verschuren MC, Heemskerk MH, Bakker AQ, van Gastel-Mol EJ, Wolvers-Tettero IL, et al. 
TCR gene rearrangements and expression of the pre-T cell receptor complex during human T-cell 
differentiation. Blood 1999; 93:3033-43.
5. Langerak AW, Wolvers-Tettero IL, van Gastel-Mol EJ, Oud ME, van Dongen JJM. Basic helix-loop-
helix proteins E2A and HEB induce immature T-cell receptor rearrangements in nonlymphoid cells. 
Blood 2001; 98:2456-65.
6. Schlissel MS. Regulating antigen-receptor gene assembly. Nat Rev Immunol 2003; 3:890-9.
7. Verschuren MC, Wolvers-Tettero IL, Breit TM, Noordzij J, van Wering ER, van Dongen JJM. 
Preferential rearrangements of the T cell receptor-delta-deleting elements in human T cells. J 
Immunol 1997; 158:1208-16.
8. Breit TM, Wolvers-Tettero IL, van Dongen JJM. Unique selection determinant in polyclonal V delta 
2-J delta 1 junctional regions of human peripheral gamma delta T lymphocytes. J Immunol 1994; 
152:2860-4.
9. van Dongen JJM, Langerak AW, Bruggemann M, Evans PA, Hummel M, Lavender FL, et al. Design 
and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell 
receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted 
Action BMH4-CT98-3936. Leukemia 2003; 17:2257-317.
10. Carrasco YR, Trigueros C, Ramiro AR, de Yebenes VG, Toribio ML. Beta-selection is associated 
with the onset of CD8beta chain expression on CD4(+)CD8alphaalpha(+) pre-T cells during human 
intrathymic development. Blood 1999; 94:3491-8.
11. Spits H. Development of alphabeta T cells in the human thymus. Nat Rev Immunol 2002; 2:760-
72.
12. Villey I, Caillol D, Selz F, Ferrier P, de Villartay JP. Defect in rearrangement of the most 5’ TCR-J alpha 
following targeted deletion of T early alpha (TEA): implications for TCR alpha locus accessibility. 
Immunity 1996; 5:331-42.
13. Hoffmann R, Bruno L, Seidl T, Rolink A, Melchers F. Rules for gene usage inferred from a comparison 
of large-scale gene expression profiles of T and B lymphocyte development. J Immunol 2003; 
170:1339-53.
14. von Boehmer H, Fehling HJ. Structure and function of the pre-T cell receptor. Annu Rev Immunol 
1997; 15:433-52.
15. Villey I, de Chasseval R, de Villartay JP. RORgammaT, a thymus-specific isoform of the orphan 
nuclear receptor RORgamma / TOR, is up-regulated by signaling through the pre-T cell receptor and 
binds to the TEA promoter. Eur J Immunol 1999; 29:4072-80.
16. Chen HT, Bhandoola A, Difilippantonio MJ, Zhu J, Brown MJ, Tai X, et al. Response to RAG-
mediated VDJ cleavage by NBS1 and gamma-H2AX. Science 2000; 290:1962-5.
17. Morshead KB, Ciccone DN, Taverna SD, Allis CD, Oettinger MA. Antigen receptor loci poised 
for V(D)J rearrangement are broadly associated with BRG1 and flanked by peaks of histone H3 
dimethylated at lysine 4. Proc Natl Acad Sci U S A 2003; 100:11577-82.
18. Wolfer A, Wilson A, Nemir M, MacDonald HR, Radtke F. Inactivation of Notch1 impairs VDJbeta 
rearrangement and allows pre-TCR-independent survival of early alpha beta Lineage Thymocytes. 
Immunity 2002; 16:869-79.
19. Mayall TP, Sheridan PL, Montminy MR, Jones KA. Distinct roles for P-CREB and LEF-1 in TCR 
alpha enhancer assembly and activation on chromatin templates in vitro. Genes Dev 1997; 11:887-
99.
20. Eyquem S, Chemin K, Fasseu M, Bories JC. The Ets-1 transcription factor is required for complete 
pre-T cell receptor function and allelic exclusion at the T cell receptor beta locus. Proc Natl Acad Sci 
U S A 2004; 101:15712-7.
Chapter 3
76
21. Lu R, Medina KL, Lancki DW, Singh H. IRF-4,8 orchestrate the pre-B-to-B transition in lymphocyte 
development. Genes Dev 2003; 17:1703-8.
22. Schweitzer BL, DeKoter RP. Analysis of gene expression and Ig transcription in PU.1/Spi-B-deficient 
progenitor B cell lines. J Immunol 2004; 172:144-54.
23. Bergqvist I, Eriksson M, Saarikettu J, Eriksson B, Corneliussen B, Grundstrom T, et al. The basic 
helix-loop-helix transcription factor E2-2 is involved in T lymphocyte development. Eur J Immunol 
2000; 30:2857-63.
24. Capone M, Hockett RD, Jr., Zlotnik A. Kinetics of T cell receptor beta, gamma, and delta 
rearrangements during adult thymic development: T cell receptor rearrangements are present in 
CD44(+)CD25(+) Pro-T thymocytes. Proc Natl Acad Sci U S A 1998; 95:12522-7.
25. Langerak AW, Nadel B, De Torbal A, Wolvers-Tettero IL, van Gastel-Mol EJ, Verhaaf B, et al. 
Unraveling the consecutive recombination events in the human IGK locus. J Immunol 2004; 
173:3878-88.
26. Szczepanski T, van der Velden VH, van Dongen JJM. Real-time (RQ)-PCR for the detection of 
minimal residual disease in childhood acute lymphoblastic leukemia. Haematologica 2002; 87:183-
91.
27. van der Velden VH, Wijkhuijs JM, Jacobs DC, van Wering ER, van Dongen JJM. T cell receptor 
gamma gene rearrangements as targets for detection of minimal residual disease in acute 
lymphoblastic leukemia by real-time quantitative PCR analysis. Leukemia 2002; 16:1372-80.
28. van Dongen JJM, Macintyre EA, Gabert JA, Delabesse E, Rossi V, Saglio G, et al. Standardized 
RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for 
detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of 
minimal residual disease in acute leukemia. Leukemia 1999; 13:1901-28.
29. Beillard E, Pallisgaard N, van der Velden VH, Bi W, Dee R, van der Schoot E, et al. Evaluation of 
candidate control genes for diagnosis and residual disease detection in leukemic patients using 
‘real-time’ quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe 
against cancer program. Leukemia 2003; 17:2474-86.
30. Staal FJ, Weerkamp F, Baert MR, van den Burg CM, van Noort M, de Haas EF, et al. Wnt target 
genes identified by DNA microarrays in immature CD34+ thymocytes regulate proliferation and cell 
adhesion. J Immunol 2004; 172:1099-108.
31. Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, Stoeckert C, et al. Minimum 
information about a microarray experiment (MIAME)-toward standards for microarray data. Nat 
Genet 2001; 29:365-71.
32. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, et al. Exploration, 
normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 
2003; 4:249-64.
33. Bolstad BM, Irizarry RA, Astrand M, Speed TP. A comparison of normalization methods for high 
density oligonucleotide array data based on variance and bias. Bioinformatics 2003; 19:185-93.
34. Ge U, Dudoit S, Speed TP. Resampling-based multiple testing for microarray analysis. Test 2003; 
12:1-77.
35. Davies DL, Bouldin D. A cluster separation measure. IEEE Trans. Pattern Anal. Mach. Intell. 1979; 
1:224-7.
4
THE HUMAN THYMUS CONTAINS MULTIPOTENT 
PROGENITORS WITH T/B LYMPHOID, MYELOID 
AND ERYTHROID LINEAGE POTENTIAL 
Floor Weerkamp1, Miranda R.M. Baert1, Martijn H. Brugman2, 
Willem A. Dik1, Edwin F.E. de Haas1, Trudi P. Visser2, Christianne 
J.M. de Groot3, Gerard Wagemaker2, Jacques J.M. van Dongen1 
and Frank J.T. Staal1
1Department of Immunology, 2Department of Hematology, 3Department of 
Obstetrics and Gynecology, Erasmus MC, University Medical Center Rotterdam, 
The Netherlands 
Submitted

Multipotent progenitors in the human thymus
79
ABSTRACT
It is a longstanding question which bone marrow-derived cell seeds the thymus and 
to what level this cell is committed to the T-cell lineage. We sought to elucidate this issue 
by examining gene expression, lineage potential and self-renewal capacity of the two 
most immature subsets in the human thymus, namely CD34+CD1a- and CD34+CD1a+ 
thymocytes. 
DNA microarrays revealed the presence of several myeloid and erythroid 
transcripts in CD34+CD1a-, but not in CD34+CD1a+ thymocytes. Lineage potential of 
both subpopulations was assessed using in vitro colony assays, bone marrow stroma 
cultures and in vivo transplantation into NOD/SCID mice. The CD34+CD1a- subset 
contained progenitors with lymphoid (both T and B), myeloid and erythroid lineage 
potential. Remarkably, development of CD34+CD1a- thymocytes towards the T-cell 
lineage, as shown by T-cell receptor delta gene rearrangements, could be reversed into 
a myeloid cell-fate. In contrast, the CD34+CD1a+ cells yielded only T cell progenitors, 
demonstrating their irreversible commitment to the T-cell lineage. Both CD34+CD1a- 
and CD34+CD1a+ thymocytes failed to repopulate NOD/SCID mice.
Together, these observations suggest that the human thymus is seeded by multipotent 
progenitors with a much broader lineage potential than previously assumed. These cells 
resemble hematopoietic stem cells, but lack sufficient self-renewal capacity. 
INTRODUCTION 
The thymic microenvironment is exceptional in its ability to sustain production of T 
cells1. However, hematopoietic stem cells (HSCs) that will eventually give rise to T cells, 
are derived from the bone marrow (BM). The nature of the thymus-seeding cell and its 
relation to several BM progenitors has remained elusive, despite being the subject of 
intense investigation. Furthermore, it is controversial whether cells commit to the T-cell 
lineage pre- or intrathymically2,3. 
Aided by modern cell sorting techniques, many studies in the mouse have recently 
readdressed these issues. Adult murine BM has been demonstrated to contain precursors 
with a restricted T/B lymphoid potential, so-called common lymphoid progenitors 
(CLPs)2,4. However, the earliest thymic immigrants were shown to differ from CLPs 
in several aspects5. In peripheral blood, T-lineage potential appeared to be restricted 
to Lin-Sca-1+c-Kit+ (LSK) progenitor populations, rather than to CLPs6. Recently, two 
detailed analyses of the earliest subpopulations in the murine thymus showed variable 
lineage potential of different subsets7,8. Together, these studies point towards a model 
in which a range of BM-derived progenitors colonize the thymus, probably including 
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multipotent progenitors and more lineage-restricted precursor cells9. For the human 
system, comparable experimental data are lacking. Determining lineage potential of 
early thymocytes will help to unveil the identity of the thymus-seeding cell in man. 
Both in man and mouse, the most immature cells in the thymus do not express CD4 
and CD8 and therefore are called double negative (DN). In humans, the DN stage can be 
further subdivided by staining for CD34 and CD110,11. CD34 is a marker for hematopoietic 
stem cells and progenitors in all hematopoietic organs. Also in the thymus, the most 
immature cells are highly positive for CD34 and levels decline as the cells mature10,11. 
Concomitant with the decrease of CD34, thymocytes acquire expression of CD112. This 
is usually detected by staining for CD1a, but CD1b, c, d and e are also expressed. This 
order of developmental steps is supported by the rearrangement status of the T-cell 
receptor (TCR) loci in the consecutive stages. The CD34+CD1a- cells start to rearrange 
their TCRD genes, but mostly have their TCRG and TCRB loci still in germline position, 
whereas expression of CD1a is accompanied by rearrangements of TCRD (V to DJ), 
TCRG and TCRB (D to J) loci13. The immature single positive (ISP) cells have lost CD34 
expression and contain mature TCRB (V to DJ) rearrangements13. The CD34+CD1a- and 
CD34+CD1a+ subsets comprise about 0.4% and 0.6% of all thymocytes respectively11.
Because of their TCR gene rearrangement status, CD34+CD1a+ thymocytes are 
thought to be irreversibly committed to the T-cell lineage. Nevertheless, their potential 
to differentiate into other lineages has not been studied in detail. Lineage potential of 
CD34+CD1a- is generally thought to be less restricted, but the range of progeny they 
can generate is under debate. The capability of human CD34+ thymocytes to develop 
into natural killer (NK) cells and dendritic cells (DCs) has been demonstrated by several 
studies, both in fetal14,15 and adult15,16 thymus. B-cell precursor potential of CD34+CD1a- 
thymocytes has, to our knowledge, never been reported. However, we and others 
have shown the presence of significant numbers of B cells in the human thymus11,17,18. 
Furthermore, in the thymus we could detect the presence of all BM B-cell progenitor 
stages, indicating that B cells develop in the thymus, albeit at much lower frequencies 
than in BM11.
Myeloid potential of CD34+ thymocytes was investigated by a number of studies 
several years ago, yielding contradictory results. While one study could generate myeloid 
colonies from CD34+ as well as from CD34- thymocytes19, others could not confirm any 
myeloid potential in CD34+ thymocytes20. Toribio and co-workers demonstrated that 
myeloid DC precursors can be generated from CD34+ thymocytes in cultures containing 
M-CSF21. 
In this study, we investigated the potential of CD34+CD1a- and CD34+CD1a+ 
thymocytes to develop into all hematopoietic lineages, as well as their ability to self-
renew.
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RESULTS
CD34+CD1a- but not CD34+CD1a+ thymocytes express genes of the myeloid and 
erythroid/megakaryocyte lineages 
Previously, gene expression profiles have been generated of eight thymocyte subsets 
corresponding to consecutive differentiation stages13. We here studied the expression 
profiles of two populations in greater detail: the most immature CD34+CD1a- subset that 
that at least retains NK and DC potential10 and the CD34+CD1a+ thymocytes that are 
presumed to be T-cell committed (Figure 1). 
As expected, CD34+CD1a- cells expressed high levels of progenitor marker 
transcripts such as CD34 and CD133 (Figure 2A), reflecting their immature phenotype. 
In the CD34+CD1a+ population upregulation of T-cell specific transcripts (e.g. CD3, 
PTCRA (the gene for pTα) and LAT) and genes involved in TCR rearrangements 
(e.g. RAG, DNTT (the gene for TdT), sterile TCRB transcripts) occurred (Figure 2B). 
To our surprise, we found that concurrently transcription of many myeloid-associated 
genes, including myeloperoxidase (MPO), CD13 and CD33 was downregulated during 
development from CD34+CD1a- to CD34+CD1a+ cells (Figure 2C). In addition, the gene 
for the erythrocyte/megakaryocyte specific transcription factor NF-E2 (nuclear factor 
erythroid-derived 2) was transcribed at significantly lower levels in the CD34+CD1a+ 
cells (Figure 2C). 
Our microarray data were validated using flow cytometry. The percentage of cells 
positive for CD13/33 and MPO proteins was higher in the CD34+CD1a- population than 
in the CD34+CD1a- cells (Figure 2D). 
Figure 1. Purification of cell subsets. 
(A) Total CD34+ cells were isolated from human thymus using AutoMACS and subsequently FACS 
sorted into CD34+CD1a- (lower panel) and CD34+CD1a+ (right panel) fractions. (B) CD34+ cells were 
isolated from human UCB using AutoMACS and FACS sorting.
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These data suggest that CD34+CD1a- thymocytes are not only immature and not yet 
committed to the T-cell lineage, but may in addition still possess myeloid and erythroid 
potential.
CD34+CD1a- but not CD34+CD1a+ thymocytes have myeloid and erythroid potential 
in vitro 
To study the myeloid and erythroid lineage potential of the two CD34+ thymocyte 
populations, cells were sorted and cultured in in vitro assays that allow outgrowth of 
either granulocyte/monocyte colony forming units (CFU-GM) or erythrocyte burst 
forming units (BFU-E). As a positive control, CD34+ cells from human umbilical cord 
blood (UCB) were used. The CD34+CD1a+ thymocytes did not give rise to any colonies 
in our assays, but the CD34+CD1a- thymocytes yielded clearly detectable colonies, both 
CFU-GM and BFU-E (Table I and Figure 3A and B). The efficiency of CD34+CD1a- 
thymocytes to yield myeloid colonies was about 30 times lower than that of CD34+ UCB 
cells, while erythroid potential was about 100 times less efficient (Table I). 
Figure 2. Gene expression of CD34+CD1a- and CD34+CD1a+ thymocytes. 
Expression levels (in arbitrary fluorescence units) of several genes were extracted from previously 
performed Affymetrix microarrays13. (A) ‘Stem cell-like’ genes, (B) T-cell specific genes, (C) ‘non-T 
lineage’ genes. (D) Expression patterns of MPO and CD13/CD33 were validated at the protein level 
using flow cytometry. CD34+ cells from thymus and UCB were purified using AutoMACS and gated for 
the indicated populations. Expression of CD13/33 in mature granulocytes was at least 10 fold higher 
than in CD34+ UCB cells. 
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Figure 3. In vitro colony assays. 
Sorted CD34+CD1a- and CD34+CD1a+ thymocytes and CD34+ UCB cells were plated in semi-solid 
cultures containing appropriate cytokines to generate myeloid (CFU-GM) or erythroid (BFU-E) colonies. 
(A) Typical myeloid (left) and erythroid (right) colonies generated from CD34+CD1a- thymocytes. (B) 
Overview of BFU-E dishes in which 105 CD34+CD1a- or CD34+CD1a+ thymocytes or 103 CD34+ UCB 
cells were plated. No colonies were detected in dishes with CD34+CD1a+ thymocytes. (C) RQ-PCR 
analysis of immature TCRD gene rearrangements (Dδ2-Dδ3) in original CD34+CD1a- thymocytes, 
myeloid and erythroid colonies generated from CD34+CD1a- thymocytes, myeloid colonies generated 
from CD34+ UCB cells and CD34+ cells from children’s BM sorted into either CD13/33- (mostly B cell 
progenitors) and CD13/33+ (myeloid progenitors) fractions. Percentages of rearranged alleles in each 
sample are shown.
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Rearrangements of the TCRD locus were quantitatively determined in the acquired 
colonies. While colonies derived from CD34+ UCB cells did not contain any rearranged 
TCRD genes, the most immature TCRD rearrangements (Dδ2-Dδ3) were present in 
about 10% of the alleles in the CD34+CD1a- thymocyte-derived colonies, both CFU-GM 
and BFU-E (Figure 3C). The proportion of Dδ2-Dδ3 found in the original CD34+CD1a- 
thymocytes was approximately 60%13, while CD34+CD13/33+ myeloid progenitor 
cells from children’s BM did not contain any TCRD rearrangements (Figure 3C). 
CD34+CD13/33- BM cells, which represent mainly B-cell precursors, did have (very low) 
levels of TCRD rearrangements (Figure 3C), consistent with earlier reports22. These data 
demonstrate that the developmental fate of cells that have initiated their differentiation 
into the T-cell lineage can still be reversed towards the myeloid and erythroid lineages. 
Lineage capacity and frequency of CD34+CD1a- and CD34+CD1a+ thymocytes
To assess the ability of CD34+CD1a- and CD34+CD1a+ thymocytes to develop into 
different hematopoietic lineages in more detail, we performed cultures on OP9 BM 
stromal cells expressing either GFP alone (OP9-GFP) or Notch ligand Delta1 (DL) in 
combination with GFP (OP9-DL). Culturing of CD34+ UCB cells on OP9-GFP has been 
previously shown to induce myeloid and B lymphoid development, while OP9-DL allows 
the development of T cells23. Both CD34+CD1a- and CD34+CD1a+ thymocytes efficiently 
developed into CD4+CD8+ double positive cells when cultured for 14 days on OP9-DL 
(Figure 4A), although CD34+CD1a- cells yielded four fold higher cell numbers (Figure 
4B), probably because they have higher proliferative capacity. 
As was expected from the colony assays (Table I), there were large differences 
between CD34+CD1a- and CD34+CD1a+ thymocytes when cultured on OP9-GFP. The 
CD34+CD1a- cells were able to proliferate on OP9 cells lacking DL, although they yielded 
significantly lower cell numbers than when cultured with DL (Figure 4B). In contrast, 
CD34+CD1a+ cells did not grow on OP9-GFP (Figure 4B), illustrating their irreversible 
commitment to the T-cell lineage and thereby need for continuous Notch signaling24. 
After culturing CD34+CD1a- thymocytes on OP9-GFP for 14 days, a subset of cells 
was found to be negative for CD7 (Figure 4C) and had developed into myeloid and B 
cells (Figure 4D). In some cultures both myeloid and B lymphoid cells were detected, 
1 Numbers of myeloid (CFU-GM) and erythroid (BFU-E) colonies calculated per 105 input cells. Means 
and standard errors of triplicate wells. Results are representative of three independent experiments.
  CFU-GM1  BFU-E1
CD34+ UCB  3267 ± 176  533 ± 233
CD34+CD1a-  108 ± 3  4.5 ± 1.5
CD34+CD1a+  0  0
Table I. In vitro colony assays.
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whereas in others cells from a single lineage were observed (Figure 4D). On the 
contrary when cultured on OP9-DL, all CD34+CD1a- thymocytes developed into CD7 
positive cells (Figure 4C) and only minute percentages (<1%) of cells representing non 
T-cell lineages were detected (Figure 4D right panel).
To determine the frequencies by which CD34+CD1a- thymocytes can develop into the 
different lineages, we performed limiting dilution cultures on OP9-GFP. The frequency 
of progenitors with B lineage potential was approximately 1 in 540 and with myeloid 
potential approximately 1 in 160 (Figure 5). In the presence of GM-CSF, the frequency 
of myeloid progenitors was increased to 1 in 48 CD34+CD1a- thymocytes (Figure 5).
As a control, the progenitor frequency of CD34+CD1a- thymocytes that can give rise 
to T cells was determined by culturing cells on OP9-DL for 14 days and staining for CD4 
and CD8. The T-cell progenitor frequency was found to be only 1 in 27 CD34+CD1a- 
thymocytes (Figure 5, right panel). A similar frequency was found when single cells were 
seeded on OP9-DL: after 14 days growing cells were found in 7 out of 192 wells. As it 
can be presumed that in an in vivo thymus environment the vast majority of CD34+CD1a- 
cells would develop into T cells, the OP9 system appears to be rather inefficient for 
culturing human cells. The real frequencies of myeloid and B lineage progenitors within 
Figure 4. OP9 co-cultures. 
(A) Development of CD4+CD8+ double positive cells from CD34+CD1a- (left panel) and CD34+CD1a+ 
(right) thymocytes cultured for 14 days on OP9-DL; 1000 cells per well were seeded. (B) Cell numbers 
per well after 14 days of culturing 1000 CD34+CD1a- or CD34+CD1a+ thymocytes on OP9-GFP or OP9-
DL. (C) CD7 staining of 300 CD34+CD1a- thymocytes cultured on OP9-GFP (left panel) or OP9-DL 
(right) for 14 days. (D) Presence of CD19+ B cells and/or CD13/33+ myeloid cells in 14-day co-cultures 
of 300 CD34+CD1a- thymocytes on OP9-GFP (left and middle panel) or on OP9-DL (right panel). 
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CD34+CD1a- thymocytes are therefore probably also a factor 30 higher than calculated 
from our experiments.
CD34+CD1a- and CD34+CD1a+ thymocytes lack in vivo repopulating capacity, 
inherent to HSCs
The finding that CD34+CD1a- thymocytes have T/B lymphoid, myeloid, and erythroid 
developmental capacity, together with the previously demonstrated NK cell and DC 
potential, raises the possibility that these cells either behave as very immature multi-
lineage progenitors or as true HSCs. A hallmark of HSCs is self-renewal capacity, of 
which NOD/SCID repopulating ability is the most commonly accepted read-out for the 
human system25.
Consequently, we performed transplantations of CD34+CD1a- and CD34+CD1a+ 
thymocytes into sublethally irradiated immunodeficient NOD/SCID mice. As a control we 
transplanted 105 sorted CD34+ UCB cells and showed that these efficiently repopulated 
BM and spleen (but not the thymus) of all mice tested (4-54% of BM cells positive for 
human CD45; mean 26%) and gave rise to B-cell and myeloid lineages (Figure 6A). 
In contrast, transplantation with CD34+CD1a- or CD34+CD1a+ thymocytes did not yield 
any cells positive for human CD45 above background levels (non-transplanted mice) in 
any organ, even when administered in a very high dose (5x106 CD34+ thymocytes per 
mouse) (Figure 6B). These results suggest that CD34+ thymocytes do not have self-
renewal capacity.
Figure 5. Frequencies of myeloid, B- and T-cell lineages. 
Precursor frequencies within the CD34+CD1a- thymocyte population were determined by limiting dilution 
assays and calculated using the method of maximum likelihood. Left panel: CD19+ B cells on OP9-
GFP. Frequency 1 in 644 (720 and 270 in subsequent experiments). Middle panel: CD13/33+ myeloid 
cells on OP9-GFP. Frequency 1 in 193 (126 in a second experiment) in the absence of GM-CSF (open 
squares) and 1 in 48 in the presence of GM-CSF (solid squares). Right panel: CD8+ T cells on OP9-DL. 
Frequency 1 in 29. 
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DISCUSSION
Our study demonstrates that CD34+CD1a- thymocytes have potential to generate 
T, B, myeloid and erythroid cells in vitro. Megakaryocytic potential was suggested by 
the expression of NF-E2 in CD34+CD1a- thymocytes and was confirmed by culturing 
thymocytes in suspension in the presence TPO and SCF. While CD34+CD1a+ thymocytes 
did not survive, CD34+CD1a- thymocytes could be cultured in this condition for at least 
14 days and developed into large cells resembling megakaryocytes, although definitive 
flow-cytometric characterization (e.g. by staining for CD41) was hindered by high 
autofluorescence (data not shown). As previous studies have already provided evidence 
for development into NK and DC cells from CD34+CD1a- thymocytes14-16, precursors for 
the full range of hematopoietic cells appear to be present in the human thymus. Although 
we did not formally prove that all these lineages can be attributed to a single progenitor 
cell, our data are evocative of the existence of an immature, stem cell like progenitor in 
the human thymus. Also studies in the murine thymus have shown that the DN1 subset 
(the earliest DN subset in the mouse) contains multilineage progenitors7,8,26. These 
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Figure 6. Repopulation of NOD/SCID mice. 
(A) Human CD34+ UCB cells efficiently repopulate BM of NOD/SCID mice. Left panel: expression of 
human CD45 within the lympho/monogate. Right panel: expression of CD19 and CD14 within the CD45 
gate. (B) No human CD45+ cells were detected in BM of mice transplanted with CD34+CD1a- thymocytes 
(left panel) or with CD34+CD1a+ thymocytes (right panel).
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included precursors for T, B and NK cells and DC and macrophages, but erythrocyte 
development has not been shown before.
Frequencies of myeloid and erythroid potential, as determined by in vitro colony 
assays, were markedly lower in the CD34+CD1a- thymocytes than in CD34+ UCB cells, 
probably because UCB contains higher numbers of more mature progenitors. Also in 
the OP9 co-cultures we found low frequencies of myeloid and B lineage progenitors 
in the CD34+CD1a- subset. As frequencies of the different lineages did not overlap, 
we could not provide definitive evidence for a thymic pluripotent progenitor. Instead, 
the CD34+CD1a- population may contain committed precursors for alternative (non-T) 
lineages. However, we think it highly unlikely that, for instance, a committed erythroid 
progenitor would enter the thymus. More efficient single cell assays will be needed 
to definitely solve the question of pluripotent progenitors versus mixtures of lineage-
committed progenitors. In our hands, single cell cultures were technically difficult and 
inconclusive, probably because the OP9 system is not optimal for human cells. La 
Motte-Mohs et al.23 have demonstrated that the OP9-DL culture system allows T-cell 
development from human CD34+CD38- UCB cells, but in this study large numbers of 
cells (>10,000 per well) were seeded and no limiting dilutions were performed. 
Although seeding efficiencies on OP9-GFP were too low to draw definitive 
conclusions, we did find wells containing both B and myeloid cells, also among wells 
seeded with limited numbers of cells (e.g. 10 or 30). Furthermore, the frequency of 
myeloid progenitors, when cultured on OP9-GFP in the presence of GM-CSF, was only 
two times lower than the frequency of T-cell progenitors. Together these data point 
towards the existence of multilineage progenitors in the human thymus.
The remarkable finding that normal human thymocytes that have undergone 
immature TCRD rearrangements can still be induced to develop into myeloid and 
erythroid cells, while these rearrangements are absent in CD13/33+ myeloid progenitors 
in BM, demonstrates that the distinction between lymphoid, myeloid and erythroid 
development is not as rigid as often assumed. A close lineage relationship between 
myeloid cells and T cells has also been suggested by experiments in the fetal mouse, 
by Katsura and co-workers27. 
The range of lineage potentials of early thymocytes may give clues about the 
identity of the BM progenitor that seeds the thymus. In the mouse, several candidate 
thymus-colonizing progenitors have been proposed. These include lymphoid-restricted 
common lymphoid progenitors (CLPs)2, early lymphoid progenitors (ELPs) that have 
limited myeloid potential28, multipotent Lin-Sca-1+c-Kit+ (LSK) cells6 and bipotent T/
myeloid progenitors29. Experimental data in the mouse argue against the CLP as a 
likely candidate. Although CLPs were detected in murine BM2, cells with the same 
surface markers could not be detected in the thymus5,6. Furthermore, BM contains 
other progenitors upstream of CLPs (e.g. LSK cells) that can efficiently generate T 
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cells6,30. Our finding that the earliest subset in the human thymus (as a population) has 
a very broad lineage potential, suggests that also the human thymus is not seeded by 
lymphoid restricted CLPs, but probably by more stem-cell like progenitors. This view is 
strengthened by our observation in OP9-GFP co-cultures that the frequency of myeloid 
potential within CD34+CD1a- thymocytes was higher than that of B cells, as is the case 
for normal human HSCs. Adolfsson and co-workers recently identified a population in 
the LSK compartment of murine BM that has lymphoid and myeloid, but not erythroid 
and megakaryocytic potential31. The fact that we find cells with erythroid potential within 
the CD34+CD1a- population suggests that at least part of the thymus-seeding cells are 
true HSCs.
The hypothesis that that the human thymus is seeded by a stem-cell like cell is 
supported by the fact that HSCs circulate in adult peripheral blood, both in mouse32 and 
human33 and can repopulate the thymus of irradiated mice6. However, this suggestion 
is contradicted by our finding that CD34+CD1a- thymocytes lack sufficient self-renewal 
capacity, as they could not repopulate NOD/SCID mice. In the mouse it has been shown 
that proliferation of a precursor that enters the thymus is limited to several weeks and 
that no permanent endogenous stem cell exists34. Nevertheless, it remains possible that 
the thymus is seeded by a HSC that rapidly looses self-renewal capacity and reduces 
non-T cell potential after entering the thymus and interacting with molecules on the 
thymic epithelium, for instance Notch ligands. Another possibility is that only a minute 
fraction of the cells that seed the thymus retains self-renewal and that this population is 
too rare to be detected with currently employed assays. 
An alternative explanation for the fact that CD34+CD1a- thymocytes could not 
repopulate NOD/SCID mice is that they lack BM homing capability. One of the adhesion 
molecules necessary for BM homing is CXCR435,36. However, using flow cytometry 
we could not detect any difference in CXCR4 expression between CD34+ UCB cells, 
which efficiently repopulate NOD/SCID BM, and CD34+ thymocytes (data not shown). 
This suggested that the BM homing capacity through CXCR4 is not affected, although 
absence of other homing signals in CD34+ thymocytes cannot be excluded. Poor 
homing capability can be considered as an additional argument against the existence 
of a thymic HSC, as murine HSCs were shown to have high BM-seeding efficiency37. 
In contrast to the immature characteristics of the CD34+CD1a- cells, the CD34+CD1a+ 
thymocytes showed a T-cell specific gene expression pattern and did not yield any non-
T-lineage cells in in vitro cultures. We did not test NK and DC potential, but previous 
studies have shown a very limited NK and no DC precursor activity of CD34+CD1a+ 
cells10. Together these findings suggest that human CD34+CD1a+ thymocytes are 
the equivalents of murine DN3 cells, in which final commitment to the T-cell lineage 
occurs38. This confirms our recently proposed scheme in which the stages of human 
T-cell development are highly similar to those in the mouse13.
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In summary, we here characterized the CD34+CD1a- and CD34+CD1a+ thymic 
populations by gene expression profiling and functional studies with respect to lineage 
potential and self-renewal capacity. We show that lineage potential of the CD34+CD1a- 
thymocytes is much broader than previously thought and includes erythrocytic and 
B-lymphocytic capacity. Although clonal assays with a higher seeding efficiency 
than those used here are necessary to prove whether all lineages can be attributed 
to a single progenitor, our data strongly suggest that the human thymus is seeded 
by multipotent progenitors. These progenitors are distinct from CLPs and may be 
pluripotent HSCs, which immediately loose self-renewal capacity upon contact with the 
thymic epithelium. 
MATERIALS AND METHODS
Thymus and umbilical cord blood material
Human thymus, UCB and BM material was obtained according to the informed consent guidelines 
of the Medical Ethical Committee of Erasmus MC, Rotterdam. Thymus material was obtained from 
children operated for congenital heart disease. All children were between 8 days and 2 years of age and 
did not suffer from hematological or immunological diseases. Thymocytes were isolated by disrupting 
the thymus on an iron filter and frozen until further use. After thawing, viable thymocytes were isolated 
using Ficoll density centrifugation.
BM material was obtained from remaining graft cells of BM transplantation procedures. UCB and 
BM mononuclear cells were isolated using Ficoll density centrifugation and frozen down until further 
use. Over 90% of UCB mononuclear cells were viable after thawing. 
Cell purification
For each sorting experiment, frozen thymocytes or UCB mononuclear cells from three to five 
different human donors were used. CD34+ progenitor cells were pre-purified by AutoMACS (Milteny 
Biotec) before FACS sorting. Cells were stained with CD1a-RD1 (Beckman Coulter) and/or CD34-APC 
(BD Pharmingen) for 30 minutes on ice, washed and sorted on a FACS Digital Vantage (DiVa) cell sorter 
(BD Biosciences) (Figure 1).
BM mononuclear cells were not MACS pre-purified but immediately stained with CD3-FITC, CD20-
FITC, CD34-APC (all from BD Pharmingen) and CD13-RD1 and CD33-RD1 (Beckman Coulter) and 
sorted on a DiVa cell sorter. 
Microarray analysis
RNA was isolated from purified UCB and thymocyte subsets and processed to cDNA and cRNA 
according standard methods for microarray analysis. Gene expression profiles were generated using 
Affymetrix U133A microarrays and have been described previously13.
Flow-cytometric validation of microarray results
For all flow-cytometric analyses, CD34+ cells were purified using AutoMACS (Myltenyi Biotec). For 
surface markers, cells were stained with CD34-APC (BD Pharmingen), CD1a-RD1 (Beckman Coulter), 
CXCR4-FITC (R&D Systems) or CD13-RD1 and CD33-RD1 (Beckman Coulter) for 10 minutes at room 
temperature. For intracellular staining of MPO, cells were stained first with surface markers, then fixed and 
permeabilized using IntraPrep reagent (Beckman Coulter) and stained with MPO-FITC (DakoCytomation). 
Cells were analyzed using a FACSCalibur flow cytometer (BD Biosciences) and Cell Quest Pro software.
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In vitro colony assays
Purified thymocyte and UCB subsets and chimeric mouse BM samples were assayed for the 
presence of human granuloctye-macrophage colony-forming units (CFU-GM) and erythroid burst-
forming units (BFU-E) by in vitro colony formation in viscous methylcellulose culture medium as described 
previously39. After 14 days of culture, the number of colonies was counted under a microscope.
Real-time quantitative PCR (RQ-PCR) of TCR gene rearrangements
DNA was isolated from cell samples using a GenElute mammalian genomic miniprep kit (Sigma). 
Gene rearrangements in the TCRD locus were quantitatively determined using TaqMan-based RQ-PCR 
as described previously13. Albumin DNA was determined in each sample to normalize for cDNA input. 
Nalm16 DNA was used as clonal control and reference sample in each experiment.
Stroma cultures
OP9 cells (BM stromal cell line, obtained from the ATCC) that either expressed human Delta1 
(DL) in combination with GFP (hereafter called OP9-DL) or GFP alone (OP9-GFP) were generated by 
retroviral transduction. OP9-GFP and OP9–DL were grown in confluent layers in 96 well plates in αMEM 
(Cambrex) containing 20% fetal calf serum. CD34+CD1a- and CD34+CD1a+ cells were FACS sorted 
onto the OP9 layers using a FACS Digital Vantage (DiVa) cell sorter (BD Biosciences). CD34+CD1a- 
thymocytes were seeded on OP9-GFP at 1000, 300, 100, 30, 10 and 3 cells per well (48 wells per 
condition per experiment) and on OP9-DL at 1000, 300, 100 and 30 cells per well (12 wells per condition) 
or 100, 30, 10 and 3 cells per well (48 wells per condition) or 1 cell per well (192 wells). CD34+CD1a+ 
cells were seeded on OP9-GFP and OP9-DL at 1000 cells per well (12 wells). Cells were cultured for 14 
days in the presence of 5 ng/ml human IL-7 and 25 ng/ml human SCF (both R&D Systems) and in one 
experiment with 80 ng/ml human GM-CSF (PeproTech).
Transplantations of NOD/SCID mice
10-15 weeks old NOD/LtSz-scid/scid (NOD/SCID) mice received a sublethal dose of 3.5 Gy of 
total body irradiation. Mice were intravenously injected with 105 FACS sorted CD34+ UCB cells or 106 
(1st experiment) or 5x106 (2nd experiment) sorted CD34+CD1a- or CD34+CD1a+ thymocytes in 250 µl of 
PBS. In the first experiment, five mice per group were used. In the second experiment, two mice per 
thymocyte group were used, because of the difficulty of obtaining sufficient cell numbers. To prevent 
infections, mice received 100 mg/l ciprofloxacin (Bayer) in their drinking water.
Thirty-five days after transplantation, the mice were killed and femurs, spleen and thymus were 
isolated. In each organ, total cell numbers were determined and the percentage of human cells and their 
subset distribution was assayed by flow cytometry using the following antibodies: CD8-PE (Sanquin) 
and CD4-FITC, CD14-FITC, CD19-PE, CD3-PerCP, CD45-APC (all from BD Pharmingen). Cell samples 
of non-transplanted mice were stained as negative controls.
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ABSTRACT
Wnt signaling is essential for T-cell development in the thymus, but the stages in which 
it occurs and the molecular mechanisms underlying Wnt-responsiveness have remained 
elusive. Here we examined Wnt signaling activity in different thymocyte populations by 
determining β-catenin levels, Tcf-reporter activation and expression of Wnt target genes. 
We demonstrate that Wnt signaling occurs in all thymocyte subsets, including the more 
mature populations, but most prominently in the double negative (DN) subsets. This 
differential sensitivity to Wnt signaling was not caused by differences in the presence 
of Wnts or Wnt receptors, as these appeared to be expressed at comparable levels 
in all thymocyte subsets. Rather, it can be explained by high expression of activating 
signaling molecules in DN cells, e.g. β-catenin, plakoglobin and long forms of Tcf1, and 
by low levels of inhibitory molecules. By blocking Wnt signaling from the earliest stage 
onwards using overexpression of Dickkopf, we show that inhibition of the canonical 
Wnt pathway blocks development at the most immature DN stage. Thus, Wnt signaling 
occurs most prominently in the DN thymocytes, which appear to be preprogrammed to 
respond to Wnt signals.
INTRODUCTION
The thymus is a primary lymphoid organ that provides a unique microenvironment for 
the development of bone marrow- or fetal liver-derived progenitors into mature T cells. 
This process involves a series of discrete phenotypic stages that can be recognized 
by expression of several key membrane molecules1. In both human and mouse, 
thymocytes are subsequently CD4-CD8- (double negative, DN), CD4+CD3- (human 
immature single positive, ISP) or CD8+CD3- (mouse ISP), CD4+CD8+ (double positive, 
DP) and finally CD4+CD3+ or CD8+CD3+ (single positive, SP). In the mouse, the DN 
subset can be further subdivided into four stages: CD44+CD25- (DN1), CD44+CD25+ 
(DN2), CD44-CD25+ (DN3) and CD44-CD25- (DN4). In the human thymus, CD34+CD1a- 
cells correspond to murine DN1+2 thymocytes and CD34+CD1a+ cells are homologous 
to DN32. The proliferation, differentiation and T-cell receptor (TCR) rearrangement steps 
that occur in the thymus are tightly regulated by a number of molecular pathways. One 
such pathway that is increasingly recognized to be important for T-cell development 
is the Wnt signaling cascade3. Several Wnt transduction routes have been described 
(reviewed by Veeman et al.4). The focus of this report is on the canonical (β-catenin 
dependent) Wnt signaling pathway.
Wnt proteins are secreted molecules that regulate cell-to-cell interactions in many 
different cell types and various species. In the thymus, Wnts are produced mainly 
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produced by the thymic epithelium5 . A role for Wnt proteins in T-cell development 
has been deduced from mice deficient for both Wnt1 and Wnt46. These mice show 
decreased thymocyte numbers, but no change in developmental pattern, suggesting a 
principally proliferative function for these Wnts. 
Wnts bind to a receptor complex consisting of a member of the Frizzled (Fz) family 
of seven transmembrane proteins and the LDL-receptor-related proteins LRP-5 or LRP-
6. Knock-out mice have been generated for a number of Fz, but, possibly partly due to 
their often early lethal phenotypes, defects in hematopoiesis have only been found in 
the Fz9 null mice7. The most notable defects in Fz9 null mice are partial blocks in pro- 
and pre-B-cell development and accelerated thymic atrophy in aging animals.
As the high redundancy of the different Wnts and Fz in the thymus3 obscures their 
importance when studied in straight knock-outs, overexpression of negative regulators 
of the Wnt pathway may be more informative. For instance, soluble Fz receptors have 
been shown to block early thymocyte development in fetal thymic organ culture (FTOC) 
at the DN to DP transition8. These studies have indicated an important role for the 
membrane proximal components of the Wnt pathway, but the exact contribution of 
the different Wnts, Fz and LRPs that are expressed by thymic stroma and thymocyte 
subsets in human and mouse are unknown.
After binding of a Wnt protein to a Fz receptor, a complex cascade of events is 
initiated, finally leading to the inhibition of the negative regulatory kinase GSK-3β9 
which, in a complex together with Axin and APC, phosphorylates β-catenin. Inhibition 
of β-catenin phosphorylation prevents its ubiquitylation and proteasomal breakdown. 
Furthermore, various studies indicate that only dephosphorylated β-catenin is the 
transcriptionally active form10,11. Overexpression of a constitutively active form of β-
catenin has been shown to induce self-renewal of hematopoietic stem cells12, but the 
role of β-catenin in T-cell development is controversial. Mice with β-catenin deleted in 
all T cells from DN3 onwards showed impaired T-cell development at the β-selection 
checkpoint13, but mice transplanted with hematopoietic stem cells in which β-catenin 
had been inducibly deleted did not show in any thymic defect14. However, the normal 
expression of both total and dephosphorylated β-catenin in the different thymocyte 
subsets under physiological conditions has not been studied.
Dephosphorylated β-catenin is targeted to the nucleus by Pygopus and Legless/
BCL915, where it binds to Tcf/Lef transcription factors16, in thymocytes predominantly 
Tcf1. Young Tcf1 deficient mice have an incomplete block at the DN1, DN2 and ISP 
stages, while older mice display a complete block at the DN1 stage of thymocyte 
development17,18. 
In the absence of β-catenin, Tcf1 functions as a repressor of transcription19. Binding 
of β-catenin to Tcf/Lef recruits chromatin-modifying and -remodelling complexes 
to transcribe Wnt target genes20, which in the most immature thymocytes regulate 
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proliferation and cell-adhesion21.
Although the phenotype of the Tcf1 deficient mouse suggests a role for Wnt signaling 
in the early stages of T-cell development, definite proof for a role of Wnt signaling is not 
provided by such mice, as the block might be a result of abolishment of the repressive 
functions or other Wnt independent functions of Tcf1. Additional roles for Wnt signaling 
have been reported in more advanced stages of thymocyte development, including 
differentiation into DP cells22, survival of DP cells23 and generation of mature CD8+ 
thymocytes24 have been reported. It remains unclear during which stages of T-cell 
development Wnt signalling occurs and is functionally important.
In this study we set out to answer a number of important questions with respect 
to Wnt signaling in the thymus (Figure 1). First we investigated at which stages in the 
thymus Wnt signaling occurred and which cells were able to respond to Wnt. Second, 
we carefully analyzed the expression of Wnts, Fz and LRPs throughout mouse and 
human T-cell development. Third, we studied the molecular mechanisms underlying 
the differential Wnt responsiveness between subsets. Finally, we performed functional 
studies blocking the canonical Wnt pathway from DN1 onwards to assess the earliest 
stage in the thymus where Wnt signaling might be required. 
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Figure 1. Experimental dissection of critical steps in the Wnt signaling pathway in thymocyte 
subsets.
 Arrows indicate the different levels of Wnt signaling that were studied in human and murine thymocyte 
subsets. First, it was determined in which thymocyte subsets Wnt signaling occurs (1). Subsequently, 
levels of membrane proximal (2), cytoplasmic (3) and nuclear (4) Wnt signaling components were 
measured by various methods, as indicated. Finally, the effect of blocking Wnt binding in the thymus 
was studied (5). 
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RESULTS 
Wnt signalling occurs mainly in the early DN stages
We have used three read-outs for active Wnt signaling, namely levels of β-catenin, 
the activation of a Tcf reporter and the transcription of known thymic Wnt target genes 
(Figure 1). 
Levels of β-catenin in thymocyte subsets
As dephosphorylated β-catenin is highly stable and not degraded in the proteosome, 
elevated levels of total β-catenin are an indication that Wnt signaling occurs in a cell. 
We have developed a flow-cytometric assay to determine the presence of β-catenin 
in thymocyte subsets. This assay was validated by treating Jurkat cells with lithium 
chloride, which inhibits GSK-3β and leads to a profound increase in β-catenin levels 
(Figure 2A).
In the human thymus, the highest levels of β-catenin were observed in the DN 
cells and especially in the most immature DN CD34+ fraction, which corresponds to 
murine DN1-3 cells2 (Figure 2B). This finding suggested that Wnt signaling is active 
preferentially in these cells. 
Similarly, in the adult murine thymus, β-catenin was present predominantly at the 
DN and ISP stages (Figure 2C). In fetal thymic lobes of embryonic day 14, 15 and 16, 
high levels of β-catenin were present. Levels were higher at the DN1+2 stages than at 
the DN3+4 stage and clearly decreased in the DP cells that arose on embryonic day 
16 (Figure2D).
An antibody against active (dephosphorylated) β-catenin has been developed10. 
Unfortunately, we were unable to detect dephosphorylated β-catenin by flow cytometry 
(data not shown), presumably because of its strong nuclear localization, which precludes 
access to the antibody. We have, however, detected signals by Western blotting (see 
below).
Activation of a Tcf/Lef reporter
The next vital step in the Wnt signaling cascade is the binding of dephosphorylated 
β-catenin to Tcf/Lef high mobility group (HMG) box transcription factors. To study the 
transcriptional activation of the Tcf/β-catenin complex at sequential stages of T-cell 
development, we used a lentiviral Tcf reporter system, in which expression of GFP is 
driven by a Tcf/Lef-responsive promoter (TOP-GFP)12. As a negative control, we used a 
vector containing mutated Tcf binding sites (FOP-GFP). 
Hematopoietic stem cells from human cord blood were infected with this these 
lentiviruses and induced to develop into T cells in vitro in fetal thymic organ cultures 
(FTOC). After two days of transduction, none of the cells expressed GFP (Figure 3A), 
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indicating that in vitro cultured HSC do not undergo active Wnt signaling. However, after 
inducing T-cell development in FTOC, a population of GFPhigh cells could be observed 
that was absent from the FOP-GFP control (Figure 3B). GFP levels were analyzed 
in DN, ISP, DP and SP thymocyte subsets (Figure 3C). Surprisingly, Tcf-dependent 
signaling was detected in all thymocyte subsets, including the more mature populations. 
However the mean fluorescence of the GFP-positive fraction was 2-3 times higher in 
the DN cells, consistent with the high levels of β-catenin in these cells. 
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Figure 2. Differential expression of β-catenin in thymic subsets. 
Intracellular β-catenin levels were determined by flow cytometry in (A) Jurkat cells stimulated for 24 
hrs with either KCl or LiCl, (B) freshly isolated human thymocytes, (C) freshly isolated adult murine 
thymocytes and (D) murine thymic lobes from 14, 15 and 16 day old embryo’s. All thymus samples were 
counterstained to distinguish different subsets. As CD25 antibodies failed in this protocol, only DN1+2 
versus DN3+4 distinctions could be made. Dotted lines represent isotype (human) or unstained (mouse) 
controls. Mean fluorescence intensity (MFI) of the β-catenin signal - background signal is indicated in 
each graph.
Chapter 5
102
Expression of Wnt target genes
Cells undergoing Wnt signaling are expected to induce expression of Tcf dependent 
target genes. We have previously identified a core set of seven Wnt target genes in 
human CD34+ DN thymocytes, namely c-fos, fosB, c-jun, CL100, integrin p150,95, 
hsp70 and NRPB21. Using RQ-PCR we studied the expression of these target genes 
in all human thymocyte subsets and found that c-fos, CL100 PTPase and hsp70 were 
expressed preferentially in the most immature DN populations, while fosB and c-jun 
were higher expressed in the more mature stages21. 
Microarray studies of the murine thymocyte subsets have been performed by Petrie 
and co-workers25. By mining these data for thymic Wnt target genes, we found that 
p150,95 was expressed at high levels at the DN1 stage and rapidly decreased in the 
more mature stages (Figure 4A). For c-fos, fosB and c-jun this differential expression 
was less clear. However, Petrie and co-workers studied the expression of fos and jun 
also by RQ-PCR and found that they were expressed preferentially at the DN1 stage 
and were virtually absent in the other stages25. 
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Figure 3. Tcf-reporter expression during human thymocyte development. 
CD34+ precursor cells from human cord blood were transduced with a lentiviral vector encoding a Tcf 
reporter (TOP) or a reporter containing mutated Tcf binding sites (FOP) and cultured in FTOC. (A) Tcf 
dependent GFP expression after two days of transduction and (B) after three weeks of FTOC. (C) Tcf-
dependent GFP expression in the different thymocyte subsets after three weeks of FTOC. ISP and 
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mean fluorescence of the GFP positive population is indicated in each graph. Mean fluorescence of GFP 
positive cells transduced with FOP was similar in all subsets (around 60).
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Figure 4. Expression of thymic Wnt target genes during thymocyte development. 
(A) Thymic Wnt target genes in murine thymocyte subsets as determined by microarray analysis by 
Tabrizifard et al.25 (B) Hierarchical clustering of gene expression profiles generated from murine thymic 
lobes of embryonic day 14, 15, 16 and 18. (C) Expression of Wnt target genes in embryonic thymi 
determined by microarray analysis. Fluorescence units were normalized over the whole experiment. A 
signal over 100 indicates presence of a gene. (D) RQ-PCR validation of c-fos and c-jun expression in 
embryonic thymi, relative to house-keeping gene GAPDH.
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During ontogeny, the DN subset is the first subpopulation to arise in the embryonic 
thymus and is the only population at day 14, followed by the appearance of ISP at day 
15, DP at day 16 and CD4 and CD8 SP at day 17. We generated expression profiles 
of thymic lobes of 14, 15, 16 and 18-day-old mouse embryos using DNA microarray 
technology (Figure 4B). In these expression profiles, we investigated the expression 
of the same core set of target genes. While p150,95 was expressed at all embryonic 
stages at similar levels, all other genes were expressed most prominently at day 15 
(Figure 4C), when thymocyte numbers are rapidly increasing but all cells still are very 
immature. For c-fos and c-jun this finding was confirmed using RQ-PCR (Figure 4D). 
The lower expression of Wnt target genes from day 16 onwards, likely reflects the 
increasing contribution of DP and SP cells and the reduced levels Wnt signaling in 
those subpopulations.
Taken together these results point to a high level of Wnt signaling preferentially in 
the most immature DN, and to a lesser extend ISP, thymocyte subsets. 
Wnts and receptors are present in all thymocyte subsets
To investigate which factors determine whether cells are receptive to Wnt signaling, we 
examined the presence of several Wnt signaling components in the different thymocyte 
subsets. First we determined the expression of the membrane-associated factors: 
expression of Wnt, Fz and LRP genes. As no reliable antibodies for flow cytometry are 
available against these components, we used TaqMan RQ-PCR to determine mRNA 
levels in sorted thymocyte populations in both human and murine thymus, as well as in 
embryonic thymic lobes (Figure 5A-I and Supplementary Figure 1).
Both in man and in mouse, most Wnts investigated appeared to be expressed in all 
thymocyte subsets, but at different levels. Both in human and murine thymus, Wnt5 and 
Wnt10 were the most prominent Wnts (Figure 5A and D). Both in human and mouse, 
Wnt expression was most marked in the SP subsets, although in mice Wnt5b was 
expressed at high levels in the DP subset as well. In the thymic stroma, high levels 
of Wnt5a (human) and Wnt4, Wnt5b and Wnt10 (mouse) were detected, generally at 
levels significantly higher than in thymocytes (Supplementary Figure 1 and data not 
shown).
Of the Frizzled receptors, Fz6 was by far the most prominent in the human thymus 
(Figure 4B) and Fz5 and Fz6 in the murine thymus (Figure 5E). Levels of Fz varied 
between thymocyte subsets and tended to be lowest in the DP fraction. LRP5 and 6 
were expressed at similar levels, both in mouse and in human, and expression was 
more or less equal between the different thymocyte subsets (Figure 5C and F). 
Interestingly, during fetal development a different set of Wnts was expressed than 
in the mature thymus: here Wnt3a and Wnt4 were most prominent, although Wnt 5b 
was also present at moderate levels (Figure 5G). While expression of Wnt4 decreased 
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gradually in time, Wnt5b seemed to increase to levels detected in the mature thymus, 
possibly reflecting a decreased contribution of stromal cells in more mature thymic 
lobes. Also, in contrast to the mature thymus, all Fz investigated were present at readily 
detectable levels, although in accordance with the mature thymus, Fz6 was the most 
prominent (Figure 5H). The Fz tended to be expressed highest at embryonic day 14 
and gradually decreased with time, presumably reflecting diminishing contribution of 
very immature cells to the total thymocyte population, and therefore the need for Wnt 
signaling. LRP5 and 6 were expressed at equal levels during all examined days of 
embryonal development (Figure 5I). 
The expression pattern of the Wnts (mainly by the stroma and the more mature 
SP thymocytes), Fz (variable levels in thymocyte subsets) and LRPs (constitutively 
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Figure 5. Expression of Wnts, Fz and LRPs in thymic subsets. 
mRNA levels of different Wnts and Fz were determined by RQ-PCR. (A) Human Wnts, (B) human Fz, 
(C) human LRPs, (D) murine Wnts, (E) murine Fz, (F) murine LRPs, (G) murine Wnts in embryonic 
thymi, (H) murine Fz in embryonic thymi, (I) murine LRPs in embryonic thymi. All graphs show results of 
a single representative experiment out of 2-5 performed, as replicate experiments always showed the 
same trend, but absolute expression levels varied. Expression levels are relative to GAPDH expression 
in the same sample.
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expressed), cannot account for our finding that active Wnt signaling occurs predominantly 
in the DN and ISP subsets. Other mechanisms must therefore regulate differential Wnt 
signaling.
Expression of intracellular signaling molecules predisposes DN thymocytes to 
respond strongly to Wnt signals
We studied the expression of several intracellular Wnt signaling components 
using Western blot and microarray analysis. As there is no antibody against murine 
Tcf1 available26, these experiments were performed using sorted human thymocyte 
subsets.
Protein levels of intracellular Wnt signaling components
Western blotting showed presence of total β-catenin in all thymocyte populations, 
but mainly in the CD34+ DN1-3 populations and somewhat lower in the ISP subset 
(Figure 6A), confirming our results obtained by flow cytometry (Figure 2B). The same 
distribution was detected for active (dephosphorylated) β-catenin, although this was 
completely absent from the DP stage onwards. Staining of human thymus tissue slides 
with the same antibody against dephosphorylated β-catenin, showed a pattern of 
nuclear foci in thymocytes (Figure 6B), confirming a function as an active transcription 
factor in these cells.
In many cell types, β-catenin is bound to E-cadherin at the cell membrane and 
functions in cell adhesion (membrane bound β-catenin pool), rather than as a signaling 
component (cytoplasmic β-catenin pool)27. In human thymocytes, high levels of β-
catenin were not caused by elevated expression of E-cadherin in the same subsets, as 
E-cadherin levels were relatively constant and low in all subsets (Figure 6A). 
Presence of Tcf/Lef proteins is obviously a prerequisite for Wnt signalling to occur and 
Tcf1 is the most important family member expressed in mature thymocytes3. Expression 
of Tcf1 protein was detected in all populations at similar levels (Figure 6A). Interestingly, 
however, the ratio between expression of the long (activating) and short (repressing) 
splice-isoforms of Tcf1 differed between the different thymocyte subsets. This ratio was 
highest in the CD34+CD1a- (DN1+2) cells (Figure 6C), allowing the final transduction of 
Wnt signals to occur preferentially in these immature cells. 
mRNA levels of intracellular Wnt signaling components
Presence of other intracellular Wnt signaling components was extracted from gene 
expression profiles of human thymocytes subsets2. Plakoglobin (γ-catenin), another 
armadillo protein that can activate Tcf/Lef transcription factors28, showed an expression 
pattern highly similar to that of β-catenin (Table I), also peaking in the CD34+ (DN1-
3) thymocytes. Conversely, expression of Axin, one of the molecules that functions to 
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retain β-catenin in the complex in the cytoplasm, increased gradually during thymocyte 
maturation. Also HMG2L1, a nuclear negative regulator of Wnt signaling29, was 
expressed at lower levels in the most immature (and also the SP) populations (Table I). 
Levels of APC, Groucho and transcriptional activators Pygopus and Legless/Bcl915 did 
not change during thymocyte differentiation (Table I). 
Together these results suggest that active Wnt signaling in the early thymocyte 
subsets is determined by elevated levels of activating and lower levels of inhibiting 
factors in the Wnt signaling cascade, as summarized in Figure 6D. The most immature 
thymocytes therefore appear to be preprogrammed to respond to Wnt signals. 
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Figure 6. Expression of intracellular Wnt signaling components in the human thymus. 
DN1/2 thymocytes were defined as CD34+CD1a- and DN3 as CD34+CD1a+. (A) Protein levels in 
sorted thymocyte subsets determined by Western blot. An arrow indicates the very faint, but visible 
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determined in human thymocyte subsets by microarray analysis.
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Wnt signaling is crucial for early thymocyte development 
The data presented above show that Wnt signalling is preferentially active in the 
most immature DN subsets. However, the importance of Wnt signalling during the DN 
stages of thymocyte differentiation has not been studied, largely because conditional 
deletion of Wnt components during thymocyte development relies on Cre-transgenic 
mice that fail to show significant expression in DN1 and DN2 subsets (e.g. the Lck 
or CD4 promoter). To examine the effect of inhibited Wnt signaling on early T-cell 
development, we employed a retroviral vector encoding the gene for mouse Dickkopf-
1 (mDkk-1). This protein binds to the LRP co-receptor for Wnt and thereby potently 
inhibits binding of Wnt and activation of the Wnt signaling cascade30. We transduced 
murine bone marrow and fetal liver cells with the mDkk-1 retrovirus and studied the 
ability of these cells to develop into T cells in FTOC. Although the results of six different 
experiments were variable, in all cultures of mDkk-1 transduced cells a strong selection 
against high mDkk-1 expression (i.e. high GFP signals) was detectable (Figure 7A). 
In experiments in which a meaningful number of GFP expressing cells survived, the 
GFP+ cells exhibited a complete block at the DN1 stage (Figure 7B). This block was 
less severe for the cells expressing intermediate amounts of GFP. These results show 
that Wnt signaling is crucial for developing thymocytes, already at the DN1 stage. The 
striking similarity between the Tcf1 deficient mice and the block induced by inhibition of 
Wnt binding, strongly suggest that Wnt signaling is the sole or main inducer of Tcf1/β-
catenin dependent transcription in the thymus.
Table I. Expression levels of intracellular Wnt signaling molecules1. 
DN1+2 DN3 ISP DP CD4+SP CD8+SP
JUP 327.2 184.3 112.8 88.5 108.4 156.7
APC 84.0 65.0 57.7 70.5 65.8 57.3
Axin1 182.9 165.2 173.9 205.2 217.4 227.5
TLE3 192.3 213.7 206.9 200.6 177.0 208.5
Pygo1 39.2 40.7 35.3 39.9 32.7 33.2
Bcl9 93.8 103.6 80.4 94.0 118.5 130.7
HMG2L1 144.5 146.8 185.1 202.6 161.7 147.1
1Relative mRNA expression levels of different Wnt signaling components in human thymocyte subsets 
determined by microarray analysis. TLE3 is the only Groucho homologue that was found to be expressed 
at significant levels in thymocytes. JUP: junction plakoglobin.
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DISCUSSION 
Although various reports have indicated a functional role for Wnt signaling in the 
thymus6,8,17,31, several important aspects have remained elusive. These include the 
nature of Wnt ligands and Fz receptors expressed by the various thymocyte subsets 
and during thymic ontogeny, the stages in which Wnt signaling takes place and why it 
takes place in those subsets.
Both levels of β-catenin and GFP expression from a Tcf reporter construct were 
found to be highest in the DN1-3 subsets, in humans characterized by expression of 
CD34. After these stages, cells stop proliferating and start rearranging their TCR genes. 
Although ISP cells had higher levels of total β-catenin, Tcf-dependent transcription was 
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Figure 7. Overexpression of mouse mDkk-1 blocks T-cell development at the DN1 stage. 
(A) Murine bone marrow cells (experiment #1,2 and 4) or fetal liver cells (#3, 5 and 6) were transduced 
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not increased in these cells. Presumably, proliferation from DN3 onwards is mainly 
driven by (pre-) TCR signaling rather than by Wnt signals.
It was unexpected to find that also the more mature populations in the thymus 
undergo Wnt signaling, albeit at low levels, since Wnts are thought to give mainly 
proliferative signals21,32 and since in the Tcf1 knock-out mouse only the DN and ISP 
stages are affected18. However, a number of reports have demonstrated a role for Wnt 
signaling in more mature stages of T-cell development22-24. The function of Wnt signaling 
in the more mature subsets is probably directed towards prevention of apoptosis rather 
than towards proliferation.
To investigate which factors determine whether cells can respond to Wnt signals, we 
made an inventory of Wnt signaling components in different stages of T-cell development 
in human and mouse. Because of the lack of suitable antibodies against Wnts and Fz, 
assessment of proximal Wnt signaling components has thus far relied largely on non-
quantitative PCR detections and Northern blot experiments8. We confirm the finding 
of Jenkinson and co-workers5 that the thymic epithelial cells (TECs) comprising the 
stromal compartment are the major source of Wnt factors in the thymus. TECs are the 
main source of growth factors for developing thymocytes, not only of classical cytokines 
such as Il-7 and SCF, but apparently also of Wnt proteins. 
Surprisingly, the SP thymocyte subsets also expressed significant levels of Wnt 
genes. As Wnt proteins are highly insoluble and presumably are unable to diffuse 
throughout the thymus, the Wnts produced by more mature medullary thymocytes 
are unlikely to reach the cortical immature cells and most likely represent autocrine 
signals. High concentration of Wnts surrounding the more mature cells may explain 
why they undergo (low level) Wnt signaling, while expressing many negative regulatory 
factors of the Wnt signal transduction pathway. Alternatively, these Wnts may bind to 
neighbouring stroma cells, which also express Fz and LRP receptors, to provide ‘cross-
talk’. It would be interesting to study whether Wnts are produced in specific stromal 
niches, e.g. subcapsular or at the corticomedullary junction. 
All thymocyte subsets express Fz receptors and LRP5 and 6 at high levels and 
are therefore theoretically able to respond to exogenous Wnt proteins. However, Tcf1 
dependent transcription was detected mainly in the early DN cells, indicating that other 
positive factors essential for Wnt signaling were missing in more mature cells. We found 
that β-catenin levels were significantly higher in the most immature DN subsets and 
the same was true for mRNA levels of the β-catenin homologue plakoglobin. The role 
of β-catenin during T-cell development has been addressed in two different conditional 
knockout mouse models, which have generated conflicting results. The study by Sen 
and co-workers indicated that β-catenin-mediated signals are required for normal T 
cell development13, while Radtke and colleagues reported that hematopoiesis including 
T-cell development in the thymus proceeded normally in absence of β-catenin14. As a 
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possible explanation for their negative results, Cobas et al. suggested that expression of 
plakoglobin may compensate for the absence of its homologue β-catenin14. The parallel 
expression of β-catenin and plakoglobin in our experiments provides evidence that this 
is a plausible explanation and may account for the relatively mild or absent phenotype 
of β-catenin deficient mice13,14. 
In addition to elevated β-catenin, we show that the ratio between the long and short 
splice-isoforms of Tcf1 is highest in the DN subsets. Different isoforms of Tcf1 have 
been described33, but their function remains unclear. Some of these isoforms lack 
the β-catenin binding domain and therefore probably function as dominant negative 
proteins with regard to Wnt signaling. The various molecular forms of Tcf1 arise by 
both alternative splicing and alternative promoter usage. It would be of obvious interest 
to study regulation of these processes. We propose that the short Tcf1 isoforms have 
regulatory functions in the thymus and that a critical balance between long and short 
isoforms determines whether Wnt signals are finally transduced into transcription of 
target genes. Likewise, it is of interest to understand how expression of Wnt, Tcf and 
other components of the pathway are transcriptionally regulated, as their differential 
expression during thymocyte development is likely controlled at the level of gene 
expression.
Our results show that Wnt signalling mainly occurs in the most immature DN stages. 
However, the role of Wnt signaling in these subsets has not been conclusively studied. 
The Tcf1(VII) knock-out mouse has a severe phenotype in the early stages of T-cell 
development17,18, but this might be due to the loss of repressive functions of Tcf1. In the 
conditional β-catenin knock-out employed by Sen and co-workers, the effect on early DN 
cells can not be studied as a consequence of the later expression of Lck (DN3)13, while 
the complete β-catenin knock-out has no phenotype at all14. Finally, targeted mutation 
of Wnts or Fz receptors would not give a clear answer, since they are highly redundant 
as we show in this study and has been observed in Wnt1Wnt4 double deficient mice. 
To circumvent these problems, we overexpressed the mDkk-1 gene to block binding 
of Wnt proteins to the LRP co-receptor in stem cells. When induced to develop into T 
cells in FTOC, mDkk-1 expressing cells were blocked in the DN1 stage. This effect was 
dose dependent, with the cells expressing low levels of GFP still being able to develop 
into DN2 cells. These findings are consistent with a function of mDkk-1 as competitive 
inhibitor of Wnt proteins. 
During the DN1 and 2 stages of T-cell development, thymocytes undergo massive 
proliferation to expand the thymocyte pool before the TCR rearrangement and selection 
processes are initiated34. The strong complete block of T-cell development in DN1 when 
Wnt signaling is inhibited, demonstrates the importance of Wnts as proliferation factors 
for these immature cells.
In summary, we demonstrate that all thymic subpopulations can undergo low levels 
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of Wnt signaling, but the highest levels of active Wnt signaling were detected in the most 
immature DN cells. This differential responsiveness is not determined by expression 
of membrane associated factors, but rather by the balance between activating and 
inhibiting intracellular components of the Wnt signaling pathway, as shown in Figure 6D. 
The high levels of β-catenin expression in the DN subsets, coupled with high expression 
of the Wnt-responsive long Tcf1 isoforms compared to the shorter inhibitory isoforms, 
as well as low levels of factors that negatively control Wnt signaling such as Axin and 
HMG2L1, predetermine a high responsiveness to Wnt signaling in DN thymocytes.
The regulation of responsiveness to developmental clues by differential expression 
of intracellular regulators rather than by abundance of receptors or ligands provides 
a previously unrecognized mechanism to regulate signal transduction events. To our 
knowledge this is the first demonstration that only cells preprogrammed to respond 
to external stimuli do so during differentiation. It seems likely that such mechanisms 
operate during other developmental processes in other tissues.
Since Wnt signals are important for survival and expansion of lymphocyte 
progenitors, it has been suggested that deregulated Wnt signaling may be a mechanism 
underlying leukemogenesis. Indeed, several reports have now indicated that in various 
hematological malignancies, aberrant Wnt signaling constitutes a key oncogenic event; 
these include AML, CML, CLL, precursor B-ALL and multiple myeloma (reviewed by 
Staal and Clevers35). For the malignant counterparts of normal T-cell progenitors, i.e. 
T-cell acute lymphoblastic leukemias (T-ALL), such indications have not been found. 
Given the immature (CD3-) phenotype of most T-ALL and the high level of Wnt signaling 
in the normal immature thymocytes, as we report here, simple detection of elevated 
levels of (dephosporylated) β-catenin in T-ALL may not suffice to indicate a causative 
role for Wnt signaling in the leukemogenic process. It may well be that mutations in 
the Wnt pathway, for instance activating mutations in β-catenin, will lead to high levels 
of Wnt signaling in T-ALL, thereby contributing to leukemogenesis. A comparable role 
has been documented for another pathway important in DN thymocytes development, 
namely the Notch pathway36. 
MATERIALS AND METHODS
Isolation of cells
Human thymus material was obtained from children operated for congenital heart disease, according 
to the informed consent guidelines of the Medical Ethical Committee of Erasmus MC, Rotterdam. All 
children were between 8 days and 2 years of age and did not suffer from hematological or immunological 
diseases. Thymocytes were isolated by disrupting the thymus on an iron filter. The remaining stroma 
was carefully washed to remove all remaining thymocytes and lysed in RLT buffer (Qiagen) for RNA 
isolation. Cells were either directly used for flow-cytometric analysis or frozen until further use. After 
thawing, viable thymocytes were isolated using Ficoll density centrifugation.
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All animal experimentation was done in accordance with legal regulations in The Netherlands, which 
include approval by the local Animal Experiments Committee. Mouse thymi were obtained from 2 and 
4 weeks old female C57Bl/6 mice. Thymocytes were isolated by disrupting the thymi through a 70 μm 
cell strainer (Falcon) and immediately used for flow cytometry or sorting. The remaining stroma was 
washed thoroughly to remove all thymocytes, then snap-frozen and grained into small particles that 
were dissolved into RLT buffer (Qiagen) for RNA isolation.
Mouse fetal thymic lobes were obtained from embryos from 14, 15, 16 and 18 days pregnant C57Bl/6 
mice. Thymic lobes were disrupted by gently passing them through a 24G syringe. 
Antibodies
All monoclonal antibodies against human and mouse proteins were obtained from BD Pharmingen, 
except for human CD1a-RD1, which was from Beckman Coulter.
Cell sorting
For each sorting experiment, frozen thymocytes of five different human donors or fresh thymocytes 
of four different mice were used. CD34+ human thymocytes were pre-purified by AutoMACS (Milteny 
Biotec) before FACS sorting. Cells were stained for 30 minutes on ice, washed and sorted on a FACS 
Digital Vantage (DiVa) cell sorter (BD Biosciences). Purity of the recovered subpopulations was checked 
and was always greater than 95%.
Intracellular staining of β-catenin
Freshly isolated thymocytes were immediately fixed in 2% paraformaldehyde at 37°C and 
permeabilized in PBS containing 0.5% saponin, 4% fetal calf serum, 1mM glycerolphosphate and 
phosphatase inhibitor cocktails I and II (Sigma). Cells were stained for one hour with an antibody 
against β-catenin (clone 8E4 (Upstate), FITC labeled according to standard procedures) at 4°C. Cells 
were washed, resuspended in PBS containing 0.5% BSA and stained with cell surface markers for 1 
hour at room temperature. After washing, cells were analysed using a FACSCalibur flow cytometer (BD 
Biosciences). Unstained and isotype-control stained samples showed similar patterns.
TaqMan-based real-time quantitative-PCR (RQ-PCR) 
All primer and probe sequences were designed with the Primer Express version 1.5 software (Applied 
Biosystems) and are listed in Table II. One µg RNA isolated from sorted subpopulations was treated with 
1U of DNase I and subsequently transcribed to cDNA with Superscript II Reverse transcriptase (200 
U), oligo(dT) and random hexanucleotide primers. A 1/20 cDNA mixture was used for RQ-PCR for each 
primer/probe set and performed in duplicate. The RQ-PCR mixture of 25 µl contained TaqMan Universal 
mastermix, 900 nM primers and 100 nM probe and was run on the PRISM 7700 sequence detection 
system containing a 96 well thermal cycler (Applied Biosystems). 
For each primer/probe set, a dilution curve was made using cell line DNA as a target. The relative 
amount of Wnt/Fz/LRP cDNA in every thymocyte subset was read from the corresponding dilution curve. 
The amount of input cDNA was normalized to GAPDH expression (human kit from Applied Biosystems, 
mouse kit from Biosource) in the same sample.
Efficiencies of most RQ-PCRs were similar, and therefore it was possible to compare expression 
levels of the different Wnts, Fz and LRPs. As no good dilution curve was obtained for human Wnt1 and 
Fz8 and mouse Wnt4 and Wnt10b, these were read from another representative curve. No successful 
primer/probe sets could be developed for mouse Wnt1 and Wnt5a.
 
Microarrays
RNA was isolated using RNeasy columns as described by the manufacturer (Qiagen). The 
integrity of the RNA was tested on an agarose gel. 5 µg of RNA was used to generate ds cDNA using 
superscript reverse transcriptase and a T7-oligo dT primer. The resulting cDNA was used in an in vitro 
cRNA reaction using T7 RNA polymerase and biotinylated ribonucleotides employing an ENZO kit 
(ENZO). The biotinylated cRNA was cleaned up using RNeasy spin columns (Qiagen) and quantified 
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by spectrophotometric methods. Fragmentation of 20 µg cRNA was performed at 95°C for 35 min. 10 
µg of fragmented cRNA was subsequently hybridized for 16 hrs to MG-U74Av2 microarrays (Affymetrix) 
at 45°C. After staining with Streptavidin-PE and washing, the arrays were scanned in an HP/Affymetrix 
scanner at 570 nm. For all experiments the 5’/3’ ratios of GAPDH (0.82-0.88), scaling factor, noise and 
presence calls were comparable. Scanned images were analyzed using Affymetrix Micorarray Suite 
5.0 software and Rosetta Gene Resolver System Biosoftware. All expression data are available as 
Supplementary Information and can be found at our website http://franklin.et.tudelft.nl.
Western blot
Sorted cells were directly lysed in SDS sample buffer. Proteins were separated on a denaturing 
12.5% polyacrylamide gel for 1 hour and transferred to a nitrocellulose membrane. After blocking, 
blots were probed with the following antibodies: anti-β-catenin (clone 14, Transduction Laboratories), 
anti-dephosphorylated β-catenin (clone 8E7, Upstate), anti-E-cadherin (clone 36, Transduction 
Laboratories), anti-β-actin (Abcam Ltd) and rat anti-mouse-HRP (Pierce) and visualized by enhanced 
chemiluminescence (Amersham). Tcf1 bands were quantified using ImageJ software (http://rsb.info.nih.
gov/ij/).
Immunofluorescence
6 μm frozen sections from human thymus were fixed with methanol and stained for 1-2 hours with 
anti-dephosporylated β-catenin (clone 8E7, Upstate), labelled with Alexa fluor 594 (Molecular Probes) 
and anti-total β-catenin (clone 14, Transduction Laboratories), labelled with Alexa Fluor 488 (Molecular 
Probes). Sections were embedded in vectashield containing DAPI (Vector Laboratories). Specimens 
were viewed on a Zeiss AxioPlan2 microscope.
 
Retroviral and lentiviral transduction and FTOC 
The retroviral mDkk-1 containing plasmid LZRS-mDkk1-IRES-eGFP (mDkk-1) and control plasmid 
LZRS-IRES-eGFP (GFP) were transfected into Phoenix Ecotropic packaging cells. Stable high-titer 
producer clones were selected with puromycin and virus was frozen down until use. Lentiviral Tcf1 
reporter vectors have been described12. Virus was produced by transfection of 293T cells using 3rd 
generation packaging system plasmids37. Viral supernatant was collected for two days and frozen down 
until use.
Bone marrow cells from 16-26 weeks old C57Bl/6 mice were passed over a Percoll density gradient. 
Fetal liver cells were isolated from day 14 embryos. Cells were cultured over night in serum free enriched 
Dulbecco’s modified Eagle’s medium38 supplemented with 50 ng/ml human Flt3-L, 50 ng/ml human TPO 
and 100 ng/ml murine SCF. CD34+ cells were isolated from human cord blood using AutoMACS (Milteny 
Biotec) and cultured over night in RPMI with 10% FCS, 10 ng/ml human Flt3L, 10 ng/ml human TPO 
and 50 ng/ml human SCF. 0.5-3x106 cells were transduced with viral supernatant in the presence of the 
same cytokines.
After 2 days of transduction, cells were harvested, counted and transduction efficiency was 
measured using flow cytometry. 30,000 human CD34+ cells or 50,000 murine cells were transferred into 
irradiated day 14 fetal thymic lobes using the hanging drop method39. After 24-72 hours, the lobes were 
transferred to a filter (Whatman) floating on medium. After 9 or 21 days of culturing, cells were harvested 
and stained for flow cytometry. 
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ABSTRACT
The thymus is seeded by very small numbers of progenitor cells that undergo 
massive proliferation before differentiation and rearrangement of T-cell receptor genes 
occurs. Various signals mediate proliferation and differentiation of these cells, including 
Wnt signals. Wnt signals induce the interaction of the cytoplasmic co-factor β-catenin 
with nuclear Tcf transcription factors. We identified target genes of the Wnt/β-catenin/
Tcf pathway in the most immature (CD4-CD8-CD34+) thymocytes using Affymetrix DNA 
microarrays in combination with three different functional assays for in vitro induction of 
Wnt signaling. A relatively small number (~30) of genes changed expression, including 
several proliferation-inducing transcription factors such as c-fos and c-jun, protein 
phosphatases and adhesion molecules, but no genes involved in differentiation to 
mature T-cell stages. The adhesion molecules likely confine the proliferating immature 
thymocytes to the appropriate anatomical sites in the thymus. For several of these 
target genes, we validated that they are true Wnt/β-catenin/Tcf target genes using real-
time quantitative PCR and reporter gene assays. The same core set of genes was 
repressed in Tcf1-null mice, explaining the block in early thymocyte development in 
these mice. In conclusion, Wnt signals mediate proliferation and cell adhesion, but not 
differentiation of the immature thymic progenitor pool. 
INTRODUCTION
The Wnt protein family consists of 18 secreted factors that regulate cell fate, polarity 
and cell growth in receptive cells1. Many of the Wnt genes in the mouse have been 
investigated by targeted mutation, leading to very specific developmental defects2. In 
addition, deregulated Wnt signaling is involved in oncogenesis of several different types 
of human cancers, including tumors of the colon, kidney, liver, prostate and ovarium3. 
Current models of Wnt signaling assume that secreted Wnt proteins bind to receptors 
of the Frizzled family on the cell surface. Via several different proteins, the signal 
is transduced to cytoplasmic β-catenin, which then enters the nucleus and forms a 
complex with members of the Tcf family of transcription factors to activate transcription 
of Wnt target genes4. 
The founding members of the Tcf family are T cell factor 1 (Tcf1) and Lymphoid 
Enhancing Factor 1 (Lef1)5. In adult mammals, Tcf1 is expressed uniquely in T 
lymphocytes, whereas Lef1 is expressed at lower levels in T cells, as well as in B cells 
and other cell types6. The functions of both these genes have been investigated by 
targeted mutation experiments. Tcf1 null mice have an incomplete, but marked block in 
thymocyte development7, and fail to generate de novo thymocytes after transplantation 
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of hematopoietic precursors in irradiated hosts8. Two different Tcf1 mutant mice have 
been generated7. In Tcf1(V) mutant mice, a low level of a truncated yet functional Tcf1 is 
still expressed, whereas the Tcf1(VII) mutation abolishes the DNA binding activity of Tcf1 
completely and these mice are regarded as true Tcf1 null mutants. Young Tcf1(VII)-/- mice 
have an incomplete block at the CD4-CD8- double negative (DN) and a more prominent 
block at the immature single positive (ISP) stages of thymocyte differentiation, whereas 
older mice display a complete block at the DN1 stage of development. Lef1 null mice lack 
hair, teeth, mammary glands and trigeminal nuclei and die around birth9, but have normal 
thymocyte development. Lef1 can partially compensate for the Tcf1 defect, especially in 
the neonatal and fetal thymus. While Tcf1(V) mutant mice are viable and have modestly 
impaired thymocyte development, Lef1/Tcf1(V) double mutant mice display a complete 
block in thymocyte development at the ISP stage10. Lef1/Tcf1(VII) double mutant mice 
die at day 10 of embryogenesis11 with dramatic developmental defects affecting the 
limb buds and neural tube. Interestingly, the phenotypic abnormalities of these double-
mutant mice are highly reminiscent of those in Wnt3a mutant mice11.
Both Tcf1 and Lef1 function as nuclear effectors of Wnt signals12,13. Both nuclear 
proteins are activated by binding to β-catenin, which supplies a powerful transactivation 
domain to the DNA binding activity of Tcf family members. β-catenin is subject to 
complex regulation via several key components of the Wnt pathway, including the 
tumor suppressor genes Axin and APC (adenomatous polyposis coli) and the negative 
regulatory protein kinase GSK-3β1 (see Figure 1). In absence of Wnt signaling, GSK-
3β is actively inducing phosphorylation of β-catenin and its subsequent degradation 
cadherins
-catenin
Wnt
frizzled
GSK-3
APCaxin
TCF
-catenin
target genes
Wnt3a supernatant
(extracellular)
lithium inhibits GSK-3
(cytoplasmic)

S33 -catenin transduction
(nuclear)

Wnt pathway stimulus
Figure 1. Simplified overview of Wnt signaling and stimuli used in this study. 
The Wnt pathway can be activated at multiple levels, either by stimulation of a Wnt ligand binding to a 
Frizzled receptor, by pharmacological inhibition of the GSK-3β kinase, or by providing the activated form 
of β-catenin. All three ways lead to the formation of an active β-catenin-Tcf transcription factor complex. 
The target genes of this pathway in the thymus were unknown until this study.
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via the ubiquitin/proteasome pathway. In the absence of β-catenin in the nucleus, Tcf 
proteins may recruit members of the TLE/Grg family, which act as global repressors 
of transcription14. Upon Wnt signaling, GSK-3β is inactivated leading to accumulation 
of dephosphorylated β-catenin. Lithium can strongly inhibit GSK-3β activity and can 
therefore be used to mimic Wnt signaling15. Lithium treatment can activate transcription 
of Tcf reporter genes in fibroblasts and epithelial lines15, and to a lesser extend in T cells16.
Wnt signaling has been shown to occur in hematopoietic stem cells and developing 
T and B cells17-20. Several reports indicate that Wnts can act in synergy with cytokines 
as hematopoietic growth factors. For instance, Wnts induce expansion of murine fetal 
liver stem cells and induce proliferation of human CD34+ hematopoietic stem cells17. In 
addition, Reya et al. demonstrated that Wnts can act as growth factors for pro-B cells18. 
We have shown that Wnt signaling induces proliferation of fetal DN thymocytes19. 
Moreover, retroviral expression of soluble Wnt receptor mutants that block Wnt signaling 
impairs thymocyte development, indicating that Wnt signaling is required for normal T-
cell development19. Finally, Wnt signaling is important in the regulation of survival of DP 
thymocytes20.
To further understand the role of Wnt signaling in T-cell development, it is imperative to 
identify the target genes of the β-catenin/Tcf transcription factor complex in thymocytes. 
The recent development of DNA microarrays allows the rapid and unbiased identification 
of genes expressed under different conditions. We have chosen to purify human CD34+ 
DN thymocytes instead of murine early DN thymocytes for several reasons. First, many 
more thymocytes can be obtained from human thymi than from the mouse. Given that 
the most immature DN thymocytes (DN1 and DN2) comprise only a small (~1%) subset 
of adult thymocytes, the choice of human thymocytes allows more readily the isolation 
of sufficient amounts of RNA for use on DNA microarrays. Second, the currently 
available microarrays for humans generally contain more genes than the murine chips. 
Third, human immature thymocytes can easily be purified based on the presence of the 
CD34 stem/progenitor cell marker on their cell surface. Here we have used Affymetrix 
microarrays to identify the transcriptional response the Wnt/β-catenin/Tcf pathway in 
the most immature thymocytes. 
RESULTS
The experimental system
It is well established that recombinant Wnt proteins are difficult to produce in soluble 
form in vitro, with the notable exception of murine Wnt3a, which can be made in 
biologically active form by transfected L cells, a system which very recently has become 
available (http://www.stanford.edu/~rnusse/assays/wntproteins.html). In almost all 
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studies, researchers have therefore relied on pharmacological or genetic ways to 
induce Wnt signaling in vitro. Here we have used three functional assays to induce Wnt 
signaling (see Figure 1): 1. treatment with LiCl, which inhibits GSK-3β, a key step in 
activating the Wnt pathway; 2. retroviral expression of an activated form of β-catenin; 
3. supernatant from L cells transfected with a Wnt3a expression vector. Treatment with 
LiCl has the advantage of its rapid action, allowing time course investigations of Wnt 
signaling, but lacks some specificity, because GSK-3β also is involved in regulation of 
Rel/NF-AT transcription factors21,22. The retroviral system is highly specific, but is not 
suited for time course experiments, because of the nature of the transduction process.
To isolate sufficiently high numbers of CD4-CD8- immature thymocytes that can be 
manipulated to induce Wnt signaling and yield sufficient RNA for microarray experiments, 
we isolated human CD34+ thymocytes. CD34+ immature thymocytes were isolated by 
magnetic beads to >96% purity (Figure 2A) and treated with LiCl and KCl for various 
lengths of time. LiCl is a well-known inducer of Wnt signaling, but its induction of Tcf-
dependent transcription (the ultimate nuclear consequence of the Wnt cascade) is not 
as strong in mature T lymphocytes as in other cell types (e.g. fibroblasts, epithelial 
cells23), but using sensitive reporter assays a 5- to 10-fold induction of Tcf-dependent 
FL1-H
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Figure 2. Lithium activates Wnt signaling in CD34+ immature thymocytes. 
(A) Purification of immature CD34+ thymocytes. Thymocytes were purified by magnetic-bead isolation 
using the CD34 marker. In fresh thymocytes this CD34+ population constitutes ~1% of the cells, but in 
frozen and subsequently thawed thymocytes 3-7%, because of the selective loss of DP thymocytes after 
freeze/thawing. After MACS purification cells were >96% CD34+. (B) Lithium activates Wnt signaling 
in CD34+ immature thymocytes. Purified CD34+ thymocytes were treated for 6 hours with 20 mM LiCl 
or KCl. Cytospins were made and analyzed by immunofluorescence using an antibody specific for 
dephosphorylated β-catenin, followed by a FITC-labeled secondary antibody. The clear increase in 
nuclear β-catenin indicates that Wnt signaling has been induced in these cells.
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transcription can be observed in Jurkat T cells (data not shown). We therefore first 
evaluated whether LiCl could induce Wnt signaling in primary prothymocytes. These 
primary cells are not transfectable with reporter gene plasmids and therefore we used a 
recently developed antibody that specifically recognizes the activated, dephosphorylated 
form of β-catenin24,25. LiCl indeed induced an increase in the amount of dephosphorylated 
β-catenin (Figure 2B).
Wnt signaling induced by lithium treatment
We isolated RNA from CD34+ thymocytes treated for 3, 6 or 18 hours with 20 mM 
LiCl, using KCl as control treatment. Microarray analysis on Affymetrix U95 GeneChips 
(containing 12,600 genes) revealed that approximately ~15 genes were upregulated 
and ~10 downregulated more than 3 fold at the 3 and 6 hour time points (Table I). 
During the shorter time points (3 and 6 h) cycloheximide (CHX) was added to inhibit 
de novo protein synthesis, thereby allowing identification of primary target genes. For 
the 18-hour timepoint this was not possible due to cytotoxicity of longer CHX treatment. 
Most genes were slightly more upregulated after 6 hours compared to 3-hour treatment. 
The upregulated genes included proliferation-inducing transcription factors such as c-
fos, fosB and other nuclear proteins (AHNAK, GILZ, cysteine-rich protein (CRP)1 and 
CRP2), cell cycle regulators (Checkpoint suppressor 1, CDK15 kinase, cdc-like kinase 2 
and EB3 which binds mitotic spindles) and signaling molecules such as the CL100 dual 
specificity phosphatase. Downregulated genes also concerned nuclear targets such as 
BTG1, BRCA2, nuclear pore complex proteins (Nup88), c-myb and signaling molecules 
such as PTPase2A. In addition, the pro-apoptotic gene TRAIL was downregulated. 
Several other genes were induced albeit at a low level (2-2.5 fold), including the T-box 
transcription factor Brachyury, a known Wnt target gene in other cell types. 
In order to identify those genes that were statistically significantly changed, we 
performed the 18-hour treatment with biological triplicates (6 microarrays). Significance 
analysis of microarrays (SAM) is a statistical test specifically developed for identification 
of such genes26. A tuning parameter δ can be set corresponding to the number of 
false positive genes included in the set of genes identified as significantly changing in 
expression. We chose to have less than one false positive gene included and performed 
SAM analysis on the three 18-hour treatment experiments. In doing so, we identified 9 
transcripts that significantly changed, all upregulated after LiCl treatment (see Table II). 
Four of these genes were also found at the earlier time points, suggesting that they are 
direct target genes. These are the CRP1 and CRP2 genes, which are highly conserved 
nuclear proteins with a LIM/ double Zn finger motif, the large (700 kD) nuclear protein 
AHNAK (meaning ‘giant’ in Hebrew), and the anti-apoptotic, lymphoid specific Zn 
finger protein GILZ (glucocorticoid induced lymphoid Zinc-finger). The other genes are 
apparently induced with slower kinetics or may not be direct target genes.
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Another way to identify relevant genes in the wealth of microarrays data is clustering 
analysis. We performed hierarchical clustering on the three time points to identify 
clusters of genes that behaved similarly in terms of induction or repression (Figure 3A). 
In general, similar sets of genes were found as those described in Table I and II. As 
expected, the c-fos and fosB genes were most highly induced after 3 and 6 hours, but 
not after 18 hours. To further validate the differential expression of the identified genes, 
we performed TaqMan-based RQ-PCR analysis for several transcripts. In general these 
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Figure 3. Target genes of the Wnt/b-catenin/Tcf pathway induced by LiCl. 
(A) Cluster analysis of Wnt target genes at 3, 6 and 18 hours after stimulation with LiCl. The data from 
the genes found to be differentially induced or repressed with Microarray Suite software were used to 
perform hierarchical clustering using GeneLinker Gold program. Although this cluster analysis does not 
indicate statistical significance, similar sets of genes were found as by SAM analysis. (B) Independent 
validation of Wnt target genes by TaqMan RQ-PCR. RNA was extracted from KCl and LiCl treated 
immature thymocytes. RQ-PCR was done for c-fos, GILZ, CL100 phosphatase and fibronectin. Data 
shown are the average of triplicate measurements of one experiment out of three done. NT= not tested 
(because fibronectin is not induced at earlier time points).
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data correlated well with the microarray findings (Figure 3B) for both the earlier and later 
time points.
Table I. Induced and repressed genes in CD34+ thymocytes after treatment with LiCl1.
Annotation induced genes Fold change (3 h) Fold change (6 h)
CDK15 kinase 4.3 1.3
CL100 phosphatase 3.2 2.0
EGR 1.7 3.0
HrpA0 4.4 3.0
hyp protein with Ankyrin repeats 1.6 3.2
 rhinovirus receptor (HRV) 2.7 3.4
α-tubulin 2.6 3.4
ADP ribosylation factor-like protein 4.6 3.6
GILZ 2.2 3.9
FosB 5.7 5.4
c-Fos 6.8 4.5
EB3 protein 4.7 6.3
Cys rich protein (CRP) 3.9 10.1
AHNAK 5.7 13.2
Check point suppressor 4.0 13.8
Annotation repressed genes Fold change (3 h) Fold change (6 h)
diacylglycerol kinase -2.3 -3
ISGF-3, -1.9 -3
CD8 β-chain -4.6 -3.1
ganglioside expression factor 2-like -1.7 -3.2
PP2A -4.5 -3.3
RNA polymerase II largest subunit -2.6 -3.4
phosphodiesterase -2.5 -3.6
TRAIL -2.1 -3.6
SLP-76 -2.1 -3.2
CD53 -1.8 -4.1
BTG nuclear protein -3.8 -4.6
Nup88 -1.8 -4.8
1 CD34+ thymocytes were treated with LiCl or KCl for 3 or 6 hours after which RNA was isolated and 
probed on U95A GeneChips. Only genes that were expressed and showed reliable upregulation or 
downregulation of 3-fold or more at at least one time point are shown.
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Wnt signaling induced by retroviral transduction with constitutively active β-
catenin
As a second treatment to induce Wnt signaling in CD34+ immature thymocytes, 
we transduced the cells either with a mouse CD8 (Lyt2a) marker virus or a retrovirus 
encoding a constitutively active form of β-catenin linked via an IRES sequence to the 
Lyt2a marker gene. The S33-β-catenin mutant is a specific activator of Wnt signaling 
and provides a strong transactivation domain for its nuclear partner Tcf1, whilst not being 
under negative control of GSK-3β because one of the serine residues phosphorylated 
by GSK-3β (S33) is mutated.
Immature CD34+ thymocytes were transduced with the IRES-Lyt2a marker gene 
or S33-β-catenin-IRES-Lyt2a with very similar efficiencies (Figure 4A) making them 
comparable for microarray analysis. After transduction, RNA was isolated and used for 
microarray analysis. Similar to the experiments described above, only a limited number 
of genes (N=14) was found to be differentially regulated between the two treatments 
(Figure 4B). Wnt target genes identified after transduction with S33-β-catenin include 
c-fos, fosB, the CL100 dual specificity phosphatase and β7 and p50,95 integrins which 
were also found in the lithium experiments, as well as JWA and NRPB. Down regulated 
were the structural proteins laminin and the pro-apoptotic gene Requiem (HREQ) (both 
low, 2-fold). Repeat experiments revealed similar clusters of genes, although the fold 
induction or repression varied. We reasoned that this could be caused by differences 
in kinetics in the retroviral transduction experiments. The complexities of transduction 
experiments, including integration, expression of β-catenin and induction of Wnt/Tcf 
target genes, do not allow direct assessment of the kinetics of induction and consequently 
Table II. SAM analysis of triplicate microarrays1.
Annotation Average fold change (LiCl/KCl)
CRP1 9.1
AHNAK 6.5
Fizzy related cell cycle regulator 5.3
GILZ 6.2
cysteine protease 4.7
cellular fibronectin 5.5
S100 Calcium bindingprotein 5.3
CRP2 6.5
Fibronectin, alternative splice 4.0
1Eighteen-hour treatment of CD34+ thymocytes with LiCl and KCl. Three independent experiments were 
performed (six U95A microarrays). Average fold change in LiCl treated CD34+ thymocytes as compared 
to control (KCl treated)
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Figure 4. Wnt target genes identified after transduction of CD34+ immature thymocytes with a 
retrovirus encoding constitutively active β-catenin. 
(A) Transduction of CD34+ cells with a retrovirus encoding the marker gene Lyt2a (murine CD8), or 
the S33-β-catenin-IRES-Lyt2a gene. Cells were transduced in the presence of IL-7 for 2 days and 
stained with antibodies against CD34 and murine CD8. (B) Genes induced or repressed by induction 
of Wnt signaling as identified by Affymetrix microarray analysis of Lyt2a vs. S33-β-catenin-IRES-
Lyt2a transduced immature thymocytes. Shown is a dot plot for all genes expressed after 2 days of 
transduction. Gene expression level is indicated in arbitrary fluorescence units. Genes that do not 
change in expression (the vast majority) follow the line under a 45° angle. The other lines indicate 2-, 3-, 
5- and 10-fold changes in gene expression. (C) TaqMan RQ-PCR validation of differential expression of 
Wnt target genes after induction of Wnt signaling by transduction of S33-β-catenin. RNA extracted from 
Lyt2a- or S33-β-catenin-IRES-Lyt2a-transduced cells was used for quantitative PCR analysis using 
GAPDH as control gene. Results are shown as a ratio of S33-β-catenin vs. Lyt2a signals. A time course 
was done at various time points (9-48 hours) after initiation of transduction. Shown are data for c-fos, 
fosB, CL100 phosphatase, and GILZ.
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may cause variations in the target genes detected. We therefore performed a time 
course experiment for many time points after transduction of immature thymocytes with 
S33-β-catenin using RQ-PCR as the read-out for several Wnt target genes (Figure 4C). 
These kinetic experiments revealed a rapid induction of c-fos and GILZ (presumably 
by transcription of β-catenin from the unintegrated proviral DNA) followed by a lag time 
and a 2- to 2.5-fold induction at later time points (presumably expression of β-catenin 
from the integrated retroviral LTR). This induction of Wnt target genes in the time course 
experiments therefore confirms the microarray experiments.
Wnt signaling induced by stimulation with supernatant from Wnt3a 
transfectants
During the course of our studies, L-cells transfected with murine Wnt3a were shown 
to produce biologically active Wnt3a. For two reasons this system may also be able 
to induce Wnt signaling in human CD34+ immature thymocytes. First, murine and 
human Wnt3a are highly homologous (85% amino acid identity) and second, Wnt3a is 
expressed in the thymus (Chapter 5). 
Immature thymocytes were incubated with supernatant from Wnt3a transfected L 
cells and from parental L cells (negative control) and analyzed on Western blot using the 
above described antibody against the active (dephosphorylated) form of β-catenin. Wnt3a 
containing supernatant was able to induce active β-catenin in immature thymocytes, 
indicating that Wnt signaling was active in these cells (Figure 5). We next used similar 
conditions for microarray experiments. Genes that were induced or repressed over 2.5 
fold are listed in Table III. The genes for Fos and Jun and for several other transcription 
factors were induced, such as LMO2, NRPB, CREM and at lower levels of significance, 
CL100 phosphatase, β7 integrin and AHNAK. Cytochrome P450, which was modestly 
induced after β-catenin transduction, was more clearly induced after Wnt3a stimulation. 
Interestingly, the most highly induced gene after Wnt3a stimulation encodes an ubiquitin 
KCl LiCl L-cell Wnt3a
total -catenin
dephosphorylated -catenin
Figure 5. Murine Wnt3a activates Wnt signaling in immature CD34+ thymocytes. 
CD34+ DN thymocytes were isolated and incubated with supernatant from parental L cells or L cells 
stably transfected with a Wnt3a expression construct. As a positive control purified CD34+ thymocytes 
were also treated for 6 hours with 20 mM LiCl or KCl. Cells were lysed in boiling SDS sample buffer 
and analyzed by Western blotting with anti-ABC, an antibody specific for the activated form of β-catenin 
(bottom) and with an antibody recognizing the total β-catenin pool (top). The expected increase in total 
β-catenin levels after LiCl treatment, were also seen after stimulation with Wnt3a.
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ligase, known to be involved in degradation of β-catenin, thereby providing a negative 
feedback on Wnt signaling. Among the downregulated genes several proteases that 
modify extracellular matrix (ECM) components stand out (MMP7, tryptase1), potentially 
influencing cell adhesion to ECM components.
We again validated the microarray results using RQ-PCR for the Wnt target genes c-
fos, CL100 phosphatase and β7 integrin. For unknown reasons the differential expression 
Table III. Stimulation of CD34+ immature thymocytes with Wnt3a1.
Annotation induced genes Fold change (Wnt3a vs L cell)
Ubiquitin ligase E2 9
GPNMB glycoprotein 8
c-jun 5.7
CYBB 4.6
LMO2 4.3
HRY 3.7
ENC1 nuclear matrix protein 2.8
EST (?) 2.6
MIR-7 2.6
Dual-specificity PTPase 6 2.6
CREM 2.6
c-fos 2.5
TSH-R 2.5
cytP450 2.5
IFI30 2.5
TIEG 2.5
Annotation repressed genes Fold change (Wnt3a vs L cell)
NK4 -5.8
MMP7 matrilysin -4.8
PDCL -4.3
IL1beta -3.8
tryptase1 -3.1
TNFRSF4 -2.9
GRO1 -2.9
MAP4K2 -2.5
1Induced and repressed genes (> 2.5 fold) after stimulation with parental L cell supernatant vs Wnt3a-
containing supernatant for 4 hrs. A 2.5-fold threshold is set, as this is the lowest difference that can be 
reliably validated by RQ-PCR.
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as detected by RQ-PCR was significantly higher than detected by microarray, namely 
c-fos: 5 fold, CL100 phosphatase: 4.8 fold and β7 integrin: 2.2 fold (data not shown), 
more in line with the fold induction in the retroviral transduction experiments.
TCF-reporter gene assays
To validate the identification of target genes of the Wnt/β-catenin/Tcf pathway, we 
performed two different types of experiments on selected target genes. First, we tested 
the promoters of several genes identified by different treatments (fibronectin, c-fos, 
brachyury, and β7 integrin) for induction of Tcf dependent transcription in transient 
transfection assays with luciferase reporters. Second, we checked expression of core 
target genes in thymocyte subsets of Tcf1(VII)-/- mice. 
Reporter gene experiments reveal much smaller differences with natural promoters 
(containing binding sites for many transcription factors in addition to the one being 
tested) than with artificial promoters consisting of multimerized binding sites for the 
tested transcription factors. Nevertheless, we could demonstrate a small induction of 
promoter activity for fibronectin, brachyury, and β7 integrin (Figure 6) whereas for fos the 
effect was minimal, probably because our 600-bp fos promoter construct contained only 
suboptimal Tcf binding sites. Most likely other promoter/enhancer sites around the c-fos 
gene contain additional Tcf sites. Functional identification of such sites is a daunting 
task, given that enhancers can lie >50 kb up- and downstream of their target genes. Our 
reporter assays are consistent with the microarray and RQ-PCR data in identification of 
Wnt target genes, but show a smaller induction. For instance, although the induction of 
Figure 6. TCF-reporter gene analysis of several Wnt target genes. 
Promoters of c-fos, fibronectin and brachyury were cloned in front of a luciferase reporter gene and used 
in transient transfection assays together with co-transfection of S33-β-catenin or vector control. For 
reference the optimal Tcf reporter construct (TOP), consisting of multimerized binding sites for Tcf was 
included as well (>50 fold activation; not shown). The brachyury and β7 integrin promoter constructs 
contain one optimal Tcf binding site, the fibronectin promoter two, whereas the c-fos promoter used 
only contains two suboptimal sites. Data shown are the average of duplicate measurements of one 
experiment out of three done. The luciferase values obtained with vector control were set as 1.0.
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fibronectin by LiCl was approximately 4-fold as assessed by microarray, the induction 
of fibronectin promoter activity in the luciferase reporter gene assay was barely 2-fold. 
A likely explanation for this difference is that the fibronectin reporter construct lacks 
important Tcf sites that are activated by Wnt signals in vivo. Similarly low induction 
of the fibronectin promoter by Wnt signals has recently been reported for Xenopus 
fibronectin27. Our reporter gene data also show that genes identified by only one 
stimulus, such as brachyury and fibronectin, behave as target genes in isolated reporter 
gene assays, whereas in functional assays they may not be bona fide Wnt targets in 
prothymocytes because of the lack of induction by Wnt3a or S33-β-catenin. Thus, we 
regard c-fos as a true Wnt target gene, because it was found in all three conditions to 
induce Wnt signaling (including those under cyclohexamide treatment), even though 
in the reporter gene asasys with the short c-fos promoter we could not demonstrate 
induction by Wnt signals. In contrast, genes such as fibronectin or brachyury were only 
found after lithium treatment and are Wnt targets in other cell types, but probably not in 
thymocytes.
We checked the expression of the core set of seven Wnt target genes by RQ-PCR 
throughout T-cell development (see Table IV). Interestingly, many of these genes were 
expressed at the highest level in CD34+ thymocytes (c-fos, CL100 PTPase, hsp70), 
suggesting that their expression is significantly regulated by Wnt signals. Undoubtedly 
other pathways also regulate expression of Wnt target genes, in particular those found 
to be highly expressed at later stages of development (c-jun, fosB). 
Expression of Wnt target genes in Tcf1 null mice (Tcf1(VII)-/-)
It is likely that important Wnt target genes are evolutionary conserved in the same 
types of cells. We therefore checked the expression of three prominent target genes, 
c-fos, c-jun and CL100 phosphatase in mice that lack the Tcf1 transcription factor 
Table IV. Expression of core Wnt target genes during thymocyte development as measured by 
RQ-PCR1.
Stage c-fos fosB c-jun CL100 NRPB P150,95 HSP70
CD34+CD1a- 92 1 1 466 < 1 < 1 522
CD34+CD1a+ 93 0.4 10 367 < 1 < 1 561
DN (CD34-) 19 6 22 49 < 1 < 1 11
DP 30 9 32 64 < 1 < 1 15
CD4 SP 55 11 16 37 < 1 < 1 4
CD8 SP 80 35 26 110 < 1 < 1 5
1Data are presented as 1000 times the level of a particular transcript compared to the level of GAPDH as 
housekeeping gene (i.e. 1000 corresponds to the level of GAPDH in a particular subsets). Subpopulations 
were sorted from the human thymus to >95% purity.
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(hereafter referred to as Tcf1(VII)-/-). These mice are not able to induce Wnt target genes 
because of the lack of nuclear integration of Wnt signals. Young Tcf1(VII)-/- (<12 weeks) 
mice have an incomplete block in T-cell development at the ISP stage, later (around 
6 months of age) followed by a more complete block at the DN stage. We used thymi 
from 7-week-old wild type control mice and Tcf1(VII)-/- mice, sorted the DN and ISP cell 
populations and checked the levels of Wnt target genes by RQ-PCR (Figure 7A). While 
the levels of c-fos, c-jun and CL100 phosphatase were not dramatically different in the 
DN stage (where cells still develop normally in Tcf1(VII)-/- mice of this age), the levels 
of c-fos and c-jun were dramatically reduced in ISP cells (Figure 7B). In addition, the 
levels of CL100 phosphatase were 3-fold reduced. These experiments underscore that 
these genes function as Wnt target genes and confirm the microarray experiments.
Figure 7. Expression of Wnt target genes is decreased in Tcf1(VII)-/- mice compared to wild type 
mice. 
(A) Thymi from wild type and Tcf1(VII)-/- mice were sorted in DN and ISP populations based on staining 
with CD4, CD8 and CD3. DN cells were defined as CD4-CD8-CD3-, ISP cells as CD8+CD3-. Upper 
panels depict starting populations, lower panels show populations after sorting. All sorted populations 
were >98% pure and CD3- (not shown). (B) RNA was extracted and the expression of c-fos, c-jun and 
CL100 phosphatase was analyzed in DN and ISP cells by RQ-PCR, with GAPDH as control. Values are 
given as percentage of GAPDH x 1000.
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DISCUSSION
Target genes of the Wnt/β-catenin/Tcf pathway in thymocytes have remained elusive. 
Here we have investigated the target genes induced by Wnt signals that activate the 
β-catenin/Tcf complex in CD34+DN thymocytes (prothymocytes) using three different 
functional assays to activate Wnt signaling in vitro. Remarkably, no markers of T-cell 
differentiation were induced; we instead found that markers of proliferation and cell-cell 
adhesion were upregulated. This is consistent with the notion that Wnt proteins can 
provide proliferative signals for stem cells in various tissues, such as crypt cells in the 
colon, hematopoietic stem cells, pro-B cells and pro-T cells. 
In general, a relatively small number of Wnt target genes (in total approximately 
30) was found. LiCl, although widely used as a pharmacological agent to mimick Wnt 
signaling, is somewhat nonspecific, as is reflected by the much larger number of genes 
found after LiCl treatment than with the other two stimuli (Figure 8). By definition, genes 
identified by transduction with S33-β-catenin or Wnt3a stimulation are Wnt target 
genes. A core set of seven genes is induced by both specific stimuli: c-fos, fosB, CL100 
phosphatase, integrin p150,95, c-jun, hsp70 and NRPB; most of these genes are 
induced by LiCl as well. Because the three functional stimuli differ in modes of action, 
signal strengths, and kinetics of induction, it is not surprising that some differences in 
gene expression were found, but the functional clusters were highly comparable. The 
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Figure 8. Venn diagram of Wnt target genes in prothymocytes identified by three different 
functional stimulations. 
The area of each circle is proportional to the number of target genes identified by each stimulus. Note 
that not all genes induced by LiCl are bona fide Wnt targets. A core set of 7 genes is identified among 
the 31 Wnt target genes defined.
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identified target genes can be clustered into several groups: genes encoding transcription 
factors and other nuclear proteins (c-fos, fosB, AHNAK, GILZ, NRPB, LMO), together 
forming a cluster of genes involved in cell proliferation; signaling molecules in particular 
phosphatases (CL100 phosphatase); molecules involved in apoptosis (GILZ, TRAIL); 
cell adhesion molecules (fibronectin, laminin, p150,95, β7 integrin) and ECM modifiers 
((MMP7, tryptase1). 
Some genes found only after lithium treatment may be true Wnt targets in thymocytes 
as well, because they have been identified as Wnt targets in other species, including 
the T box transcription factors brachyury in murine ES cells40 and cellular fibronectin 
in Xenopus27. Promoters of these genes are responsive to β-catenin (see Figure 5). 
However, because they were not significantly induced by S33-β-catenin transduction 
nor Wnt3a stimulation, we have excluded them in the cluster of 31 target genes.
It should be noted that a number of known Wnt target genes in other tissues are 
apparently not induced by Wnt signaling in CD34+ thymocytes. Of note, CyclinD1 and 
c-myc expression were not changed, even though both genes are represented on the 
arrays used. In addition, expression of anti-apoptotic gene Bcl-x did not change, even 
though this gene has been proposed to play role in Tcf-induced protection against 
apoptosis in DP thymocytes20. Apparently, Wnt signaling differs between immature and 
more mature stages of T-cell differentiation. 
The lack of known T-cell differentiation genes among the identified target genes 
seems at variance with data from Gounari et al.,28 who showed that transgenic mice 
over expressing constitutively active β-catenin seem to by-pass signals transmitted via 
the pre-TCR and differentiate into DP cells. However, in vivo differentiation experiments 
cannot evaluate the effects of constitutively active β-catenin per differentiation stage. 
For example, the pre-TCR provides proliferative signals as well. These proliferative 
signals superimposed on other differentiation signals given in the context of the thymus 
might be sufficient to induce differentiation. However, the DP and SP cells generated 
by somatic activation of β-catenin lack rearranged TCRβ chains and do not survive 
properly28, indicating that the proliferative signals provided by ectopic activation of 
Wnt signaling do not mimic normal proliferation and differentiation signals emanating 
from the pre-TCR. In conclusion, our results support the idea that Wnt signals induce 
proliferation, but not differentiation of the earliest progenitor cell compartment in the 
thymus. This is consistent with a recent report by Sen and colleagues showing a 
proliferative defect in thymocytes of Wnt4/Wnt1 null mice29. 
c-fos is one of the target genes induced the strongest (>5 fold) and found in all 
three types of experiments, whereas c-jun is found in the Wnt3a and S33-β-catenin 
experiments. Both c-fos and c-jun are well-known transcription factors that mediate cell 
cycle progression and proliferation30,31. c-fos null mice show a reduced cellularity in the 
thymus32, without any strong blocks at a particular stage, consistent with a proliferative 
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defect at various stages of development and somewhat reminiscent of thymi from young 
Tcf1(VII)-/- mice. FOS family members (fos, fosB, fra1) form the so-called Activator 
Protein 1 complexes by heterodimerization with JUN family members (jun, junB, junD). 
Because redundancy between these factors (e.g., between fos and fosB) can affect 
the consequence of gene targeting experiments, dominant negative molecules may 
better reveal the importance of fos/jun in biological processes. Mice with a dominant 
negative c-jun have been made33 and display a defect in cell cycle progression during 
the transition of DN to DP thymic development, indicating that fos/jun transcription 
factors promote proliferation at DN and ISP stages. These are the same stages of 
development affected in Tcf1(VII)-/- mice. Given that fos/jun transcription factors are 
strongly decreased in expression in those thymic subpopulations that are affected in 
Tcf1(VII)-/- mice (Figure 7), lack of Wnt-induced fos/jun-mediated proliferation explains 
the defect in Tcf1(VII)-/- mice. Thus our findings provide a molecular mechanism for the 
developmental defect in Tcf1(VII)-/- mice.
Interestingly, in a differential screen between genes expressed in CD34+CD38- 
hematopoietic stem cells (HSC) versus CD34+CD38+ progenitor cells in the human bone 
marrow, Eaves and colleagues have identified Fos and Jun as genes highly expressed 
in HSCs (CD34+CD38-) compared with more mature progenitor cells (CD34+CD38+), 
consistent with a role of these factors in proliferation of stem cells35. 
Among the several signaling molecules found, CL100 dual specificity phosphatase 
was highly induced in all three types of experiments. This gene encodes a MAPK3 
phosphatase implicated in cell proliferation36,37. Interestingly, this gene is preferentially 
expressed in CD34+CD38- HSCs compared to CD34+CD38+ cells38, similar to c-fos (see 
above), suggesting that Wnt signaling in early progenitor cells in the thymus induces 
similar target genes as those expressed in HSCs. 
Several genes involved in cell-cell adhesion, including fibronectin and integrins 
β7 and p150,95 were found as target genes as well. These proteins are involved 
in compartmentalization and cell migration within the cortical region of the thymus 
and perhaps in attracting common lymphoid progenitors to the thymus. Petrie and 
coworkers39 have found that DN1 cells are confined to the perimedullary cortex, while 
DN2 and DN3 cells are found in the outer cortical regions. At the transition of DN1 
to DN3 cell (CD34+ pro-T cell to pre-TCR+ T cell) thymocytes upregulate β7 integrin 
expression (β7 heterodimerized with α4 or αE integrins) and become more adhesive 
to fibronectin. Thus, Wnt signals may assure a proper migration of precursors along 
this stromal matrix or keep cells localized to a certain region of the cortex where cells 
receive proliferative signals before pre-TCR expression and TCRβ selection.
Based on these findings, we propose that Wnt induced β-catenin/Tcf target genes 
in immature thymocytes are not directly involved in inducing differentiation, but instead 
provide proliferative signals (for instance via c-fos and c-jun) to induce cell division in 
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the precursor cell compartment of the thymus (Figure 9). In fact, because only very few 
progenitor cells from bone marrow or fetal liver seed the thymus, a vigorous proliferation 
of the most immature cells in the thymus is required. This has been recognized for over 
two decades by various groups and is still studied41-43. The nature of this proliferative 
signal is provided by cytokines such as IL-7 and SCF, but apparently also by Wnt 
proteins19. Additionally, Wnt signals can be involved in the migration of immature 
thymocytes through thymic cortex or in confinement of precursor cells to those cortical 
regions where proliferation can occur (Figure 9). This may help preventing TCR gene 
rearrangement at proliferative stages of development or occurrence of selection 
processes at the corticomedullary junction at inappropriate stages of development. 
Apparently, the Wnt/β-catenin/Tcf pathway provides both proliferative signals for 
immature thymocytes in order to maintain the thymic precursor cell compartment and 
adhesion signals that assure that T-cell development proceeds at the appropriate 
anatomical sites in the thymus. 
Figure 9. Model: Wnt signals induce proliferation and cell adhesion of immature CD34+ 
thymocytes. 
HSC or common lymphoid progenitors are seeding the thymus from the bone marrow and undergo 
proliferation, partially driven by Wnt signals, but also by cytokines such as IL-7 and SCF (1). Cells 
migrate to the outer cortex via different integrins and extracellular matrix components, some of which 
are Wnt targets (β7 integrin, fibronectin). After this proliferative stage, rearrangement of TCRb occurs, 
leading to expression of the pre TCR (TCRβ/pTα) on the cell membrane. This generates another stage 
of proliferation (2) where Wnt signaling may play a role after which cells start expressing CD4 and CD8 
to become DP thymocytes (3), followed by rearrangement of TCRa and positive and negative selection 
at the corticomedullary junction (3). Mature SP thymocytes subsequently end up in the medulla (4).
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MATERIALS AND METHODS
Isolation of immature human thymocytes 
 Thymic tissue was obtained from children undergoing cardiac surgery who did not have any 
immunological abnormalities. All tissues were obtained according to the guidelines of the Medical 
Ethical Committee (IRB) of Erasmus MC, Rotterdam, The Netherlands. Thymocytes were isolated by 
mechanical disrupture of the tissue and squeezing through a mesh. Thymocytes were frozen in liquid 
nitrogen in RPMI medium containing 10% FCS and 10% DMSO. Thymocytes from 5-10 donors were 
pooled to reduce individual variation. After thawing, pooling and Ficoll density centrifugation, CD34+ 
thymocytes were purified by MACS (Miltenyi), according to standard protocols. The degree of purification 
was assessed by flow cytometry.
Isolation of murine thymocytes
 Thymi were removed from 7 weeks old C57Bl/6 and Tcf1(VII) null mice (backcrossed to C57Bl/6). 
Cell suspensions were made and stained with antibodies specific for mouse CD4, CD8 and CD3. DN 
and ISP subpopulations were sorted on a FACS Digital Vantage (DiVa) cell sorter (BD Biosciences) to 
greater than 98% purity and immediately used for RNA isolation.
Methods for in vitro induction of the Wnt/β-catenin/Tcf pathway 
Treatment with pharmacological agents. 10x106 CD34+ thymocytes were treated with 20 mM LiCl 
or KCl as control for the indicated length of time. In some experiments cells were also treated with the 
protein synthesis inhibitor cycloheximide (CHX, 1 µg/ml). These treatments were done in the presence 
of 10 ng/ml human IL-7 to make the results comparable to the retroviral transduction data. LiCl induced 
Wnt signaling was assessed by staining of dephosphorylated β-catenin24.
Retroviral transduction. The retroviral plasmids LZRS-S33-β-catenin-IRES-Lyt2a and LZRS-IRES-
Lyt2a (as control) were constructed and transfected into Phoenix amphotropic packaging cell lines 
using Fugene-6 (Roche). Stable high titer producer clones were selected with puromycin (1 µg/ml). 
CD34+ thymocytes (30-50x106) were pre-stimulated with IL-7 (10 ng/ml) for one day, and subsequently 
transduced using Retronectin coated petri dishes (Takara) and recombinant retrovirus containing 
supernatant for two days, with daily replenishing of retroviral supernatant. The efficiency of the retroviral 
transduction was evaluated by flow cytometry. Cells were stained with antibodies against human CD34 
and mouse CD8 (Lyt2a) and analyzed on a Calibur flowcytometer using Cell Quest-pro software (Becton 
Dickinson).
Stimulation with Wnt3a containing supernatant. For stimulation with Wnt3a, cells were incubated 
with conditioned medium from L cells stably transfected with a pcDNA-Wnt3a construct. The supernatant 
was filtered through a 0.22 µm filter and incubated with immature thymocytes for 4 hrs, using supernatant 
from parental L cells as negative control. 
Induction of Wnt signaling in CD34+ thymocytes by Wnt3a was assessed by Western blotting. In 
short, immature thymocytes were isolated, treated with Wnt3a or control supernatant and lysed in boiling 
2x SDS sample buffer as described. Lysates were run on a 10% SDS-PAGE gel, blotted and stained 
with an antibody against the activated form of β-catenin (anti-ABC)24,25 or a pan-β-catenin antibody 
(Transduction Laboratories) and visualized by Enhanced Chemiluminescence (Amersham). Treatment 
with LiCl or KCl was used as extra positive or negative control for detection of activated β-catenin
Microarray analysis 
RNA was isolated using RNeasy columns as described by the manufacturer (Qiagen). The integrity of 
the RNA was tested on 1% formaldehyde containing agarose gels. 5-8 µg of RNA was used to generate 
ds cDNA using superscript reverse transcriptase and a T7-oligo dT primer. The resulting cDNA was used 
in an in vitro cRNA reaction using T7 RNA polymerase and biotinylated ribonucleotides employing an 
ENZO kit. The biotinylated cRNA was cleaned up using RNeasy spin columns (Qiagen) and quantified 
by spectophotometric methods. An adjusted cRNA yield was calculated to reflect carryover of unlabeled 
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total RNA. Fragmentation of 20 µg cRNA was performed at 95°C for 35 min. 5 µg of cRNA was hybridized 
to a Test3 microarray (Affymetrix) to check the quality of the procedure. 10 µg of fragmented cRNA 
was subsequently hybridized for 16 hrs to U95Av2 microarrays (Affymetrix) at 45°C. After washing and 
staining, the arrays were scanned in an HP/Affymetrix scanner at 570 nm. For all experiments reported 
here the 5’/3’ ratios of GAPDH were 1.5 or less (usually 0.9-1.1). In comparison experiments, care was 
taken that the scaling factor, noise and presence calls were comparable.
Bioinformatics
Data reported here are extracted from a total of 16 different U95Av2 GeneChips used under the 
various conditions described. The scanned images were analyzed using Affymetrix Microarray suite 4.2 
software, using the KCl treated samples or the Lyt2a transduced sample or the sample treated with L 
cell supernatant as baseline. Further analysis was done using microDB and desktop Mining Tool 3.0 
software. Statistical significance of the overnight LiCl treatment was tested using the freeware program 
SAM (Significance Analysis of Microarrays) version SAM 1.12. The false discovery rate (FDR) was 
9% for the SAM analysis. Hierarchical clustering was done on the three time points analyzed using 
GeneLinker Gold 2.0 (Molecular Mining Corporation). 
Transcription factor binding sites in promoter sequences were identified using Alibaba 2.1 and 
Transfac 4.0 (Gene regulation web site www.gene-regulation.com).
TaqMan-based real-time quantitative-PCR (RQ-PCR)
The mRNA expression of several target genes was tested using TaqMan-based RQ-PCR. The 
isolated RNA was treated with 1U of DNase I and subsequently 1 µg RNA was transcribed to cDNA with 
AMV-RTase (5 U), oligo(dT) and random hexanucleotide primers. 1/20 cDNA mixture was used for RQ-
PCR for each primer/probe set and performed in duplicate. The cDNA was normalized to GAPDH (Applied 
Biosystems). The RQ-PCR mixture of 25 µl contained TaqMan Universal mastermix, 900 nM primers 
and 100 nM probe and was run on the ABI PRISM 7700 Sequence Detection System containing a 96 
well thermal cycler (Applied Biosystems). All primer and probe sequences were designed with the Primer 
Express version 1.5 software (Applied Biosystems). Primer and probe sequences used were: CFOS 
(forward) 5’-AACCTGTCAAGAGCATCAGCAG-3’, CFOS (reverse) 5’-GAGCGGGCTGTCTCAGAGC-
3’, CFOS (probe) 5’-AGCTGAAGACCGAGCCCTTTGATGACTT-3’, CL100 (forward) 5’-GCA 
GAGGCGAAGCATCATCT-3’, CL100 (reverse) 5’-CAGCACCTGGGACTCAAACTG-3’, CL100 (probe), 
5’- CCAACTTCAGCTTCATGGGCCAGC-3’, GILZ (forward) 5’-GCGTGAGAACACCCTGTTGA-3’, GILZ 
(reverse) 5’-GGCTCAGACAGGACTGGAACTT -3’, GILZ (probe) 5’-ACCCTGGCAAGCCCAGAGCAGCT-
3’, Brachyury (forward) 5’-TCCTTCCTGCTGGACTTTGTG-3’, Brachyury (reverse) 5’ 
CATTCCCCGTTCGCGTACT-3’, Brachyury (probe) 5’-CGGCGGATAACCACCGCTGG-3’, Fibronectin 
(forward)  5’-TGAGGAACAT GGTTTTAGGCG-3’ , Fibronectin (reverse)  5’-CTTGGCCTATGCCTTATGGG 
-3’, Fibronectin (probe) 5’-CACCGCCCACAACGGCCAC-3’. For murine genes we used CL100 
(forward) 5’-TGTTGGATTGTCGCTCCTTCT–3’, CL100 (reverse) 5’-TGAAGCGCACGTTCATCGAG-
3’ and CL100 (probe) 5’- TCAACGCCGGCCACATCGC-3’ , c-fos (forward) 5’- GGAGGTCTGCCT 
GAGGCTTC-3’, c-fos (reverse) 5’- CACGTTGCTGATGCTCTTGAC-3’, c-fos (probe) 5’- 
CAACGACCCTGAGCCCAAGCCAT-3’, c-jun (forward) 5’- GACGGACCGTTCTATGACTGC-3’, c-jun 
(reverse) 5’-GGAGGAACGAGGCGTTGA-3’ , c-jun (probe) 5’-TGGAAACGACCTTCTACGACGATGC
C-3’. 
Reporter Gene assays
293T cells were transfected with the luciferase reporter genes TATA-TOP (Tcf-optimal), TATA-FOP 
(mutated constructs) and natural promoter constructs from Wnt target genes together with a pCI-S33-
β-catenin expression construct or a pCI-neo negative control construct. For natural promoters we 
constructed pGL3-fibonectin by cloning the fibronectin 1.7 kb promoter from FN-CAT (kindly provided 
by Dr. T. Gorogh, University of Kiel, Germany), into the pGL3 basic luciferase vector (Promega). The 
brachyury-promoter-luc was generated by cloning the brachyury promoter from brachy-LacZ into pGL3-
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basic-luciferase (brachyury promoter kindly provided by Dr. B. Herrmann, Germany). The Fos-luc 
reporter construct was kindly provided by Dr. T. Moeroey (University of Essen, Germany) and the β7 
integrin promoter-luc by Dr. G. Krissansen (University of Auckland, New Zealand). Luciferase assays 
were essentially done as described previously19. 
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ABSTRACT
Wnt proteins are considered to be essential for proliferation of hematopoietic 
progenitor cells, but direct genetic evidence for this notion is lacking. Support for this 
hypothesis comes in part from in vitro studies employing soluble Wnt3a. Nevertheless, 
the physiological function of Wnt3a and other Wnt proteins during hematopoiesis 
remains elusive. Because of the early embryonic lethality of the mutation, our studies 
were restricted to day 12 fetal thymic lobes and fetal liver stem cells. Using culture 
systems and reconstitution of sublethally irradiated mice, we found a hematopoietic stem 
cell defect with severely disturbed myelopoiesis, erythropoiesis and T-lymphopoiesis. 
Cultured Wnt3a deficient thymic lobes presented with diminished thymocyte numbers 
and an over time decreasing percentage of double positive cells. Wnt3a deficient fetal 
liver stem cells normally developed into B and T cells in culture systems with wild-
type stromal support, but yielded reduced numbers of myeloid and erythroid cells in 
colony assays. A hematopoietic stem cell defect was indicated by significantly reduced 
numbers of Lin-Sca-1+c-Kit+ cells in Wnt3a deficient fetal livers and severely impaired in 
vivo reconstitution, with complete absence of T cells and myeloid cells.
Thus, we show that targeted mutation of a Wnt gene results in various severe defects 
in hematopoiesis.
 
INTRODUCTION
Wnt proteins are secreted factors that regulate proliferation and cell fate determination 
in many different cell types and organisms1. In mice and man, 19 Wnt family members 
are recognized. Upon binding of a Wnt protein to a receptor of the Frizzled family on the 
cell surface, a complex cascade is initiated, eventually (in the canonical Wnt pathway) 
leading to the accumulation and activation of cytoplasmic β-catenin2,3. Subsequently, 
β-catenin enters the nucleus and forms a complex with members of the Tcf family of 
transcription factors (comprising Tcf1, 3 and 4 and Lef1) to activate transcription of Wnt 
target genes.
Accumulating evidence suggests a role for Wnt proteins in the hematopoietic system4. 
This was initially recognized by studies in mice that have targeted mutations of Tcf family 
members. In adult mammals, Tcf1 is expressed uniquely in T lymphocytes, whereas 
Lef1 is expressed at lower levels in T cells, as well as in B cells and other cell types5. 
Tcf1 null mice have an incomplete, but marked, block in thymocyte development6,7. Lef1 
mutant mice have normal T-cell development8, but mild defects in B-cell development 
in the bone marrow (BM)9. Later it was found that Tcf1/Lef1 double mutant mice display 
a complete block in the thymus at the immature single positive (ISP) stage of T-cell 
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development10, indicating functional redundancy of these two transcription factors. 
Subsequent studies analyzed upstream components of the Wnt signaling pathway 
in the hematopoietic system, most extensively so in T-cell development. Until recently, it 
has been unclear at which stages of T-cell development Wnt signaling occurs. Using a 
Tcf-GFP reporter we have shown that especially the earliest double negative (DN1 and 
2) thymocytes undergo Wnt signaling, although later stages still show some Wnt activity 
(Chapter 5). Several Wnt and Frizzled family members are expressed in the thymus, 
some at high levels11. Blocking Wnt binding in in vitro fetal thymic organ cultures (FTOCs) 
using soluble Fz receptors completely inhibited early thymocyte development12. In 
addition, mice deficient for both Wnt1 and Wnt4 as well as mice transgenic for Axin, an 
inhibiting factor in the Wnt pathway, showed reduced thymic cellularity13,14. 
The main function of Wnt signaling in the thymus probably is to induce proliferation, 
as Wnt1 and Wnt4 have been shown to be growth factors for early T cells in FTOCs12. 
Furthermore, we have shown that most Wnt target genes in human CD34+ thymocytes 
are involved in proliferation15. 
Despite this large body of evidence, the importance of Wnt signaling for early T-
cell development has recently been challenged by studies that examined two different 
conditional β-catenin deficient mice. Mice with β-catenin deleted from DN3 onwards 
showed impaired T-cell development at the β-selection checkpoint16, but mice 
transplanted with hematopoietic stem cells in which β-catenin had been inducibly deleted, 
did not show any thymic effect17. The effect of β-catenin deficiency in the latter system is 
probably limited because of redundancy with β-catenin homologue plakoglobin, which 
is expressed preferentially at the early stages of T-cell development (Chapter 5).
Proliferation probably is the main function of Wnt signaling in developing B cells as 
well. Addition of Wnt3a-conditioned medium to fetal liver pro-B cells induced cell cycling 
in culture9. In Lef1 mutant mice, reduced numbers of developing B cells were found in 
the fetal liver and in perinatal BM, caused by diminished proliferation and increased 
apoptosis9. In addition, mice deficient for Wnt receptor Frizzled 9 were found to have 
lower numbers of developing B cells in the BM, probably because of reduced clonal 
expansion prior to Immunoglobulin light chain rearrangement in pre-B cells18.
Besides functioning during lymphocyte development, Wnt signaling has been shown 
to be important for hematopoietic stem cell (HSC) biology. Tcf-GFP reporter studies 
have demonstrated Wnt signaling in HSCs in vivo as well as in vitro after stimulation 
with purified Wnt3a19. Here again, a role for Wnt signaling in self-renewal is likely, as 
murine Wnt1, 5a and 10b20 and Wnt3a21 and human Wnt2b, 5a and 10b22 induced in vitro 
expansion of cells closely related to HSCs. Retroviral transduction of murine HSCs with a 
constitutively active form of β-catenin promoted proliferation and maintenance of immature 
phenotype in cultures, and improved reconstitution of all lineages in irradiated hosts, 
while transduction with Wnt-signaling inhibitor Axin yielded exactly the opposite results19. 
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The function of several Wnt genes has been investigated by targeted mutations in 
the mouse (reviewed by Moon23), which lead to very specific developmental defects. 
Most of these mutant mice have severe problems, e.g. in limb formation or neural 
development, and die during embryogenesis or shortly after birth. 
Mice carrying a null allele of Wnt3a have been generated by McMahon and co-
workers24 and have been studied extensively. Wnt3a homozygous mutant embryos 
die between fetal day 10.5 and 12.5. These embryos lack caudal somites24-26, have a 
disrupted notochord24 and exhibit dysmorphology of the central nervous system24,27. 
The hematopoietic system of the Wnt3a knock-out mouse has not been examined, 
presumably because studies are complicated by the lethality of this mutation early in 
utero. Nevertheless, the high expression of Wnt3a in thymic stroma (Chapter 5) and the 
fact that it is a growth factor for pro-B cells and HSCs in vitro make it of high interest. In 
addition, Wnt3a deficient embryos are morphologically highly similar to Tcf1/Lef1 double 
deficient embryos28, suggesting comparable defects also in the hematopoietic system 
of both strains. Here we used cultures of fetal thymi and fetal liver stem cells as well as 
in vivo reconstitutions to study the effect of the Wnt3a mutation on hematopoiesis. As 
Wnt3a is the only Wnt currently available as recombinant protein, it is commonly used 
as a prototype Wnt to study effects of Wnt proteins in culture15,19,21,29,30. Here we address 
the physiological role of Wnt3a in the development of the different hematopoietic 
lineages. 
RESULTS
T-cell development in Wnt3a deficient mice
Wnt3a deficiency causes embryonic lethality between gestational day 10 and 1324. 
Mice heterozygous for the Wnt3a deletion were bred to generate Wnt3a deficient and 
wild type/heterozygous day 12 embryos (Figure 1A). No differences were observed 
between wild type and heterozygous embryos in any of our assays nor have been 
reported in literature. Therefore, wild type and heterozygous embryos were considered 
to be similar and will from here on be referred to as ‘wild type’.
First we studied T-cell development in these embryos. In the developing mouse 
embryo, the thymic rudiment is first colonized by immature cells at approximately 
day 10-11 of gestation31,32. At embryonic day 12 (E12), thymic lobes contain very few 
thymocytes, most of which are in the DN1 stage, making flow-cytometric analysis not 
very informative at this time point. Therefore, we cultured the E12 lobes on a filter 
floating on medium for 9-17 days, to allow further T-cell development. 
E12 thymic lobes are not yet well-defined structures, complicating reliable isolation. 
In general, however, Wnt3a deficient thymi were found to contain lower cell numbers 
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(usually about three fold lower) than wild type embryos (Figure 2A), irrespective of the 
duration of culturing. 
After 9 days of culturing, all stages of T-cell development could be distinguished, 
including mature single positive (SP) CD4+ and CD8+ cells, both in wild type and Wnt3a 
deficient embryos (Figure 2B). At this time-point, no differences were detected in subset 
distribution between Wnt3a deficient and wild type thymi. However, when lobes were 
cultured for prolonged times (e.g. 14 or 17 days), T-cell development in Wnt3a deficient 
thymi appeared to deteriorate (Figure 2C). This presented mainly as a decrease in 
the percentage of double positive (DP) cells and an accumulation of ISP thymocytes, 
suggesting a block at the ISP stage (Figure 2C). 
Since thymic lobes could not always be reliably distinguished in all E12 embryos 
(knock-out as well as wild type), we confirmed the presence of thymic lobes in Wnt3a 
deficient embryos using immunohistochemistry. Tissue sections of E12 embryos were 
prepared and stained with HE to visualize different tissues. Presence of a thymic anlage 
could be demonstrated in all four Wnt3a deficient embryos examined (Figure 3). This 
was confirmed by staining with ER-TR4, which identifies thymic epithelial cells33 (Figure 
3 lower panels). 
These data demonstrate that in Wnt3a deficient animals the thymic anlage is 
normally developed and is seeded with hematopoietic cells, but that T-cell development 
is affected, especially with respect to cell numbers. To investigate whether this defect 
is intrinsic to the hematopoietic cells that seeded the thymus, we cultured wild type 
and Wnt3a deficient E12 fetal liver cells in irradiated thymic lobes from wild type 
Wnt3a +/+ or +/– Wnt3a –/–
5 mm
Figure 1. E12 embryos. 
Photograph of E12 embryos that are wild type or heterozygous (left) or homozygous (right) for the 
mutated Wnt3a gene. Deficient embryos lack caudal limbs and tail, although a small tail-rudiment is 
often visible. 
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E14 embryos. After 14-21 days of culture, lobes were stained for flow cytometry. No 
differences were observed between FTOCs using wild type or Wnt3a deficient fetal 
liver cells, with respect to cell numbers or thymocyte subset distribution (Figure 4). The 
reduced T-cell development in Wnt3a deficient embryos must therefore be attributed to 
absence of Wnt3a production by the thymic stroma. 
Development of other lineages from Wnt3a deficient fetal liver cells
As Wnt3a has been shown to be a growth factor for pro-B cells when provided as a 
prototype Wnt in vitro9, we were interested in the capacity of Wnt3a deficient fetal liver 
cells to develop into B cells. This would test the function of Wnt3a in a more physiological 
setting. Wnt3a deficient fetal liver cells were co-cultured with BM stromal cell lines Sys-
Figure 2. Wnt3a deficiency affects fetal T-cell development. 
E12 thymic lobes from wild type and Wnt3a deficient E12 embryos were cultured in FTOC to allow T-cell 
development to proceed, and harvested at different time-points. (A) Total thymocyte numbers per thymic 
lobe after 13 days of culture. Similar results were obtained in all experiments, irrespective of the duration 
of culturing. (B) After 9 days of culture no differences between wild type and Wnt3a deficient lobes 
were observed. Thymocytes were stained for CD4 and CD8 to distinguish DN, DP and SP subsets (left 
panels) and within a CD4-CD8- gate with CD25 and CD44 to distinguish DN1-4 subsets (right panels). 
(C) After 14 (left panels) and 17 days (right panels) on filter, Wnt3a deficient thymic lobes contain fewer 
DP cells. 
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1 and OP9. Both wild type and Wnt3a deficient fetal liver cells efficiently developed 
into CD19 positive B cell progenitors (Figure 5A). Most cells were in the pro-B cell 
stage (Figure 5A), but after prolonged culturing expression of intracellular IgM could be 
detected both in wild type and knock-out cultures (data not shown). Surprisingly, after 
9 days of culturing, the percentage of CD19+ cells was significantly higher in the Wnt3a 
deficient cultures (Figure 5A and B). This increase, however, was not reflected by an 
absolute increase in cell numbers. Rather it could be attributed to the marked reduction 
in a population of side-scatter-high cells, that on further examination appeared to be 
MAC1 positive myeloid cells (Figure 5B), suggesting that Wnt3a deficiency negatively 
effects myelopoiesis. 
To further examine the effect of Wnt3a deficiency on myeloid development, we 
performed in vitro colony assays with E12 fetal liver cells. Wnt3a deficient fetal liver 
cells gave rise to significantly fewer myeloid colonies (Figure 5C), confirming our results 
on BM stromal cultures. Surprisingly, the effect on erythroid colony formation was even 
more striking: Wnt3a deficient fetal liver cells yielded six fold fewer erythroid colonies 
than wild type cells (Figure 5C). 
Wnt3a wt
Wnt3a –/–
T
H
L
T
H
L
T=Tongue; H=Heart; L=Liver
Thymic anlage
Thymic anlage
ER– TR4+ thymic epithelium
ER– TR4+ thymic epithelium
Figure 3. Normal thymic anlage in Wnt3a deficient embryos. 
Tissue sections of wild type (left) and Wnt3a deficient embryos. Left panels: HE staining of complete 
embryos. T: tongue, H: heart, L: liver. The region of the thymic anlage is indicated and magnified in the 
middle panels (HE staining) and right panels (ER-TR4 antibody which stains thymic epithelium). Isotype 
control for ER-TR4 was completely blank. Stainings shown are representative for four wild type and four 
knock-out embryos examined.
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Stem cell defect in Wnt3a deficient fetal liver
Differences in T-lymphoid, myeloid and erythroid development suggest that Wnt3a 
deficiency affects very immature hematopoietic lineage decisions and/or aspects of 
HSC differentiation or self-renewal. To investigate this, we analyzed hematopoietic 
progenitor cells in the fetal liver of wild type and Wnt3a deficient embryos. Total cell 
numbers and total percentage of hematopoietic cells (determined by CD45 expression) 
did not differ between wild type and Wnt3a deficient fetal livers (data not shown), nor did 
the percentage of lineage positive cells and the total population of c-Kit positive cells. 
However, the percentage of Lin-Sca-1+c-Kit+ (LSK) cells, which contain HSCs34, was 
significantly reduced in Wnt3a KO fetal livers (Figure 6A and B).
This finding suggested that Wnt3a deficient embryos have a problem in the HSC 
compartment. To test whether stem cell function is defective in these embryos, we 
performed transplantations of Wnt3a deficient fetal liver cells into sublethally irradiated 
wild type mice. 106 fetal liver cells (pooled samples of three Wnt3a deficient or three 
wild type embryos) containing the CD45.2 congenic marker were intravenously injected 
into CD45+ sublethally irradiated recipients. After five, eight and ten weeks, chimerism 
was analyzed in the blood of the recipient mice. In a number of mice, no donor cells 
were detected at any time point, probably due to failing intravenous injection. However, 
the proportion of mice in which no CD45.2+ cells were detected was higher in mice 
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Figure 4. Normal T-cell development from Wnt3a deficient fetal liver stem cells. 
Wild type (upper panels) and Wnt3a deficient (lower panels) E12 fetal liver cells were cultured in 
irradiated E14 wild type thymic lobes. After 14 days, lobes were harvested and analyzed using flow 
cytometry. FTOCs from wild type and Wnt3a deficient fetal liver cells yielded similar cell numbers (left), 
similar percentages of DN, DP and SP subsets (middle) and similar percentages of DN1-4 cells (right 
panels). Data are representative of five experiments.
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transplanted with Wnt3a deficient fetal liver cells (two out of three) than in mice receiving 
wild type cells (two out of five) (Table I). Furthermore, the percentage of CD45.2+ cells 
was much lower in the Wnt3a-/--transplanted mouse (0.2% after ten weeks) than in the 
wild type-transplanted mice (10-59%) (Table I). In a second experiment, in which a 
suboptimal number of fetal liver cells was injected, none of the six mice transplanted 
with Wnt3a deficient fetal liver cells showed any reconstitution, while four out of six 
mice transplanted with wild type fetal liver cells had a (small) population of CD45.2+ 
cells in their blood, spleen, BM and thymus (data not shown). Together these results 
indicate that Wnt3a deficient fetal liver cells much less efficiently repopulate sublethally 
irradiated mice and confirm a likely stem cell defect caused by Wnt3a deficiency.
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Figure 5. Decreased myelopoiesis from Wnt3a deficient fetal liver cells in BM stromal co-
cultures. 
Wild type and Wnt3a deficient E12 fetal liver cells were cultured for 7 (Figure A) or 9 (Figure B) days on 
confluent layers of OP9 BM stromal cells, which induces development in both myeloid and B-lymphoid 
lineages. (A) Wnt3a deficient fetal liver cells yield increased percentages of B cells. Most cells are 
CD19+CD43+ pro-B cells. (B) A population of side-scatter high cells is lacking in cultures from Wnt3a 
deficient fetal liver cells. These are MAC1+ myeloid cells. (C) In vitro colony assays. Wild type and Wnt3a 
deficient E12 fetal liver cells were plated in semi-solid cultures containing appropriate cytokines for 10 
days to generate myeloid (CFU-C) and erythroid (BFU-E) colonies. Numbers of colonies (derived from 
50,000 cells for CFU-C and from 10,000 cells for BFU-E) from individual fetal livers are shown. For BFU-
E, only large red colonies were counted. Results representative of two experiments.
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Figure 6. Decreased HSCs in Wnt3a deficient fetal livers. 
(A) Flow-cytometric analysis of wild type (upper panels) and Wnt3a deficient (lower panels) E12 fetal 
liver cells. Cells were stained for lineage markers (left panels) and for c-Kit and Sca-1 within the Lin- 
gate (right panels). The Lin-c-Kit+Sca-1+ (LSK) population is assumed to contain HSCs. (B) Percentage 
of cells highly positive for lineage markers, c-Kit+ cells and LSK cells within fetal livers. Mean and SD of 
7 wild type and 3 Wnt3a deficient fetal livers. 
Table I. Chimerism after transplantation. 
mouse transplanted with % CD45.2 cells 
wt fetal liver 53.7
wt fetal liver 58.7
wt fetal liver 10.2
wt fetal liver 0.0
wt fetal liver 0.0
Wnt3a-/- fetal liver 0.2
Wnt3a-/- fetal liver 0.0
Wnt3a-/- fetal liver 0.0
not transplanted 0.0
Percentage of CD45.2 (Ly5.2) positive cells in the blood, 10 weeks after transplantation with wild type 
or Wnt3a deficient E12 fetal liver cells.
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Figure 7. Repopulation of sublethally irradiated mice. 
Results shown are from the one mouse transplanted with Wnt3a deficient fetal liver cells and one out of 
three mice reconstituted with wild type fetal liver cells that showed reconstitution with donor (CD45.2+) 
cells. (A) Reconstitution of thymus. Left: CD45.2 staining, right: T-cell development within the CD45.2+ 
gate. (B) Reconstitution of spleen. Left CD45.2 staining, right: mature CD4+ and CD8+ T cells within the 
CD45.2+ gate. (C) Reconstitution of blood. Left: CD45.2 staining, middle: B cells and T cells, right: B 
cells and myeloid cells.
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Reconstitution of hematopoietic lineages
To monitor the ability of Wnt3a deficient fetal liver cells to reconstitute different 
hematopoietic lineages, we analyzed the thymus, spleen, BM and blood of transplanted 
mice. While wild type fetal liver cells efficiently repopulated the thymus of sublethally 
irradiated mice (15, 48 and 80% of thymocytes of donor origin), no CD45.2+ cells could 
be detected in the thymus of mice transplanted with Wnt3a deficient fetal liver cells 
(Figure 7A). The absence of thymocyte development was reflected by the complete lack 
of CD45.2+ mature CD4+ and CD8+ T cells in the spleen (Figure 7B). 
In accordance with the in vitro cultures of fetal liver cells on BM stroma, much higher 
percentages of B cells were detected within CD45.2+ population in blood, spleen and 
BM of mice transplanted with Wnt3a deficient fetal liver cells (Figure 7C, only blood 
is shown). Again, this increased percentage of B cells was caused by the absence of 
other populations, most noteworthy a complete lack of side scatterhigh, MAC1+ myeloid 
cells (Figure 7C). These results confirm that Wnt3a deficiency leads to defects in 
myelopoiesis.
Due too very low CD45.2+ cell numbers in the mouse transplanted with Wnt3a 
deficient cells, small cell populations (e.g. LSK cells and myeloid subsets) in BM could 
not be reliably analyzed (data not shown).
 
DISCUSSION
Despite a large body of evidence pointing towards an important role for Wnt signaling 
during the differentiation of various hematopoietic lineages, little genetic evidence from 
specific Wnt knock-out mice exists to support this hypothesis. As Wnt3a is the only 
Wnt available as recombinant protein, it is commonly used in in vitro studies and has 
been shown to be a proliferative factor for HSCs and thymocytes15,19,21. In this report we 
aimed to elucidate the in vivo functions of Wnt3a in hematopoiesis by studying Wnt3a 
deficient mice. 
We found that the thymic defects resulting from Wnt3a deficiency were relatively 
mild. In all embryos surviving until E12, a structure consisting of thymic epithelium 
could be detected by immunohistochemistry. This organ appeared to be seeded by 
hematopoietic cells, which on further culturing were able to develop into all thymocyte 
subsets. 
However, lower thymocyte numbers were detected in most cultures of Wnt3a deficient 
thymi, in accordance with a proliferative role for Wnt proteins in the most immature 
thymocyte subsets (Chapter 5, references 12, 14). The decreased cell numbers in Wn3a 
deficient thymi are reminiscent of both Tcf1 knock-out mice and Wnt1xWnt4 double 
deficient mice6,7,14. Wnt1xWnt4 deficiency resulted in a 50-70% decrease in thymocyte 
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numbers in E15-16 fetuses14. The only partially reduced cellularity in both Wnt1xWnt4 
and Wnt3a deficient mice, as opposed to the complete absence of mature thymocytes in 
the Tcf1/Lef1 double knock-out10, illustrates the high functional redundancy of different 
Wnt proteins in the thymus. Apart from Wnt1, Wnt4 and Wnt3a, we have shown high 
expression of Wnt5b, Wnt10a and Wnt10b in the murine thymus (Chapter 5). 
While the Wnt1xWnt4 double deficient mice showed no defects in the pattern of 
T-cell development, we found a reduction in DP cells in Wnt3a deficient thymi, mainly 
after prolonged culturing. This is very similar to the phenotype of Tcf1 knock-out mice, 
in which defective T-cell development became more pronounced as mice aged7. The 
decline in DP cells observed in Tcf1 deficient mice is presumably caused by decreased 
proliferation at the DN4 and ISP stages. 
The defects in T-cell development were mainly caused by the absence of Wnt3a in 
the thymic stroma, as fetal liver cells cultured in wild type lobes developed identical to 
wild type cells. This finding fits with the expression pattern of Wnt3a, with high mRNA 
levels in fetal thymic lobes already at E13 (Chapter 5), at which day stroma still is the 
main constituent of the lobes. Furthermore we have shown expression of Wnt3a in adult 
thymic stroma but not in thymocytes (Chapter 5). 
In contrast to the FTOC experiments, Wnt3a deficient fetal liver cells transplanted 
into sublethally irradiated animals did not yield any T cells at all, indicating a cell-
autonomous defect. The seemingly contradictory results of the cultures and in vivo 
experiments can be explained by the large differences between both assays. For 
FTOC, large numbers of progenitor cells are directly transferred into an environment 
which strongly induces T-cell development and in which no competitor cells are present, 
whereas for reconstitution of sublethally irradiated mice, cells have to home to the BM, 
proliferate, differentiate into progenitors that are able to seed the thymus, leave the 
BM and migrate to the thymus. As only very few cells home to the thymus, massive 
expansion of the earliest thymocytes is crucial. Wnt-driven proliferation (and possibly 
Wnt-induced adhesion molecules necessary for homing15) may be required at several 
of these steps and the absence of thymocytes and T-cells in the transplanted mice 
probably is the result of these cumulative defects. 
Wnt3a has been shown to be a growth factor for pro-B cells in vitro9, but in vivo 
evidence for a function for Wnt3a in B cells is lacking. As B220 positive cells were not 
yet present in E12 fetal livers of both wild type and Wnt3a deficient embryos, we studied 
B lymphopoiesis from fetal liver stem cells. We found markedly reduced numbers of B 
cells after in vivo transplantation of Wnt3a deficient fetal liver cells, but in contrast to 
T and myeloid cells, B cells were not completely absent. In stromal cultures, B cells 
appeared not to be affected at all. The mildly decreased B cell numbers in the BM of 
both the Lef1 knock-out and the Frizzled 9 knock-out mouse suggest a role for Wnt 
signaling in B-cell development9,18, but other Wnts than Wnt3a are probably more 
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important. We could not detect expression of Wnt3a in total adult BM or in BM stromal 
lines (data not shown), although expression of Wnt3a in BM cells (but not stroma) has 
been reported9. 
Myeloid populations were strongly decreased, both in stromal cultures and colony 
assays, and appeared to be absent after transplantation. These findings suggested a 
possible role for Wnt signaling in myelopoiesis. Thus far, no experimental evidence exists 
for a role of Wnt proteins in hematopoietic compartments other than T and B lymphocytes 
and HSCs. However, elevated expression of plakoglobin has been reported in acute 
myeloid leukemia (AML)35 and increased Wnt signaling during blast crisis in chronic 
myeloid leukemia (CML)36, suggesting a role for Wnts in (subsets of) myeloid cells as 
well. The question remains whether Wnt3a deficiency causes myeloid alterations by 
affecting a myeloid progenitor cell, or rather by influencing HSC differentiation or self-
renewal. 
The reduced in vivo repopulation and the fact that multiple lineages were affected 
by Wnt3a deficiency, including severely reduced erythroid development, suggested a 
stem cell problem to us. Indeed we found a significant reduction of LSK cells in Wnt3a 
deficient fetal livers. LSK cells are heterogeneous, containing true HSCs as well as 
downstream populations of multipotent progenitors that have lost the capacity to self-
renew34. Reduced numbers of HSCs or downstream precursors containing myeloid 
and erythroid potential may explain the reduced myeloid and erythroid development 
observed in Wnt3a deficient embryos. 
A role for Wnt signaling in stem cell self-renewal and inhibition of differentiation 
has been reported not only for HSCs19,20, but also for embryonic stem cells29 and stem 
cells in the gut37, skin38 and neuronal system39,40. Interestingly, the markedly reduced 
reconstitution of sublethally irradiated animals by Wnt3a deficient fetal liver cells indicates 
autocrine production of Wnt3a by progenitor cells. This is in contradiction with the often-
assumed function of Wnts as being growth factors secreted by the microenvironment. 
Using quantitative PCR we could not detect Wnt3a transcripts in total E14 fetal liver, but 
this does not exclude Wnt3a expression in purified progenitor populations. 
We conclude that Wnt3a deficiency leads to a mild thymic phenotype, no defects in 
B-cell development, severe defects in myelopoiesis and erythropoiesis and a marked 
decrease in LSK cell numbers. For the first time we demonstrate a physiological function 
for a specific Wnt in HSC biology. Although further studies are necessary to examine 
the exact identity of the decreased progenitor populations and the extend and functional 
consequences of their reduction, these results are highly encouraging for studies into 
the use of Wnt3a for clinical purposes. For instance, Wnt proteins could possibly be 
used to expand HSCs in vitro before they are genetically altered and transferred back 
into the patient during gene therapy. Additionally, Wnts could be used in vivo to aid the 
reconstitution of the immune system of patients after BM transplantation.
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MATERIALS AND METHODS
Mice
All animal experimentation was done in accordance with legal regulations in The Netherlands, which 
include approval by the local ethical committee. Mice were kept in the animal facility of the Erasmus MC. 
C57Bl/6 mice were obtained from Harlan, C57Bl/6-CD45.1 (Ly5.1) mice from the Jackson Laboratory. 
Mice heterozygous for the Wnt3a mutation were kindly provided by T. Yamaguchi (National Cancer 
Institute-Frederick, Frederick, MD). Genotyping was performed as described24.
Tissues and cells
Mice heterozygous for the Wnt3a mutation were bred and embryos of gestational day 12 (E12) were 
collected. A tissue sample of each embryo was used for genotyping. Fetal thymic lobes and fetal livers 
were isolated. Thymic lobes were cultured on a filter (Whatman) floating in medium for 9-17 days. Fetal 
livers were passed over a filter to obtain a single-cell suspension. Cells were either frozen down until 
further use or directly used for flow-cytometric analysis or culture experiments.
E14 fetal thymic lobes from normal C57Bl/6 mice were isolated and irradiated at 14.4 Gy using a 
γ-source.
Immunohistochemistry
6 μm tissue sections of frozen E12 embryos were fixed in acetone. For visualization of the different 
organ structures, sections were stained with haematoxylin-eosin (HE). To envisage thymic epithelium, 
sections were incubated with concentrated supernatant from a hybridoma producing ER-TR4 antibody33 
followed by a biotinylated rabbit anti-rat antibody (DakoCytomation) and finally with avidin-biotin complex-
horseradish peroxidase (DakoCytomation). Sections were incubated with 3-amino-9-ethylcarbazole 
(AEC) substrate (DakoCytomation) to detect peroxidase. 
Fetal thymic organ culture (FTOC) using fetal liver cells 
Fetal liver cells were cultured for 24-48 hrs in RPMI containing 10% fetal calf serum, 10 ng/μl 
recombinant murine Interleukin 7 (IL-7) and 50 ng/μl recombinant murine Stem Cell Factor (SCF) (both 
from R&D), after which 50,000 cells were transferred into irradiated E14 fetal thymic lobes using the 
hanging drop method41. After 24-72 hours, the lobes were transferred to a filter (Whatman) floating on 
medium. After 14-21 days of culturing, cells were harvested and stained for flow cytometry with CD25-
FITC, CD4-PE, CD8-PerCP and CD44-APC antibodies (all from BD Pharmingen). All flow-cytometric 
analyses were performed using a FACSCalibur flow cytometer (BD Biosciences) and Cell Quest Pro 
software.
BM stroma co-cultures of fetal liver cells
Fetal liver cells were cultured for 24-48 hrs in RPMI containing IL-7 and SCF. 10,000-50,000 cells 
were cultured in 12 wells plates on confluent monolayers of BM stromal cell lines, either Sys-1 or OP9 
in the presence of IL-7 and SCF. Medium and cytokines were refreshed every 3 days. 
After 7-16 days cells were harvested and stained for flow cytometry using the following antibodies: 
CD45-FITC, B220-FITC, CD11c-FITC, CD19-PE, CD43-PE, IgM-PE, GR1-PE, TER119-PE, B220-
APC, CD19-APC, MAC1-APC (all from BD Pharmingen) and IgM-FITC (H chain specific, from Jackson 
ImmunoResearch).
In vitro colony assays
Fetal liver cells were cultured over night with IL-7 and SCF and assayed for the presence of 
granuloctye-macrophage colony-forming units (CFU-C) and erythroid burst-forming units (BFU-E) by in 
vitro colony formation in viscous methylcellulose culture medium containing cytokines: for BFU-E 4U/ml 
human erythropoietin (EPO, Behringwerke AG) and 100 ng/ml murine SCF (R&D); for CFU-C 30 ng/ml 
murine IL-3, 100 ng/ml SCF and colony stimulating factor (CSF, 300x dilution of ConA adsorbed fraction 
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of pregnant mouse uterus extract). 10,000 and 50,000 cells were plated in duplicate dishes. The number 
of colonies was determined after 10 days of culture. 
Analysis of progenitor populations in fetal liver
Single cell suspensions of fetal liver cells were prepared and directly stained with Sca-1-FITC, 
B220-PE, MAC1-PE, GR1-PE, TER-119-PE and c-Kit-APC (all from BD Pharmingen) and analyzed 
using flow cytometry.
Fetal liver transplantations
8-11 week-old C57Bl/6 mice harboring the CD45.1 (Ly5.1) allele as a congenic marker, received a 
sublethal dose of 6 Gy total body irradiation. Mice were intravenously injected with 106 freshly isolated 
fetal liver cells (CD45.2+) in 250 µl of PBS or remained untransplanted as negative control. In a second 
experiment, 2.5x105 thawed fetal liver cells were transplanted. To prevent infections, mice received 100 
mg/l ciprofloxacin (Bayer) in their drinking water.
Five, eight and ten weeks after transplantation, blood was drawn and analyzed for cells expressing 
the CD45.2 marker. Ten weeks after transplantation, mice were killed and BM, spleen and thymus were 
isolated. In each organ, total cell numbers were determined and the percentage of CD45.2+ cells and 
their subset distribution was assayed by flow cytometry using the following antibodies: CD45.2-FITC, 
CD25-FITC, IgM-FITC, CD11c-FITC, CD4-PE, TCRγδ-PE, TER119-PE, Sca-1-PE, CD45.2-PerCP, 
CD8-PerCP, MAC1-PerCP, Lin-PerCP (CD3-biotin, B220-PerCP, NK1.1-biotin, MAC1-PerCP, GR1-
biotin, TER119-biotin, Streptavidin-PerCP), CD3-APC, CD44-APC, CD19-APC, MAC1-APC, c-Kit-APC, 
NK1.1-biotin, and Streptavidin-APC (all from BD Pharmingen). Cell samples of non-transplanted mice 
were stained as negative controls.
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INTRODUCTION
Of the many signals that are involved in T-cell development, Notch signaling is 
probably most conspicuous1. The Notch signal transduction pathway is an evolutionary 
conserved mechanism that regulates cell fate determination during developmental 
processes2. Four family members of the transmembrane Notch receptor are recognized, 
named Notch1 to 4. Signaling is initiated when the large extracellular domain of the 
Notch receptor binds a membrane-bound ligand on a neighboring cell. The five Notch 
ligands in mammals are Delta1, 3 and 4 and Jagged1 and 2. Binding of a ligand induces 
proteolytic cleavage of the intracellular part of the Notch protein (IC-Notch), which 
translocates to the nucleus and binds to the transcription factor CSL (in human referred 
to as CBF1, in mouse as RBP-Jκ), activating transcription of Notch target genes3.
T cells develop from multipotent progenitor cells that seed the thymus from the bone 
marrow or fetal liver1. The thymus is rich in expression of Notch ligands4 and after 
entering the thymic microenvironment, progenitors immediately start expressing Notch 
target genes5. These newly generated thymocytes do not express CD4 and CD8 and are 
therefore called double negative (DN). In humans, these most immature DN thymocytes 
are characterized as CD34+CD1a-CD38- and are homologous to murine DN1 cells6. In 
the next DN stage, thymocytes are CD34+CD1a-CD38+ (DN2). This subset still contains 
(at the population level) potential to develop into all hematopoietic lineages (Chapter 
4). In the subsequent stage (CD34+CD1a+, DN3), thymocytes become irreversibly 
committed to the T-cell lineage6. Finally, thymocytes lose expression of CD34 and 
proceed into the immature single positive (ISP) stage. 
The importance of Notch signaling for the induction of a T-cell fate was first 
demonstrated in mice in which the Notch1 gene was conditionally deleted, resulting 
in a complete block in T-cell development at the DN1 stage7 and the emergence of 
ectopic B-cell development in the thymus8. Conversely, overexpression of IC-Notch in 
the bone marrow instructed a T-cell fate in bone marrow progenitors and inhibited B-
cell development9. The same effect ensued when Delta4 was overexpressed in the 
bone marrow10. In vitro, this phenomenon can be mimicked by expression of Delta1, 
but not Jagged1, in bone marrow stromal cell lines. Using this co-culture system, T 
cell precursors can be efficiently generated from murine and human hematopoietic 
progenitors11-14. 
Functions of Notch in later stages of T-cell development and in other hematopoietic 
compartments have been reported as well and are reviewed elsewhere15,16.
To develop into a T cell, Notch signaling is clearly indispensable, but the downstream 
mechanisms by which a Notch signal is translated into a T-cell program are still largely 
unclear. The best known Notch target genes are Hairy-Enhancer of Split (HES)1 and 
HES5 and Hes-related repressor protein (HERP). Hes and Herp are basic-helix-loop-helix 
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(bHLH) proteins that function as transcriptional repressors17,18. Indeed overexpression 
of Hes1 and Hes5 in the bone marrow partly inhibits B-cell development19. But although 
proliferation of early thymocytes is severely affected by Hes1 deficiency20,21, thymocytes 
still develop in these mice. Hes1 can therefore not be the sole target of Notch signaling 
responsible for inducing a T-cell fate.
PTCRA (the gene for pre-T cell receptor α (pTα)) was found as a Notch target 
using Representational Difference Analysis (RDA) in murine thymoma cell lines with 
or without retroviral transduction of IC-Notch22. The pTα promoter was demonstrated to 
contain a CSL binding site and could be activated by IC-Notch in vitro23. Nevertheless, 
the physiological role of Notch signaling for pTα expression during T-cell development 
remains controversial, as pTα expression was not affected in mice in which Notch1 
was conditionally deleted from the DN3 stage onwards24. A role for Notch1 in opening 
of the T-cell receptor-β (TCRB) locus has been shown, but only for the complete TCRB 
rearrangements (V to DJ)24,25. 
Other Notch target genes identified in the thymoma cell line were DTX1 (gene for 
Deltex1), Ifi-202, Ifi-204, Ifi-D3, ADAM19 (Meltrinβ)22. A number of other genes have 
been reported as being Notch targets, including NOTCH1 itself26, NRARP in Xenopus 
embryos27, BCL2 in thymoma cells28, CCND1 (gene for cyclin D1) in a kidney cell line29, 
CDKN1A (gene for cyclin-dependent kinase inhibitor 1A (p21, Cip1)) in keratinocytes30 
and TCF3 (gene for E2A)9,31. It is unknown whether these genes are in vivo targets in 
the earliest thymocytes and whether they function in T-cell commitment.
In this study we investigated the downstream mechanisms of Notch signaling in human 
hematopoietic progenitor cells. We induced Notch signaling using two different methods 
and studied the transcription of known and newly recognized Notch target genes. Up- 
or downregulation of genes upon Notch signaling was compared to expression levels 
in the relevant thymocyte subpopulations, to examine whether these genes have a 
physiological role in T-cell commitment. We demonstrate that Notch signaling by itself 
does not induce a T-cell program, but we found several novel Notch target genes, some 
of which we have tested for their contribution to T-cell development. 
RESULTS 
Induction of Notch signaling
To identify target genes of Notch signaling, gene expression profiles were generated 
of human hematopoietic progenitors that did or did not undergo Notch signaling. We 
provided Notch signals in two different ways: by transfection of IC-Notch or by co-
culturing cells on Delta1 expressing stroma. 
A strong Notch signal was induced by transfecting CD34+ cells from human cord 
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blood (UCB) with a truncated Notch gene, encoding the intracellular, constitutively 
active part of the Notch protein (IC-Notch). It has been shown previously that human 
CD34+ cells expressing IC-Notch develop into T/NK progenitors when co-cultured 
on bone marrow stroma32. CD34+ UCB cells were transfected with an expression 
vector containing the IC-Notch gene or as a control with the empty expression vector. 
A separate GFP vector was co-transfected in 1/10 concentration in order to monitor 
transfection efficiency. Six hours after transfection, the percentage of GFP expressing 
cells was already high and comparable between IC-Notch transfected and control cells 
(Figure 1). The percentage of cells positive for the IC-NOTCH gene was probably even 
higher, as 88% of cells transfected with the same DNA amount of the GFP vector only 
were positive for GFP (data not shown). These results suggested that the IC-NOTCH 
gene was also expressed at this time point. 24 hours after transfection GFP expression 
had slightly decreased (Figure 1).
Another way to induce the Notch signaling cascade is to allow progenitor cells to 
interact with their cognate ligand responsible for inducing T-cell development. To this end, 
human CD34+ UCB cells were cultured on the bone marrow stromal cell line S17, which 
was retrovirally transduced with either human Delta1 in combination with GFP (S17-DL) 
or with GFP only (S17-GFP)11. Other groups have shown that CD34+ UCB cells cultured 
IC-Notchcontrol
C
D
34
-P
E
GFP
6 hrs after
transfection
24 hrs after
transfection
73.0% 64.2%
65.1% 56.6%
Figure 1. Transfection of hematopoietic progenitor cells. 
CD34+ progenitors from human UCB were transfected with a control vector (left panels) or a construct 
containing the gene for constitutively active Notch (IC-Notch, right panels), together with a GFP vector. 
After 6 hours (upper panels) and 24 hours (lower panels) the percentage of GFP+ cells was determined 
using flow cytometry.
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in this and similar systems develop into double positive (DP) thymocytes11,14 and also in 
our hands CD34+ progenitor cells efficiently developed into CD7+ T/NK precursors cells 
after 2 weeks of culturing on S17-DL (data not shown). CD34+ progenitor cells were 
cultured on S17-DL for 3, 6 and 24 hours, as kinetics of translocation of Notch-IC to the 
nucleus and induction of target RNA transcription are unknown.
From all samples RNA was isolated and gene expression profiles were generated 
using Affymetrix technology. Pair-wise comparisons were made between samples with 
or without Notch signaling. Numbers of significantly differentially expressed genes (≥ 
2 fold difference, p<0.003) are listed in Table I. Both up- and downregulated genes 
were found, indicating that Notch functions as an activator as well as a repressor of 
transcription in hematopoietic progenitors. 
Expression profiles of human thymocyte subsets have been previously generated 
and described in detail6. The differential expression of genes induced by Notch signaling 
in hematopoietic progenitors was compared to the relevant UCB and thymocyte subsets: 
CD34+ UCB versus DN1 (CD34+CD1a-CD38-) and DN1 versus DN2 (CD34+CD1a-
CD38+). DN1 cells have just entered the thymus and are therefore expected to upregulate 
Notch target genes5. The DN2 cells should also express Notch target genes, as they 
have contacted Notch ligands for prolonged periods and as Notch-ligand interactions 
are necessary throughout the DN1 and 2 stage for irreversible T-cell commitment33. In 
addition, during the DN2 stage, commitment to the T-cell lineage is initiated and cells 
start rearranging T-cell receptor β (TCRB) genes6. 
Expression of previously reported Notch target genes
Comparison files were mined for the expression of known Notch target genes, to 
determine whether these changed after Notch activation in hematopoietic progenitors 
as well. In all samples in which Notch signaling was activated, transcription of HES1, the 
universal Notch target2, was clearly increased (Figure 2A). This was most pronounced 
in the progenitor cells transfected with IC-Notch for 6 hours, reflecting the strong Notch 
signal induced in this way. 24 hours after transfection, HES1 was still upregulated, but 
to a lesser extend. This might indicate negative feed-back mechanisms that are initiated 
after receiving a strong Notch signal. Alternatively it may reflect the fact that transfection 
Table I. Numbers of significantly up- or downregulated genes (≥2 fold, p<0.003). 
6 hr ICN1 24 hr ICN1 3 hr S17-DL2 6 hr S17-DL2 24 hr S17-DL2
U133A array 70↑ 12↓ 17↑ 44↓ 10↑ 87↓ 13↑ 14↓ 137↑ 162↓
U133B array 35↑ 5↓ 13↑ 0↓  ND3  ND3  ND3
1ICN: progenitor cells from human UCB transfected with pcDNA-IC-Notch versus control pcDNA. 
2S17-DL: progenitor cells from human UCB cultured on S17-DL versus S17-GFP. 
3ND: microarray not performed.
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Figure 2. Differential expression of putative Notch target genes. 
(A and B) Fold changes in expression levels extracted from gene expression profiles generated from 
hematopoietic progenitor cells with or without induced Notch signaling, as well as previously performed 
gene expression profiles from human UCB and thymocyte subsets6. Left: comparisons of progenitors 
transfected with pcDNA-IC-Notch versus control pcDNA. Middle: comparisons of progenitors cultured 
on S17-DL versus S17-GFP. Right: comparisons of CD34+ UCB cells versus CD34+CD1a-CD38- (DN1) 
thymocytes and comparisons of CD34+CD1a-CD38- (DN1) thymocytes versus CD34+CD1a-CD38+ 
(DN2) thymocytes. Asterisks indicate a significant difference in expression levels (fold change >1.8, 
p<0.003). 
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was transient, consistent with the slightly diminished GFP expression found after 24 
hours (Figure 1). 
In the cells cultured on S17-DL, HES1 expression was most prominent after 24 hours 
(Figure 2A). HES1 was also highly upregulated in the DN1 thymocytes as compared to 
CD34+ UCB cells (Figure 2A), demonstrating that the artificially induced Notch signals 
in our experiments mimic the relevant processes in vivo. 
HERP1 and 2 were not expressed in any of the samples, neither before nor after 
inducing a Notch signal (Figure 2A). NOTCH1 itself is also a Notch target26 and was 
found to be significantly upregulated after 6 hours of transfection and after 24 hours 
of culturing on S17-DL (Figure 2A). This was reflected by high expression in the DN1 
subset as compared to UCB (Figure 2A). Also NOTCH3 was transcribed at high levels 
in the DN1 cells as compared to UCB, but Notch signaling in vitro induced NOTCH3 
transcription to a lesser extend and with slower kinetics than NOTCH1 (Figure 2A). 
NOTCH2 (Figure 2A) and NOTCH4 (not shown) were not differentially expressed in 
any of the samples. 
Of the other previously reported Notch target genes mentioned above, only NRARP 
was significantly upregulated after induction of Notch signaling (3.5 fold increased 
6 hours after transfection of IC-Notch (not shown)). The other genes were either 
not differentially expressed or not expressed at all (Figure 2B and data not shown), 
indicating that they are not Notch target genes in early hematopoietic progenitor cells. 
This finding is especially remarkable for Deltex1 and pTα, which are often assumed to 
be Notch targets during T-cell development12,22,23. In the thymocyte subsets, significantly 
increased mRNA expression of PTCRA was only found at the DN2 stage, but not at 
the DN1 stage (Figure 2B), while genuine Notch target genes (HES1, NOTCH1) were 
expressed already in DN1 thymocytes (Figure 2A). PTα may be a Notch target gene at 
later stages of T-cell development, but is not immediately upregulated when cells enter 
the thymus. 
For BCL2 a consistent, but not significant, trend of upregulation was observed in 
most comparisons, which was nevertheless not reflected in the thymocyte subsets 
(Figure 2B). Conversely, CDKN1A (p21) was significantly decreased in the DN1 subset, 
but did not show any differential expression after Notch activation (Figure 2B).
Notch does not induce a T-cell program
The mechanisms by which Notch signaling induces or promotes a T-cell fate still 
warrant elucidation. To investigate whether Notch signaling can trigger T-cell commitment 
by directly inducing TCR gene rearrangements or transcription of ‘classical’ T-cell 
specific genes, we mined our dataset for relevant genes. 
No induction of RAG1, RAG2 and DNTT (gene for TdT) and germline transcripts of 
TCRB, TCRD and TCRG were found after Notch signaling (Figure 3A and not shown), 
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suggesting that Notch has no direct function in opening of the TCR loci or the initiation 
of TCR gene rearrangements. 
In addition, we found no differential expression (mostly no expression at all) of T-
cell specific genes after activation of Notch signaling, while these genes were highly 
upregulated in the DN1 thymocytes (including CD7 and CD2) or in the DN2 subset 
(including CD1a, LAT and CD3γ) (data not shown). 
Next, we investigated differential expression of a number of transcription factors 
that are known to be important for T-cell development1. Tcf1 and GATA3 are among the 
first transcription factors to show up when a cell initiates a T-cell program34, which we 
confirmed in our DN1 subset (Figure 3B). Although it has been suggested that Notch1 
acts upstream of Tcf1 and GATA325, we did not find induction of these genes after Notch 
signaling (Figure 3B). 
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Figure 3. Differential expression of T-cell associated genes. 
Determined by microarray analysis as indicated for Figure 2. (A) TCR gene rearrangement-associated 
genes. (B) Transcription factors involved in T-cell development.
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Some reports have proposed that Notch inhibits B-cell development through inhibition 
of bHLH factor E2A9,31, although E2A is clearly important for T-cell development as well, 
both as a homodimer and as dimerization partner for HEB1. In our experiments, we 
found no upregulation of either E2A or HEB after Notch signaling (Figure 3B). 
Novel Notch target genes in hematopoietic progenitors
Next to the known Notch target genes HES1 and NOTCH1, we discovered significant 
differential expression of a number of previously unknown Notch target genes. Six 
hours after transfection with IC-Notch, high induction of HOXA5, HOXA9, HOXA10 
and to a lesser extend HOXA7 mRNA was detected (Figure 4A and B). Upregulation 
was markedly decreased after 24 hours. In S17-DL cultures, a small increase in HOXA 
transcripts could be detected after 24 hours by RQ-PCR but not by microarray analysis 
(Figure 4A and B). HOXA5, A9 and A10 were previously shown to be expressed in the 
human thymus35, but we did not observe upregulation of these genes in DN1 and DN2 
thymocytes (Figure 4A). 
Among the highest upregulated genes 6 hours after IC-Notch transfection were 
TCFL5 (Transcription Factor Like 5), MEK5c and DUSP6 (Dual-specificity phosphatase 
6, also termed MAP kinase phosphatase 3) (Figure 4C). TCFL5, a transcription factor 
of the bHLH family, was first identified in spermatocytes36,37. Both MEK5c and Dusp6 
can influence MAP kinase activity and interactions between the Notch and MAP kinase 
pathways have been described38. Our microarray results showed limited upregulation of 
MEK5c and TCFL5 transcripts after 24 hours of culturing on S17-DL, while for unknown 
reasons RQ-PCR validation of TCFL5 showed high induction in this condition as well 
(Figure 4D). TCFL5 and DUSP6 were significantly increased in the DN1 thymocytes 
as compared to CD34+ UCB (Figure 4C), supporting a functional role of these genes in 
T-cell differentiation. 
Lastly, we found high upregulation of a number of genes associated with 
vasculogenesis, including ANGPT2 (gene for angiopoietin), FGF22 and FBLN (gene 
for fibulin) (Figure 4E). These genes were detected only after transfection with IC-
Notch and not after co-culture on S17-DL or in thymocyte subsets, suggesting that 
their induction is not related to thymic function, but rather to other biological processes. 
These vasculogenesis genes may be physiologically induced by Notch ligands other 
than Delta1, for instance by Jagged. Interestingly, Notch signaling has been implicated 
in vasculogenesis and angiogenesis39-41. Furthermore, hemangioblasts (bipotent 
Figure 4. Differential expression of novel Notch target genes. 
(A) HoxA transcripts determined by microarray analysis as indicated for Figure 2. (B) HoxA transcripts 
determined by RQ-PCR. ND: not detected. (C) TCFL5, MEK5c and Dusp6 transcripts determined by 
microarray analysis. (D) Hes1 and TCFL5 transcripts determined by RQ-PCR. (E) Transcription of 
angiogenesis genes determined by microarray analysis.
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progenitors for endothelial and hematopoietic cells) are present among CD34+ UCB 
cells42. This intriguing finding warrants further research, but is beyond the scope of this 
report. 
Functional validation of novel Notch target genes TCFL5 and HOXA5
Perhaps the most striking novel Notch target genes identified in our studies were 
TCFL5 and the HOXA genes. The relevance of these genes is substantiated by the 
finding of putative CSL binding sites upstream of TCFL5 exon 1 and in the human 
HOXA5-HOXA4 intergenic region (data not shown). Nevertheless, functional studies are 
necessary to understand the significance of TCFL5 and HoxA proteins for hematopoiesis 
and T-cell development in particular. 
First we data-mined previously performed microarrays of all major thymocyte 
subsets6 for the expression of TCFL5. We found a progressive increase in TCFL5 
mRNA from DN1 up to the early DP stage (Figure 5A). Levels sharply dropped when 
thymocytes started expressing CD3, suggesting that TCFL5 functions mainly during the 
early stages of T-cell development (Figure 5A). 
To test whether TCFL5 is functionally important during T-cell development, we 
retrovirally expressed the TCFL5 gene together with the GFP gene in human CD34+ 
UCB hematopoietic progenitors. As a control, CD34+ cells were transduced with the 
same construct containing only the GFP gene. After transduction, cells were cultured 
in fetal thymic organ cultures (FTOC) to allow them to differentiate into T cells. After 9 
days in FTOC, thymic lobes were harvested and stained for flow-cytometric analysis. 
The TCFL5 transduced GFP+ cells showed an acceleration of T-cell development: the 
percentage of DP cells was almost doubled as compared to control transduced GFP+ 
and GFP- cells and TCFL5 transduced GFP- cells. (Figure 5B and data not shown). 
In addition, the percentage of TCRγδ+ cells was markedly increased in the TCFL5 
transduced GFP+ cells (Figure 5C). 
We found a remarkable increase in HoxA5, A9 and A10 in progenitor cells transfected 
with IC-Notch (Figure 4A), suggesting a role for these genes in hematopoiesis. Mice 
deficient for HoxA9 have previously been shown to display defects in myeloid, B-cell 
and T-cell development43,44, while on the other hand overexpression of HoxA10 inhibited 
lymphoid development45. HoxA5 deficient mice were generated some years ago46, but 
their hematopoietic system has not been studied. We now analyzed the bone marrow, 
spleen and thymus of HoxA5 knock-outs and heterozygous and wild type littermates of 
2.5, 4 and 25 weeks old. No consistent abnormalities were detected in populations of 
B, T, NK and myeloid cells in the thymus, bone marrow and spleen of HoxA5 deficient 
mice (data not shown). As the thymic defects of HoxA9 deficient mice were much more 
pronounced in fetal mice than in adults, we also analyzed HoxA5 deficient embryos. We 
found normal T-cell development in fetal thymic lobes of HoxA5 deficient embryos and in 
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Figure 5. Functional validation of a role for TCFL5 in T-cell development. 
(A) Relative amounts of TCFL5 mRNA in thymocyte subpopulations. Values extracted from previously 
performed gene expression profiles6. CB: CD34+ UCB, DN1: CD34+CD1a-CD38-, DN2: CD34+CD1a-
CD38+, DN3: CD34+CD1a+, ISP: CD4+CD3-, DP1: CD4+CD8+CD3-, DP2: CD4+CD8+CD3+, SP4+: 
CD4+CD3+, SP8+: CD8+CD3+. (B and C) Human CD34+ UCB cells were retrovirally transduced with 
a vector containing only the gene for GFP (left panels) or TCFL5 and GFP (right panels) and allowed 
to develop into T-cells in FTOC. After 9 days of culture, cells were harvested and examined by flow 
cytometry. (B) Expression of CD4 and CD8 within the GFP+ gate. (B) Expression of TCRγδ within the 
GFP+ gate. 
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FTOCs of HoxA5 deficient fetal liver cells (Figure 6A). Furthermore, no differences were 
found in numbers of Lin-Sca-1+c-Kit+ cells between the fetal livers of HoxA5 deficient 
and normal embryos (Figure 6B), indicating that hematopoietic stem cells are normally 
present in these mice. Colony assays were performed to determine the frequency of 
erythroid and myeloid progenitors in HoxA5 deficient bone marrow: no abnormalities 
were detected (data not shown). To investigate whether HoxA5 deficient bone marrow 
progenitors can reconstitute the immune system under competitive conditions, bone 
marrow cells were transplanted into sublethally irradiated recipients. After five, eight 
and ten weeks, the percentage of donor cells in the blood was identical between 
mice transplanted with wild type or HoxA5 deficient bone marrow cells (Figure 6C). 
Furthermore, all hematopoietic lineages were normally present among donor cells in 
thymus, bone marrow and spleen of the recipients. 
DISCUSSION
Despite the unmistakable role of Notch signaling for T-cell lineage specification, 
studies to identify downstream Notch target genes in relevant primary cell types have 
not been undertaken. 
In the present study we took advantage of the recently introduced  AMAXA 
nucleofection system, which allows transient transfection of primary hematopoietic 
progenitor cells with a high efficiency and relatively low mortality. Using this technique, 
we were able to induce a rapid and strong Notch signal. Furthermore, the S17-DL 
stromal cell co-culture system allowed us to more physiologically mimic the Notch signal 
encountered by progenitor cells that enter the thymus. We chose to use human CD34+ 
UCB cells as source of progenitor cells, as these are readily available, unactivated, 
multipotent, and efficiently develop into T-cells when cultured in murine fetal thymic lobes 
or on bone marrow stroma expressing Delta111,12,32. Progenitor cells start expressing 
Notch target genes only after entering the thymus5, which made them preferable over 
CD34+ thymocytes which have already contacted Notch ligands. Using CD34+ UCB cells 
and either IC-Notch transfection or the S17-DL co-culture system in combination with 
Affymetrix microarray technology, we found upregulation of the generally acknowledged 
Notch target genes HES1, NOTCH1 and NRARP, which validated our procedures. 
The delayed upregulation of target genes in cells cultured on S17-DL as compared to 
transfection with IC-Notch indicates that cells need prolonged or multiple contacts with 
the Delta1 ligand to get accumulation of significant amounts of IC-Notch.
Our assays did not show induction of a number of genes previously reported to 
function as Notch targets during T-cell development, including PTCRA, E2A and 
DTX19,22,31. This is especially critical for Deltex1, as many studies use expression of 
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Figure 6. Hematopoiesis in HoxA5 deficient mice. 
(A) Thymic lobes of normal (left and middle panels) and HoxA5 deficient (right) embryos of day 14 of 
gestation (E14) were cultured on filters. After 16 days, T-cell development in the lobes was analysed 
using flow cytometry. (B) Hematopoietic progenitor populations were determined in fetal livers of normal 
(left and middle panels) and HoxA5 deficient (right) E12 embryos. Percentages of Lin-Sca-1+c-Kit+ (LSK) 
cells are shown in the upper right quadrant. (C) Sublethally irradiated mice were transplanted with wild 
type or HoxA5 deficient bone marrow cells. After ten weeks, the percentage of CD45+ donor cells and 
the percentage of CD19+ B cells, CD3+ T cells, and MAC1+ myeloid cells within a CD45+ gate were 
determined in the blood of the recipients. 
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Deltex1 as the read-out for active Notch signaling, mostly in combination with Hes112,47, 
but in some cases as sole evidence48. The main proof for PTCRA and DTX1 as Notch 
targets in T-cell development comes from studies by Deftos et al., in which IC-Notch 
was retrovirally transduced into a murine DP thymoma cell line22,28. Apart from the 
fact that Notch signaling and downstream events may be dysregulated in malignantly 
transformed cells, retroviral transduction takes several days and identified genes may 
represent indirect targets or may have resulted from compensatory mechanisms. 
Upregulation of genes identified in the thymoma line was confirmed in the thymi of mice 
transgenic for IC-Notch22, but may again result from indirect activation. Nevertheless, 
it possible that PTCRA is a Notch target gene in more differentiated T-cell precursors. 
This would fit with our finding that PTCRA is upregulated at the DN2 stage and with the 
fact that Notch signaling continues throughout the DN2 stage33.
We did not find any evidence for direct induction of a T-cell program by Notch 
signaling. This is in contrast with a recent study by Höflinger et al., in which a Notch 
signal was induced by culturing multipotent progenitor cells on OP9-DL25. These cells 
rapidly upregulated PTCRA, DTX1, GATA3 and TCF1, but not HES1 transcripts. 
However, these results should be interpreted with caution, as this study used murine 
Pax5-/- pro-B cells expanded on the ST2 cell line as source of uncommitted progenitors: 
non-physiological cells that express many B cell specific genes and have already started 
TCR gene rearrangements (Vγ-Jγ, Vδ-Jδ and Dβ-Jβ)25. 
Our findings are consistent with experiments of Taghon et al. in which murine fetal 
liver progenitors were cultured on OP9-DL47. This study showed that GATA3, TCF1 
and PTCRA began to be expressed after three days of culture on OP9-DL, while high 
HES1 transcription was detected already after one day. These findings indicate that 
either Notch signaling induces T-cell genes in more differentiated thymocytes, or Notch 
signaling stimulates the expression of other transcription factors, which then in turn 
activate or repress lineage differentiation genes. TCFL5 is a likely candidate for such 
a function. 
TCFL5 is a member of the group B bHLH proteins and presumably binds to the 
same non-canonical E-box as Hes136. It was first found in spermatocytes, but was not 
detected in the thymus by Northern-blot analysis36,37. This might be explained by the fact 
that TCFL5 levels decrease in the more mature stages of T-cell development (Figure 
5A), which comprise the larger part of the thymus. Also during spermatogenesis, TCFL5 
is expressed in a highly cell-type and stage-specific pattern36,37.
By overexpressing TCFL5 in FTOC, we obtained preliminary clues that TCFL5 indeed 
positively regulates T-cell development. The observed effects were mild, presumably 
because TCFL5 is expressed already during the early stages of T-cell development 
(Figure 5A), and enhanced expression is not likely to induce remarkable changes. Our 
ongoing siRNA studies will further show the significance of TCFL5 function.
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The finding of the HOXA cluster genes as Notch targets is novel and intriguing. Notch 
induced HOXA transcripts may be important for T-cell development, as HoxA9 deficient 
mice have a partial block at the DN1 stage of thymocyte development44. Furthermore, 
overexpression of HOXA genes is a cause of human T-ALL49. We did not find upregulation 
of HOXA genes in DN1 cells. Possibly, HOXA genes are induced only in a tiny subset 
of DN1 cells that have just contacted Delta, and are rapidly downregulated afterwards. 
However, we did not detect any defects in T-cell differentiation or hematopoiesis in 
general in HoxA5 deficient mice. The high functional redundancy of the different HoxA 
genes probably obscures the importance of HoxA5 for hematopoiesis. It would be 
highly interesting to study T-cell development from progenitors deficient for more than 
one HoxA gene. 
Other than a role in T-cell development, the Hox genes may be involved in 
alternative Notch-regulated processes in hematopoietic stem cells. Notch signaling is 
clearly important for self-renewal of hematopoietic progenitors (reviewed in reference 
15). Interestingly, HOXA5, A9 and A10 were found to be part of the ‘stem cell profile’50. 
Without doubt, the relation between Notch signaling and HoxA expression should be 
studied in greater detail.
The mechanism by which Notch signaling initiates a T-lineage differentiation program 
in hematopoietic progenitors remains a fascinating issue for immunologists. Here we 
demonstrate that Notch does not directly activate a T-cell specific transcription program, 
nor does it directly induce TCR gene rearrangements. For sure, Hes1 executes part of 
the downstream Notch effects. In addition, TCFL5 and HoxA proteins may prove to be 
major player in Notch-regulated mechanisms during T-cell development.
MATERIALS AND METHODS
Isolation of cells
Human umbilical cord blood (UCB) material was obtained according to the informed consent 
guidelines of the Medical Ethical Committee of Erasmus MC, Rotterdam. UCB mononuclear cells were 
isolated using Ficoll density centrifugation and frozen down until further use. Over 90% of UCB cells 
were viable after thawing. For each experiment, frozen UCB cells of at least four different donors were 
used. CD34+ progenitor cells were purified using immunomagnetic beads (Miltenyi Biotec). Purity of the 
recovered subpopulations was checked by staining with CD34-PE (BD Pharmingen) and flow cytometry 
and was always greater than 95%.
Transfection of CD34+ UCB cells
Human cDNA encoding the intracellular domain of Notch1 (amino acids 1770-255551) was cloned 
into the multiple cloning site of eukaryotic expression vector pcDNA3 (Invitrogen). CD34+ UCB cells were 
cultured for one hour in the presence of 10 ng/ml recombinant human IL-7 and 50 ng/ml recombinant 
human SCF (both from R&D Systems). Subsequently, 4x106 cells were transfected with 4 μg pcDNA3-
IC-Notch or empty pcDNA3 using an AMAXA human CD34 Nucleofector kit and an AMAXA Nucleofector 
Device, according to the manufacturers protocol. 0.1 μg of pEGFP-C1 (BD Clontech) was co-transfected 
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with each sample. After transfection, cells were cultured on confluent layers of the murine bone marrow 
stromal cell line S17, in the presence of 10 ng/ml IL-7 and 50 ng/ml SCF. After 6 and 24 hours, cells 
were carefully harvested without disturbing the S17 monolayer and RNA was isolated. A small aliquot of 
cells was taken from each sample to monitor transfection efficiency: GFP expression was determined 
by flow-cytometry (FACS Calibur, BD Biosystems). 
Co-culture of CD34+ UCB cells on S17
S17 bone marrow stromal cells retrovirally transduced with either Delta1-IRES-eGFP (S17-DL) or 
control LZRS-IRES-eGFP (S17-GFP) were kindly provided by dr. L. Parreira (Faculdade de Medicina de 
Lisboa, Portugal) and have been described previously11. S17 cells were grown in confluent monolayers 
in 24 wells plates. 1x105 CD34+ UCB cells were co-cultured with S17 in the presence of 10 ng/ml IL-7 and 
50 ng/ml SCF. After 6 and 24 hours cells were carefully harvested and processed for RNA isolation.
Microarray analysis
Affymetrix microarray analysis of the samples transfected with pcDNA or pcDNA-IC-Notch was 
performed as described previously52. For the samples co-cultured on S17, an extra cycle of cDNA and 
cRNA synthesis was performed. The starting amount of RNA for the first round of cDNA synthesis was 
30-60 ng. 
For the transfected samples, Affymetrix U133A and B microarrays were used, for co-cultured samples 
only U133A arrays. In comparison experiments, care was taken that the 5’/3’ GAPDH ratio, scaling 
factor, noise, and percentage of presence calls were comparable. Scanned images were analyzed 
using Affymetrix Microarray Suite 5.1 software, and pair-wise comparisons were generated using the 
appropriate control samples (without induced Notch signaling) as baseline. Differential expression was 
considered significant when the gene received a ‘present call’ for at least one of the microarrays used 
for the comparison, the fold change was >1.8 and change-p value <0.003. Differential expression of 
genes after Notch induction was compared to expression profiles of CD34+ UCB cells and the relevant 
thymocyte subsets: comparisons of CD34+ UCB cells versus CD34+CD1a-CD38- (DN1) and CD34+CD1a-
CD38- versus CD34+CD1a-CD38+ (DN2)) (data generated previously6).
Probes for DTX1 and NRARP were present only on the U133B array. HES5 was not represented on 
the microarray used (U133). Of the Ifi family, only Ifi16 was present on the microarrays. 
Real-time quantitative-PCR (RQ-PCR) 
The expression of several target genes was tested using TaqMan-based RQ-PCR. 1 μg cRNA 
generated in the microarray analysis procedure was treated with 1U of DNase I and subsequently 
reverse transcribed to cDNA with avian myeloblastosis virus-reverse transcriptase (5 U), oligo(dT) and 
random hexanucleotide primers. 
Mixes containing the appropriate pre-designed primer/probe sets were obtained from Applied 
Biosystems. For TCFL5, Hes1, HoxA9 and HoxA10 these were Assays-on-Demand, for HoxA5 an 
Assay-by-Design. A 1/20 cDNA mixture was used for RQ-PCR for each primer/probe set and performed 
in duplicate. The RQ-PCR reaction was performed using TaqMan Universal mastermix (Applied 
Biosystems) and was run on a PRISM 7700 sequence detection system containing a 96 well thermal 
cycler (Applied Biosystems). RQ-PCR results were normalized to GAPDH expression (kit from Applied 
Biosystems) in the same sample.
Functional testing of TCFL5 in fetal thymic organ culture (FTOC) 
Full-length cDNA for human TCFL5 was obtained from Invitrogen, cloned into the retroviral vector 
LZRS-IRES-eGFP and high titer retrovirus was produced in the Phoenix packaging cell line. CD34+ UCB 
cells were cultured for one day and retrovirally transduced for two days in the presence of 50 ng/ml SCF, 
10 ng/ml recombinant human TPO and 50 ng/ml recombinant human Flt3L (all from R&D Systems). The 
percentage of GFP positive cells was determined using flow cytometry and cells were transferred into 
irradiated murine embryonic day 14 thymic lobes. After two days, lobes were cultured on filters floating 
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on medium. After an additional nine days, lobes were harvested, single cell suspensions were made and 
T-cell development was analyzed using a FACS Calibur flowcytometer (BD Biosystems). Monoclonal 
antibodies against human antigens were CD1a-RD1 (Beckman Coulter) and TCRγδ-PE, CD3-PerCP, 
CD8-PerCP, CD4-APC and CD34-APC (all from BD Pharmingen).
HoxA5 KO mice
Mice deficient for HoxA5 have been described in detail46. Mice heterozygous for the mutated HoxA5 
gene were bred to generate deficient, heterozygous and wild type littermates. HoxA5 deficient mice 
were viable and did not display evident abnormalities. In mice of 2.5, 4 and 25 weeks old, bone marrow, 
spleen and thymus were analyzed for presence of different hematopoietic lineages using flow cytometry. 
Embryonic thymic lobes of day 16 were directly stained for flow-cytometry. Embryonic thymic lobes of 
day 13 and 14 were cultured on a filter for 16 days, after which T-cell development was analyzed using 
flow-cytometry. Fetal livers of embryonic day 13 and 14 were either directly used for flow-cytometry to 
analyse progenitor populations or transferred into irradiated wild type day 14 thymic lobes for FTOC 
experiments. Chimeric thymic lobes were cultured for 14 days on a filter, after which T-cell develoment 
was analyzed using flow-cytometry. 
HoxA5 deficient BM cells were assayed for the presence of granuloctye-macrophage colony-
forming units (CFU-C) and erythroid burst-forming units (BFU-E) by in vitro colony formation in viscous 
methylcellulose culture medium containing cytokines: for BFU-E 4U/ml human erythropoietin (EPO, 
Behringwerke AG) and 100 ng/ml murine SCF (R&D); for CFU-C 30 ng/ml murine IL-3, 100 ng/ml 
SCF and colony stimulating factor (CSF, 300x dilution of ConA adsorbed fraction of pregnant mouse 
uterus extract). 40,000 and 100,000 cells were plated in duplicate dishes. The number of colonies was 
determined after 10 days of culture.
HoxA5 deficient BM cells were assaysed for their ability to reconstitute the immune system of 
sublethally irradiated mice. 8-11 week-old C57Bl/6 mice harboring the CD45.1 (Ly5.1) allele as a 
congenic marker, received a sublethal dose of 6 Gy total body irradiation. Mice were intravenously 
injected with 2x106 thawed bone marrow cells (CD45.2+) in 250 µl of PBS. To prevent infections, 
mice received 100 mg/l ciprofloxacin (Bayer) in their drinking water. Five, eight and ten weeks after 
transplantation, blood was drawn and analyzed for cells expressing the CD45.2 marker. Ten weeks 
after transplantation, mice were killed and BM, spleen and thymus were isolated. In each organ, total 
cell numbers were determined and the percentage of CD45.2+ cells and their subset distribution was 
assayed by flow cytometry. 
Monoclonal antibodies against mouse antigens were ER-MP20-FITC (anti Ly6c, own culture), CD25-
FITC, IgM-FITC, Sca1-FITC, CD45.2-FITC, CD4-PE, CD43-PE, TER119-PE, NK1.1-PE, CD127-PE, 
Sca-1-PE, CD8-PerCP, Lin-PerCP (CD3-biotin, B220-PerCP, NK1.1-biotin, MAC1-PerCP, GR1-biotin, 
TER119-biotin, Streptavidin-PerCP), CD44-APC, B220-APC, CD19-APC, MAC1-APC and c-kit-APC 
(all from BD Pharmingen).
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T-cell development in the thymus is a complex and highly regulated process. During 
the process of differentiation from multipotent stem cells to mature T cells, proliferation, 
restriction of lineage potential, TCR gene rearrangements and selection events 
occur, all accompanied by changes in gene expression. Many extracellular cytokines, 
adhesion molecules, intracellular signal transduction pathways and transcription factors 
are involved and a comprehensive understanding of thymocyte differentiation remains 
to be established. Two key issues into which the research presented in this thesis 
has provided insight are highlighted in this General discussion: detailed phenotypic 
and genetic description of the different stages of T-cell development, and cellular and 
molecular aspects of T-cell commitment.
HUMAN THYMOCYTE SUBPOPULATIONS
Before studying the molecular regulation of T-cell development, it is imperative to 
know the characteristics of the normal thymic subpopulations in which the different 
processes take place. In Chapters 2-4, our basic knowledge about the stages of human 
T-cell development was updated. The classification of thymocyte subsets based on 
expression of CD4, CD8, CD34 and CD1a is commonly used and TCR rearrangements 
in human thymocytes have been studied previously1. We used multi-color flow cytometry, 
high-speed cell sorting, quantitative PCR and microarray technology to perform more 
detailed and sensitive analyses. These findings are summarized in Figure 1. 
Based on the TCR gene rearrangement status of the various subpopulations, 
the stages of human T-cell development appear to be highly similar to the stages in 
the mouse2, allowing the use of mouse nomenclature for human thymocytes as well. 
For example, human CD34+CD38-CD1a- cells correspond to murine CD44+CD25- 
thymocytes and can therefore be called DN1. One exception exists: the human ISP 
subset is more similar to the murine DN4 subpopulation in that these are the rapidly 
cycling cells that have undergone β-selection. The murine ISP population is extremely 
small and usually ignored in studies of thymocyte differentiation.
The DN CD34- (DN4) subpopulation confronted us with some problems. This subset 
was omitted in Chapter 3, because no high quality mRNA could be obtained from these 
cells. There may be several reasons for this. First, the DN4 population is defined only 
by exclusion markers, possibly leading to the isolation of an impure fraction, containing 
dead or dying cells, stromal components and debris. Second, this population is heavily 
rearranging TCRB genes and has largely shut down proliferation, greatly reducing 
mRNA transcription. And finally, a large part of the DN4 cells may be undergoing 
apoptosis, after failing to produce a functional TCRβ chain. Nevertheless, TCR gene 
rearrangement and gene scan analyses were performed in these (suboptimally sorted) 
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cells and showed the presence of complete, in-frame TCRB genes (data not shown). 
The presence of a functional TCRβ-chain in combination with preTα (of which high 
transcript levels are present already in the CD34+CD1a+ stage) would imply that β-
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Figure 1. Characteristics of human thymocyte subpopulations. 
Percentages of the different subsets were determined in Chapter 2. Numbers shown are typical for the 
thymus of a 6 to 9-month old child. Percentages of CD3- and CD3+ DP subsets are similar, but the exact 
contribution of each is difficult to determine, as a gradual increase in CD3 expression occurs during the 
DP stage. TCR gene rearrangements were quantitatively determined in Chapter 3 and were used to 
pinpoint β-selection to the DN4 to ISP transition. Chapter 4 demonstrates that T-cell commitment (with 
respect to loss of erythroid, myeloid and B-lymphoid potential) is completed before the DN3 stage. The 
percentage of proliferating cells in each subset was analysed by flow cytometry, using intracellular Ki67 
staining. Of the CD8+ SP cells 2% was positive for Ki67. Presence of Wnt signaling in each subset was 
studied in Chapter 5, using Tcf reporter expression, β-catenin levels and Wnt target gene transcription. 
Presence of Notch signaling was deduced from the level of Hes1 transcripts, as extracted from the gene 
expression data generated using microarrays in Chapter 3. nt: not tested.
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selection takes place in the DN CD34- stage. This hypothesis is supported by the fact 
that TCRA rearrangements start in the ISP stage. However, it is somewhat later than in 
the mouse, in which β-selection occurs at the DN3 stage3. 
All thymocyte subpopulations described in Figure 1 were isolated and gene 
expression profiles were generated using microarray technology (described in Chapter 
3), resulting in a huge data-set which has already proven valuable. The thymocyte 
expression profiles were used to identify transcription factors associated with particular 
TCR gene rearrangements. In addition, the gene expression data helped to answer 
specific questions in Chapter 4, 5 and 8 as well as in other studies4,5. We are convinced 
that also in further studies regarding T-cell development these expression profiles will 
prove to be a rich source of information. Furthermore, gene expression in thymocytes 
can be compared to other cell types, e.g. to find genes functioning in similar processes 
in both T- and B-cell development, and may be used as a ‘base-line’ for comparisons 
with corresponding populations in deregulated T-cell development (e.g. T-ALL or SCID), 
to find genes involved in these diseases.
Dangers of phenotypically defined subsets
Although the thymocyte expression profiles and the data presented in Figure 
1 are useful and have provided new insights, our studies have, perhaps above all, 
demonstrated that this division into subsets is incomplete, and call attention to the 
limitations of surface immunophenotypes. Two potential ‘threats’ are being encountered: 
the sorted population might be functionally impure and a functionally uniform population 
might be spread over multiple phenotypical stages. 
Most of the studied thymocyte populations are functionally heterogeneous, first of all 
because they all contain proliferating and non-proliferating cells, as determined by Ki67 
staining (Figure 1), perhaps with the sole exception of the SP subsets, which appear 
essentially resting. Each subpopulation should reasonably contain non-cycling cells, as 
TCR rearrangements take place in every subset as well. It is generally accepted that 
proliferation and gene rearrangements do not occur simultaneously in the same cell, as 
this would bring about the danger of unwanted gene translocations which are frequently 
observed in T-ALL6. 
The massive pre-TCR independent expansion that occurs in the DN1, 2 and 3 
subsets, appears to be interrupted by rearrangements of the TCRD, TCRG and TCRB 
genes. Whether there is a dynamic alternation of proliferation and rearrangement in 
the different stages or rather a large heterogeneity in the timing of rearrangement 
initiation remains to be examined. For example, some cells may start rearranging 
TCRD already in the DN1 stage, while others keep cycling until DN3 and then start 
rearrangements. Another example of a functionally impure population is the ISP subset: 
in this stage pre-TCR driven expansion occurs, as well as termination of proliferation 
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and initiation of TCRA rearrangements. In addition, some cells are still rearranging 
TCRB genes, probably because earlier attempts at producing an in-frame TCRβ-chain 
were unsuccessful. 
Exemplary for heterogeneous surface marker expression on a functionally uniform 
population are the cells in which TCRA rearrangements occur. TCRA rearrangements 
are stretched over a number of subsets, starting in ISP and being completed only in 
the SP stages. If opening of the TCRA locus would be studied by sorting for instance 
DP CD3- cells, only a proportion of the target population would be isolated, and the 
conclusions drawn may not hold for the entire population.
Obviously, the surface markers we use now do not suffice to isolate functionally 
pure cell populations. Many of the currently employed antibodies stain surface antigens 
that do not necessarily have a direct relation to the process they are intended to 
represent. For example, upregulation of CD1a seems to correlate nicely with the point 
of T-cell commitment, but probably purely coincidental. The use of antibodies against 
proteins that are functionally involved in specific processes, e.g. proliferation or pre-
TCR signaling, would be of great help. Our microarray data may help to identify such 
markers. Unfortunately, many of such newly-identified proteins will not be expressed at 
the cell surface, and intracellular staining is at present not compatible with RNA-based 
gene expression profiling. 
T-CELL COMMITMENT
At some point during T-cell development, a thymocyte will find itself on the track 
towards becoming a T cell, while all other options are closed. This thymocyte is committed 
to the T-cell lineage. The process of T-cell commitment in a multipotent progenitor is an 
intriguing issue of which many questions remain unanswered. Several processes may 
contribute to T-cell commitment, including loss of alternative lineage gene expression, 
loss of alternative lineage potential, expression of a T-cell specific gene program and 
initiation of T-cell specific gene rearrangements. Finally the production of a functional 
TCRβ chain will induce signaling through the pre-TCR, an event that is absolutely 
specific for T cells. However, final T-cell commitment likely precedes pre-TCR signaling. 
Furthermore, the loss of alternative lineage potential does not happen at a single instant; 
in stead the moment may vary with respect to the lineage that is excluded. For example, 
differentiation into the erythroid lineage is presumably shut down at an earlier stage 
than the NK-cell lineage. 
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The thymus-seeding cell
The issue of T-cell commitment starts with the question to what level the cells that 
seed the postnatal thymus are committed to the T-cell lineage. The difficulty in answering 
this question is that cells will immediately be influenced by the thymic microenvironment 
as soon as they enter the thymus. Progenitors that have T-cell developmental capacity 
but differ from HSCs have been identified in bone marrow (BM) and blood7-10, but it is 
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Figure 2. The earliest stages of T-cell development. 
(A) Several candidate thymus-seeding cells (TSC) have been proposed, ranging from HSCs or non-
renewing multipotent progenitors to committed T-cell precursors (CLP: common lymphoid progenitor; 
T/M: T/myeloid bipotent progenitor, T: T-cell committed progenitor). Cells that enter the thymus receive 
Delta-induced Notch signals via the thymic stroma and start their development into T cells. As they 
develop, thymocytes gradually lose expression of CD34 and acquire CD1a. In addition, lineage potential 
(either of individual cells or on the population level) declines. It remains to be demonstrated whether 
thymus-seeding cells have equal potential for each lineage with rapid loss of non-T-cell potential upon 
thymic entry (depicted in A), or whether alternative lineage potential is already reduced before cells 
arrive in the thymus (depicted in B). E/M: erythroid/megakaryocytic.
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unknown whether these cells seed the thymus physiologically (Figure 2). Harman et 
al.11 have elegantly addressed this question by isolating the cells that are present in the 
mesenchyme surrounding the fetal thymus but have not yet entered. These cells were 
shown to be committed T-cell precursors11. However, the cells that initially populate the 
fetal thymus and contribute to the establishment of the thymic microenvironment may 
be entirely different from the few postnatal thymus-seeding cells that predominantly 
serve to keep the thymocyte counts at level.
In the mouse, identification of the thymus-seeding cell has lately been approached 
by sorting minute DN populations from the thymus and by studying their lineage potential 
and other characteristics, hoping to find the cells that have contacted the thymic stroma 
for a minimally short period. The thymus-seeding cell is generally thought to lie within the 
ETP (early T-cell progenitor) population. Classic ETPs are defined as being DN1, Lin- 
and c-Kithi 12 and are supposedly highly heterogeneous themselves. Additional markers, 
varying per research group, were included to subdivide ETPs and other DN populations 
into several fractions, which appeared to have different T- and B-cell developmental 
capacities. This also depended on the in vivo and in vitro tests used to delineate lineage 
potential13-15. The question remains whether these different subpopulations all arise from 
the same thymus-seeding cell or whether diverse BM precursors (some of which may 
not have T-cell potential) enter the thymus16. 
Interestingly, a recent study indicates that ETPs derive from the true thymus-seeding 
cell, which is not found within the ETP population itself17. The lineage potential of ETPs 
may therefore not reflect the full range of potentials of the thymus-seeding cell. This 
finding demonstrates that sorting of minute populations is not always advantageous, for 
two reasons. Firstly, the target subset may be entirely missed, simply because it is not 
included in any of the isolated populations. Secondly, the pure target population may 
fail to develop in subsequent in vivo or in vitro assays, because it might need accessory 
cells. It is, for instance, possible that the thymus-seeding cell needs additional thymocyte 
subsets for its survival or differentiation. 
The limited set of markers available for the studying immature human thymocytes 
can be regarded as a disadvantage, but this also created a lucky side effect (Chapter 
4). By taking the entire CD34+CD1a- population, we were sure to include the thymus-
seeding cells, even though they may represent a tiny fraction of this subset. Because 
of the large cell numbers in the human thymus and the easy purification of CD34+ 
cells, we were able to culture large numbers of these cells in colony assays. This 
may have been the reason why we could detect the low erythroid (and presumably 
megakaryocytic) potential in thymocytes (Chapter 4), which was never found in the 
mouse. We could not demonstrate that all different lineages can develop from a single 
precursor in the thymus. Nevertheless, the full range of hematopoietic lineage potentials 
in the CD34+CD1a- population, together with the fact that we found precursors for B and 
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NK cells in the human thymus (Chapter 2), suggested that the thymus is seeded by a 
HSC or a non-self renewing multipotent progenitor, or a mixture of progenitors with the 
collective potential to develop into all blood cell lineages (Figure 2). 
Alternative lineage potential in the human thymus
As erythroid potential within the CD34+CD1a- subset is very low, it is probably lost 
soon after multipotent progenitors have entered the thymus (Figure 2). Alternatively, an 
erythroid cell fate is not rapidly inhibited in CD34+CD1a- thymocytes, but has for most 
cells already been excluded in the BM (Figure 2). It will be challenging to experimentally 
prove either of these options.
Restriction of myeloid lineage potential in the thymus appears to be less stringent than 
of erythroid potential, as the frequency of myeloid progenitors within the CD34+CD1a- 
population was relatively high: in the presence of GM-CSF only two-fold lower than the 
frequency of precursors with T-lineage potential (Chapter 4). This would suggest that 
erythroid potential is excluded at an earlier stage than myeloid potential and that this 
might be regulated by different signals from the thymic microenvironment. 
B-lineage potential within the CD34+CD1a- cells was much lower than myeloid 
developmental capacity (Figure 2). This finding would argue against the CLP as the 
thymus-seeding cell and is in favor of a T/myeloid bipotent progenitor. However, it 
may also be that the thymus is colonized by HSC-like progenitors and that the thymic 
microenvironment more strictly inhibits a B-cell fate than other lineages, presumably by 
Notch signaling (see below), thereby allowing the residual myeloid potential to become 
more prominent.
In any case, potential to differentiate into erythroid, myeloid and B-lymphoid cells 
was completely abolished in the CD34+CD1a+ thymocytes, placing T-cell commitment 
before the DN3 stage (Figure 2). This is in accordance with previous findings that the 
capacity to develop into DC and NK cells is also lost in CD34+CD1a+ thymocytes18. Also 
in the mouse, DN3 thymocytes are thought to be irreversibly committed to the T-cell 
lineage19. As pre-TCR signaling occurs in the CD34- (DN4) subset and commitment is 
completed at the CD34+CD1a+ stage, signaling through the pre-TCR is most likely not 
part of the T-cell commitment process.
While we have shown that a proportion of CD34+CD1a- cells still retains a broad 
lineage potential, another part of these cells may already be committed to the T-
cell lineage. Again additional markers are needed to distinguish between committed 
and multipotent cells. Single cell differentiation assays will be needed to determine 
the proportion of T-lineage committed cells within each stage, as well as the range of 
lineage potentials within a single cell. Apart from the fact that single cell assays using 
human cells so far did not work well in our hands, no assays exist in which T- and B-cell 
differentiation from a single progenitor can be studied simultaneously. The difficulty in 
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developing a culture system in which both T cells and other lineages can be generated 
lies in the fact that T-cell development requires the presence of Notch ligand Delta, 
while Delta suppresses development into B cells, and potentially other lineages. 
 
Loss of alternative lineage gene expression
In Chapter 4 we have demonstrated the expression of non-T cell genes in the 
CD34+CD1a- subset and their downregulation in the CD34+CD1a+ stage. Why are these 
alternative lineage genes expressed in early thymocytes? Some genes may reflect 
the actual development of an alternative lineage in the thymus. We have shown the 
presence of CD34+ precursors for B and NK cells in the human thymus (Chapter 2). 
We did not study the presence of myeloid precursors in the thymus, but we did confirm 
protein expression of MPO, CD13 and CD33 within the CD34+CD1a- subset (Chapter 
4). Physiological development of small numbers of myeloid cells in the thymus could 
well be envisaged, for instance to play a role in positive or negative selection.
On the other hand, physiological development of erythrocytes and platelets in the 
thymus is unlikely and in vitro erythroid potential of CD34+CD1a- thymocytes was low 
(Chapter 4). Nevertheless, a relatively high expression of the erythroid/megakaryocytic 
transcription factor NF-E2 was detected in the CD34+CD1a- subpopulation (Chapter 4). 
Several other studies have shown ‘promiscuous’ expression of lineage-specific genes 
by multipotent cells20-22. It has been suggested that low level transcription of multiple 
genes is necessary to prime differentiation down several lineages23. Alternatively, 
promiscuous expression may be the result of the wide-open chromatin state of stem 
cells and multipotent progenitors, rather than of their active transcription directed at 
protein production. Decondensed chromatin does not necessarily mean expression, but 
for certain genes which need active repression to be turned off, it may lead to low level 
transcription. Once lineage commitment has been achieved, the genes expressed in the 
excluded lineage pathways are permanently silenced24. Thus, alternative lineage gene 
expression in CD34+CD1a- thymocytes may just mean that these cells are ‘keeping 
their options open’, another sign that the CD34+CD1a- subset contains multipotent 
progenitors.
For sure, epigenetic events occur during T-cell development25. We found differential 
expression of several regulators such as histon deacetylases between the CD34+CD1a- 
and CD34+CD1a+ subsets. Another recently identified regulatory mechanism is 
represented by microRNAs, a class of small non-coding RNA species, which presumably 
act by controlling mRNA translation26. Recent work has demonstrated a cell-type specific 
distribution of microRNAs in human tissues and tumors, suggesting that microRNAs are 
involved in establishing a lineage specific gene program27. It would be interesting to 
study the microRNA profiles of the different stages of T-cell development.
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Expression of T-cell specific genes
Many classical ‘T-cell genes’, for instance pTα, are expressed in the CD34+CD1a- 
subset, some (including CD3ε) as early as the CD38- stage (Chapters 3 and 4), i.e. 
in cells that are not yet committed to the T-cell lineage. Furthermore, many of these 
alleged T-cell genes are not specific for the T-cell lineage, for instance CD4 can be 
expressed on myeloid cells28, pTα on DCs29, and cytoplasmic CD3 can be detected in 
NK cells30, again indicating that their expression is no evidence for T-cell commitment. 
Obviously, the transcription of T-cell specific genes in uncommitted T-cell precursors 
is an indication that a T-cell program is being established, but the program is not yet 
definitive. The collection of positive regulators for a certain lineage has been termed 
‘lineage specification’19 (Figure 3). 
The specificity of these specification genes for the T-cell lineage probably lies in 
combinations that are exclusive for T cells, e.g. expression of pTα together with a 
functional TCRβ chain. Furthermore, T-cell commitment is associated with high-level 
expression of these specification genes: we found massive upregulation of these genes 
in the CD34+CD1a+ stage (Chapter 4).
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Figure 3. Hypothetical order of events during the earliest stages of T-cell development. 
The thymus-seeding cells encounter Delta ligands on the thymic stroma and start their development into 
the T-cell direction. These immature thymocytes rapidly start expressing Tcf1, which is subsequently 
activated by Wnt signals. Wnt target genes (e.g. c-fos and c-jun) and Notch target genes (e.g. Hes1 and 
HoxA) together induce massive proliferation of early thymocytes. Only after sufficient cell cycles have 
been undergone, specification can occur, which is dependent on Notch target genes (e.g. TCFL5) and 
perhaps also on Wnt signals. Specification comprises the TCR gene rearrangements and initiation of gene 
expression programs that will ultimately lead to a cell that is irreversibly committed to the T-cell lineage19.
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It is largely unknown which transcription factors regulate the expression of T-cell 
genes. We did not find any T-cell specific genes when inducing either Wnt signaling 
in CD34+ thymocytes (Chapter 6) or Notch signaling in CD34+ UCB cells (Chapter 
8), although Tcf1 has been shown to interact with sequence motifs in CD3 and TCR 
enhancers31,32 and CSL with binding sites in the pTα enhancer33. In addition, E-box 
elements are important for pTα transcription34. However, no transcription factor has been 
shown to directly induce a T-cell transcriptional program single-handedly. Presumably, 
simultaneous action of several transcription factors, as well as other factors involved in 
chromatin accessibility, are necessary for T-cell specification. 
TCR gene rearrangements
The hallmark of a T cell is the expression of a TCR. Do TCR rearrangements indicate or 
even induce T-cell commitment? Components of the rearrangement machinery (RAGs, 
TdT) are already present in the uncommitted CD34+CD1a- subset (although, like the T-
cell genes, they are highly upregulated at the CD34+CD1a+ stage) and rearrangements 
of the TCRD locus (Dδ2 to Dδ3) can be detected at this stage (Chapter 3 and Figure 1). 
However, Dδ2 to Dδ3 rearrangements are not T-cell specific: they are detected in B cells 
as well35. We (Chapter 4) and others35 could not detect immature TCRD rearrangements 
in myeloid cells (with the exception of myeloid leukemias, in which these and more 
mature rearrangements are probably caused by deregulated and prolonged RAG 
expression), suggesting that Dδ2 to Dδ3 rearrangements are lymphoid specific. The fact 
that Dδ2 to Dδ3 rearrangements are present in B cells and not in myeloid cells might 
indicate that B and T cells derive from a common bi-potent precursor. More likely is the 
explanation that in early B cells that are rearranging their B-cell receptor heavy chains, 
the D segments of the TCRD locus are not yet fully inaccessible to the rearrangement 
machinery. Another argument for the fact that Dδ2 to Dδ3 rearrangements do not 
induce commitment to T-cell or lymphoid lineages in general, is the finding that cells 
containing Dδ2 to Dδ3 rearrangements can still be induced to develop into myeloid and 
erythroid lineages (Chapter 4). Thus, the expression of rearrangement machinery and 
the occurrence of early TCRD rearrangements in the CD34+CD1a- subset presumably 
indicate T-cell specification rather than T-cell commitment (Figure 3), similar to the 
expression of T-cell specific genes.
Dδ to Jδ and Dβ to Jβ rearrangements appear to be T-cell specific (leaving aside B-
cell and myeloid leukemias) and occur during the CD34+CD1a+ stage, concurrently with 
T-cell commitment. But whether a causal relation exists between TCR rearrangements 
and T-cell commitment remains to be tested.
How TCR gene rearrangements are induced and regulated by transcription factors is 
not completely understood. IL-7R signaling36 and E-box proteins37 have been implicated 
in initiation of TCR rearrangements, but both are not T-cell specific. In Chapter 3 we 
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identified a number of transcription factors the expression of which correlates with the 
initiation of rearrangements on the different TCR genes. Whether these factors have a 
physiological function in opening of TCR loci has to be tested in rearrangement assays 
using non-lymphoid cells38 and by overexpression and inhibition (siRNA) of these genes 
in FTOC.
Molecular regulation of lineage potential
In contrast to the emerging picture of a highly complex regulation of T-cell 
development, the molecular regulation of B-cell commitment appears to be relatively 
straight-forward39. During B-cell development, lineage specification is induced by 
the transcription factors E2A and EBF, which also induce Pax5 expression. Pax5 is 
necessary for the induction of crucial B-cell genes and represses alternative lineage 
fates40,41. Interestingly, Pax5 inhibits T-cell development by active repression of Notch1 
expression42. 
For T-cell development, a master regulator comparable to Pax5 is not known. 
Notch signaling appears to be able to repress a B-cell fate, as overexpression of IC-
Notch induces T-cell development in the BM, at the expense of B cells. However, direct 
inhibition of Pax5 by Notch signaling has not been described in literature. We could 
not study downregulation of Pax5 in our thymocyte microarrays, because Pax5 is not 
expressed in any subset, including CD34+ UCB. Other studies have shown that Pax5 
is rapidly downregulated when cells developing into the B-cell lineage are cultured on 
the T-lineage supporting stromal cell line OP9-DL43. Nevertheless, Notch signaling 
is not specific for the induction of a T-cell fate: it is also involved in self-renewal of 
HSCs44, in induction of myeloid cell fates45, and in the choice between erythroid and 
megakaryocytic differentiation46. 
Studies in human progenitor cells suggested that Notch signaling also inhibits a 
myeloid cell fate47, but the molecular mechanism is unknown. Perhaps stringent molecular 
inhibition of myeloid development is not necessary during thymocyte differentiation. 
Development of myeloid lineages is strongly dependent on myeloid cytokines such as 
M-CSF and GM-CSF48. These cytokines are in all probability absent in the thymus, 
and myeloid development is thereby automatically excluded and does not have to be 
actively repressed (Figure 4). This might also explain why myeloid potential was greatly 
enhanced by addition of GM-CSF to OP9 cultures (Chapter 4). 
In contrast, CLPs in BM (which are actually B cell progenitors12,49), completely lack 
myeloid potential8. Because of the abundant presence of myeloid growth factors in the BM, 
myeloid fates have to be actively repressed in CLPs (Figure 4). Similar reasoning explains 
why T-cell potential is still present in CLPs. As T cells will normally not develop in the BM 
because of the absence of Delta ligands (they will develop as soon as Delta1 or Delta4 are 
overexpressed50), T-cell development does not have to be actively repressed (Figure 4). 
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Development of DC and NK cells appears to be more ‘tolerant’ to Notch 
signaling47,51-53. Other mechanisms should therefore exist to exclude these lineages 
during T-cell development. Spi-B, a member of the Ets family of transcription factors 
involved in plasmacytoid DC development54 was shown to be downregulated from 
the CD34+CD1a- to the CD34+CD1a+ subset55. The inhibitory bHLH proteins of the Id 
family are thought to induce an NK-cell fate at the expense of T-cell development1,56, 
although we found an increase of Id transcripts in CD34+CD1a+ thymocytes and 
subsequent stages rather than the expected downregulation (data not shown).
Notch as a T-cell commitment factor
If a quintessential T-cell commitment factor should exist, Notch would be the most 
likely candidate. Notch signaling, as measured by Hes1 expression, is absent from BM 
LSK cells, but present in the earliest thymocytes that can be identified, both in mouse13,17 
and human (Figure 1), although this may be different during fetal development11. Loss of 
Notch1 function in lymphoid progenitors results in B lymphopoiesis in the thymus, at the 
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Figure 4. Hypothetical model of B- and T-cell commitment. 
As multiple lineages develop in the BM (left), non-B-cell lineages have to be actively suppressed in CLPs. 
T cells do not develop in the BM because of the absence of Delta, and therefore do not need active 
suppression. Conversely in the thymus (right), T-cell oriented microenvironmental signaling makes sure 
that only T cells develop. Therefore, active repression of alternative lineages is not necessary in the thymus.
General discussion
201
expense of T-cell development57, while overexpression of a constitutively active form 
of Notch induces ectopic T-cell development in the BM and inhibits B-cell development 
that would normally take place there47,58. However, in Chapter 8 we show that up to 24 
hrs after Notch induction, although Hes1 is highly expressed, no T-cell genes or T-cell 
specific transcription factors (Tcf1, GATA3, HEB) are induced. Recent work in the mouse 
by Taghon et al. confirmed this finding43. In this study, murine fetal liver precursors were 
cultured on OP9-DL. After one day of culturing, Hes1 was already highly upregulated, 
but the induction of T-cell genes started only at day 3. Similarly, in OP9-control cultures, 
Pax5 began to be expressed only at day 3. Furthermore, this study found the presence 
of uncommitted cells both in OP9-DL and OP9-control cultures up to day 6 of culture. 
Thus, binding of Delta by a progenitor cell is indispensable for becoming a T cell and 
in the presence of Delta no other lineages will develop, but Notch signaling does not 
directly induce T-cell commitment itself. The presence of a Notch signal appears to 
permit other positive regulators to set up a T-cell program.
What happens during the time span when cells receive a Notch signal, but do not yet 
start a T-cell program? Of course, Hes1 is rapidly induced. Hes is required at the earliest 
stage of T-cell development59, but overexpression of Hes1 or Hes5 is not sufficient 
to promote ectopic T-cell development from BM lymphoid progenitors60. We have 
identified a number of novel factors that are induced immediately after Notch signaling, 
of which we consider the HoxA cluster (mainly HoxA5, A9 and A10) and TCFL5 the 
most interesting  ones (Chapter 8; Figure 3). Although we find no HOXA upregulation 
in the early thymocyte subpopulations, it is possible that HOXA genes are only induced 
briefly in the small fraction of true thymus seeding cells that initially encounter the Delta 
ligand on thymic stroma. In such a scenario, HoxA induces a transcriptional program 
and then is rapidly downregulated itself, so that we cannot detect its expression in the 
heterogeneous pool of CD34+CD38- cells. Interestingly, a recent study has shown that 
dysregulated HoxA expression can cause T-ALL61, suggesting a proliferative function of 
HOXA genes in thymocytes. It is an appealing thought that the earliest function of Notch 
signaling in the thymus might be to induce proliferation (see also ‘Proliferation before 
specification?’). Indeed, far larger cell numbers are generated when progenitor cells are 
cultured on OP9-DL than on control OP9 (Chapter 4), although this finding might reflect 
the higher proliferative capacity of T-cell progenitors compared to B-cell progenitors, 
rather than be a consequence of Notch signaling per se. Additional experiments are 
necessary to prove that HOXA genes are direct targets of Notch signaling and to unravel 
their function in T-cell development. The HoxA5 deficient mouse studied in Chapter 8 
did not show any thymic defects, probably because of functional redundancy between 
different HoxA proteins. Mice deficient for several HOXA genes are likely to suffer from 
severe developmental defects during embryogenesis, necessitating difficult experiments 
such as performed for the Wnt3a knock-out (Chapter 7). A more feasible approach 
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would be to knock down several HOXA genes in FTOC using siRNA. Overexpression 
studies may elucidate whether HoxA genes indeed induce proliferation. 
In contrast to HOXA genes, TCFL5 was found to be upregulated in the early thymocyte 
subsets (Chapter 8), suggesting an extended function of TCFL5 at multiple points of T-cell 
development, like that of Hes1. Indeed, overexpression of TCFL5 seemed to positively 
affect thymocyte differentiation in FTOC. Again loss- and gain-of-function experiments 
will be useful to further clarify the role of TCFL5 in T-cell development. Furthermore, the 
working mechanism of TCFL5 needs to be elucidated. TCFL5 is thought to bind DNA 
through an E-box sequence62. Can TCFL5 induce TCR rearrangments? Does TCFL5 
inhibit B-cell development, for instance by interfering with E2A function? 
Wnt signaling and T-cell commitment
Wnt proteins generally are not considered to be T-cell commitment factors. However, 
in Chapter 5 we show that Wnt signaling is mainly active at the CD34+ stages: before 
and around T-cell commitment (Figure 1). The strong blocks seen in Tcf1(VII)-/- and 
Tcf1-/-/Lef1-/- mice demonstrate that Wnt signals are involved in T-cell development, but 
this has been interpreted as a failure in expansion of early subpopulations rather than 
a differentiation defect63, 64. We confirmed a predominantly proliferative function for Wnt 
signaling in Chapter 6: target genes of Wnt signaling in CD34+ thymocytes appeared 
to be mainly involved in proliferation. No T-cell genes were found to be upregulated. 
Furthermore, Wnt3a deficiency (Chapter 7) and Wnt1/Wnt4 double deficiency65 lead to 
decreased thymocyte numbers, but only to mild defects in T-cell development. To block 
binding of all possible Wnts, we overexpressed the Dickkopf protein in hematopoietic 
progenitors (Chapter 5). When cultured in FTOC, these cells expanded less than 
untransduced cells, but in addition showed a complete block at the DN1 stage. Because 
of the low numbers of cells expressing mDkk1, we were not able to further phenotype 
these arrested DN1 cells. It would be interesting to investigate whether these cells, like 
Notch deficient thymocytes66, exhibit characteristics of B cells or other lineages.
Interestingly, Tcf1-/- hematopoietic progenitor cells failed to reconstitute the 
thymus of irradiated mice, even when injected intrathymically64. Apparently, the initial 
expansion of progenitors after entering the thymus is critical for the progression into 
T-cell development. Wnt3a deficient progenitors also failed to reconstitute the thymus 
after transplantation (Chapter 7), but whether these cells fail to expand in the thymus 
or whether they never reach the thymus because of extrathymic stem cell problems 
remains to be elucidated.
In conclusion, Wnts are probably not classic commitment factors, in that they induce 
a T-cell program and inhibit alternative lineage genes. Rather, they are necessary for 
proliferation of the early thymocyte subpopulations (Figure 3). But apparently, in the 
absence of Wnt signals and hence proliferation, T-cell differentiation is arrested. The 
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Wnt-driven expansion of the earliest thymocytes can therefore be considered as an 
essential part of the T-cell development process. 
Induction of T-cell commitment 
Having explored the different processes and factors that might play a role in T-cell 
commitment, we may now draw some conclusions. T-cell commitment is probably not 
induced by the expression of T-cell specific genes or by TCR gene rearrangements, 
as these indicate specification rather than commitment (Figure 3). For sure, lineage 
potential becomes restricted during the course of T-cell development. Nevertheless, no 
presently known factor plays a decisive lineage-specific commitment role through direct 
or indirect repression of alternative lineage genes, a role that in B-cell development is 
played by Pax5.
It is a tantalizing thought that there is no need for active suppression of alternative 
lineages in the thymus, as the thymic microenvironment only supports T-cell development 
(Figure 4). This is exemplified by the rapid increase of T-cell precursors and the almost 
complete absence of alternative lineages when hematopoietic progenitors are cultured 
on OP9-DL. Many lineages develop in the BM: B cells, NK cells, various myeloid lineages, 
erythrocytes and platelets. The stroma therefore provides growth and survival factors 
for all these lineages. Once cells start developing in one direction, other options should 
be foreclosed, to prevent any confusion of molecular programs (Figure 4). This might be 
the reason why pro-B cells, unlike DN1 thymocytes, do not develop into myeloid cells in 
colony assays after ectopic expression of the IL-2R or GM-CSF receptor67. The thymus 
provides an excellent environment for the development of early thymocytes: a high 
density of Notch ligand Delta, an abundance of Wnt proteins, presence of cytokines like 
IL-7, SCF and Flt3L and appropriate adhesion molecules. Development of any other 
lineage than T-cells simply does not stand a chance (Figure 4).
But does the thymic microenvironment actively induce T-cell commitment? Binding 
of Delta is clearly important for T-cell development, but may support other functions, 
such as proliferation or survival, rather than T-cell commitment. My conviction is that 
T-cell commitment is a not a process that is actively aimed for, but rather a spin-off of T-
cell development. To become a T lymphocyte, a cell has to rearrange its TCR genes and 
induce a T-cell program. As a result of these changes, transcriptional and epigenetic 
modifications take place. Finally the cell will have arrived at a stage where it can only 
become T cell and nothing else. 
Timing of events 
In what order are the different environmental signals received and responded to? 
Unless they have a completely unexpected phenotype (e.g. CD34-), the true thymus 
seeding cells should be contained within the CD34+CD38- fraction. This subset (as a 
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whole) already expresses Hes1 (Figure 1). The CD34+CD1a- population, containing the 
CD38- cells, has high levels of Wnt signaling (Chapter 5). In fact, expression of c-fos, 
although not necessarily only the target of Wnt signaling, peaks in the CD38- population 
(our microarray data, not shown). 
These data demonstrate that both Notch and Wnt signals are received rapidly after 
entering the thymus (Figure 3). As the CD34+CD38- population is heterogeneous and as 
yet no markers are available to further delineate this subset, we do not know whether 
either the Notch or the Wnt signal is received first. The OP9-DL co-culture system is a 
useful tool to study such questions. In Chapter 5 we have described a lentiviral Tcf-GFP 
reporter. Although this reporter needs some optimization, it can be used to determine 
how quickly cells receive a Wnt signal after starting OP9-DL culture. We are currently 
developing a similar Notch reporter, in which the DsRed gene is under control of CSL 
binding sites. If we succeed in transducing both reporters into a single progenitor cell, 
culture on OP9-DL will demonstrate whether cells first receive a Wnt or a Notch signal 
and whether these signals can simultaneously occur in a single cell or whether they are 
mutually exclusive. In even more sophisticated experiments, more reporters are added, 
to visualize signaling through E-box proteins, GATA3, STAT5 or other transcription 
factors. 
The OP9-DL system can also be used to determine how long it takes a cell to 
induce a T-cell program after the initial Wnt and Notch signals, e.g. by quantitatively 
determining T-cell genes and TCR gene rearrangements at different time-points. The 
characteristics (TCR rearrangements, gene expression profile, reporter activation) of 
cells at certain time-points after culturing on OP9-DL can be correlated to a detailed 
phenotypic analysis of the thus obtained subset, to enable discrimination of the same 
subpopulation within the normal thymus or FTOC.
Proliferation before specification?
The initial Notch and Wnt signals apparently do not (directly) induce a T-cell program. 
What is their function? For Wnt signals, this probably is proliferation. As argued above 
(see ‘Notch as a T-cell commitment factor’), Notch signals may be involved in inducing 
expansion of the earliest thymocytes as well. 
During the selection processes that are part of T-cell development, a large proportion 
of the thymocytes die from apoptosis and death by neglect. In order to get a reasonable 
number of mature T cells to reach the finish line, it is imperative that plenty of precursors 
start the T-cell development process. It is possible that progenitors entering the thymus 
are obliged to go through a fixed number of cell cycles before differentiation may start 
(Figure 3). In the previously mentioned article by Taghon et al.43, the authors propose 
the existence of a ‘factor x’, which determines whether a cell, after receiving a Notch 
signal, starts to express T-cell genes. This would explain why cells cultured on OP9-DL 
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differentiate a-synchronously43. It may well be possible that ‘factor x’ in fact represents 
a certain degree of expansion. 
Do Wnt and Notch signals combine forces to induce proliferation of the earliest 
thymocytes (Figure 3)? It is generally thought that Wnt and Notch fulfill opposing 
functions in the thymus: Wnt in proliferation, Notch in differentiation, and that these 
processes are mutually exclusive. However, as indicated in Figure 1, the patterns 
of Wnt and Notch signaling seem highly correlated: they occur in the same subsets. 
Nevertheless, as argued in the first paragraphs of this General discussion, presumably 
all subsets are heterogeneous and include both proliferating and differentiating cells. 
Reporter assays as described above should sort this out. 
Both Wnt68 and Notch44,69 signaling have been implicated in HSC self-renewal. We 
have confirmed a role for Wnt3a in HSC maintenance in Chapter 7. A recent report 
has suggested molecular cooperation between the Notch and Wnt pathways: Notch 
would keep HSCs in an undifferentiated state, allowing Wnt to induce proliferation69. 
Furthermore, Wnt signaling in HSCs upregulated Notch target genes, although no 
molecular explanation was provided69. 
Positive interaction between Wnt and Notch signaling has also been shown outside 
the hematopoietic system70-72, but other studies have indicated opposing functions for 
both pathways. For instance in skin, Notch signalling induces differentiation73,74 and acts 
as a tumor suppressor by inhibiting β-catenin-mediated signalling75.
Differential effects of Notch signaling (e.g. proliferation or differentiation) may depend 
on the ligand that is encountered. In the BM, Notch signaling through Jagged may 
inhibit differentiation of HSCs. Inhibition of differentiation may also be the role of Jagged 
in the thymus, as it has been shown that a Jagged signal is able to block differentiation 
into the B- cell lineage76, although this is controversial52. In any case, differentiation into 
the T-cell lineage is dependent on Delta50,52,76.
FUTURE CHALLENGES
The remarkable role of Notch in T-cell development was discovered only six years 
ago66. It may therefore be possible that the quintessential T-cell commitment factor 
will be found in the future. Nevertheless, it is my conviction that the major molecular 
players in T-cell development are now known. Major break-throughs with regard to T-
cell development will more likely be achieved in other areas. Three subjects will be 
pivotal for future research.
First, the thymus seeding cell and its immediate progeny will have to be identified 
by detailed immunophenotyping and subsequently characterized in terms of lineage 
potential. The best chance to find these extremely rare cells is probably in the human 
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thymus, because of the huge cell numbers it contains. But, especially for the human 
thymocyte subsets, new markers will have to be identified. A number of markers 
currently used in the mouse (e.g. CD24, CD27, CD117, Flt313-15,77 should also be tested 
for expression in the human thymus. In addition, microarray studies will be helpful to 
identify novel markers, that preferentially reflect key processes.
Second, the different features of the thymic microenvironment should be further 
characterized. The thymic microenvironment has long been known to be extraordinary78 
and I have hypothesized that it so strongly supports T-cell development that in fact 
a real T-cell commitment signal might not be needed. Preferentially using confocal 
microscopy (because of the 3D architecture of the thymus) and good antibodies, different 
microenvironmental niches (with presence of particular Wnts, high or low levels of certain 
Notch ligands, etc.) may be identified. The ultimate goal would be to identify the migration 
pattern of developing thymocytes through the putative sequential microenvironmental 
niches and to delineate how this correlates with their differentiation.
Finally, future research should focus less on individual factors and pathways and 
more on the integration of the different signals. Not only interactions between Wnt 
and Notch signaling should be further investigated, but also those involving other 
microenvironmental factors (cytokines, adhesion molecules) and other transcription 
factors (GATA3, E-box proteins and many others). How do they all cooperate to set up 
the T-cell program? Furthermore, studies into the establishment of lineage specific gene 
programs will increasingly concentrate on novel regulatory mechanisms like microRNAs 
and epigenetic phenomena. 
Step by step such studies will lead to a complete understanding of T-cell development 
in all its aspects and to the final goal: development of better diagnostics and therapies 
for diseases involving the early stages of T-cell development, such as T-ALL and SCID. 
Flow-cytometric assays will be central for fast and accurate diagnosis of patients 
into specific subcategories, associated with different prognoses and therapies. For 
such studies, development of new, highly specific high affinity antibodies against key 
molecules involved in lymphocyte development is necessary.
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ABBREVIATIONS
APC  Adenomatous Polyposis Coli
BFU  burst forming unit
bHLH  basic-helix-loop-helix
BM  bone marrow
CFU  colony forming unit
CLP  common lymphoid progenitor
CSL  CBF/Suppressor of Hairless/Lag-1
DC  dendritic cell
DL  Delta
DN  double negative
DP  double positive
E  day of embryonic development
FLT3L  Fms-related tyrosine kinase 3 ligand
FTOC  fetal thymic organ culture
Fz  Frizzled
GFP  green fluorescent protein
ISP  immature single positive
GSK3  Glycogen synthase kinase-3
Hes  Hairy-enhancer of split
HSC  hematopoietic stem cell
IL  Interleukin
IC-Notch intracellular domain of Notch
Lef  Lymphoid enhancing factor
LRP  Low-density lipoprotein-receptor-related protein
LSK  lineage- Sca-1+ c-Kit+
NK  natural killer
pTα  pre-T-cell receptor α
RAG  recombination activating gene
TPO  thrombopoietin
SCF  stem cell factor
SCID  severe combined immunodeficiency disease
SP  single positive
T-ALL  T-cell acute lymphocytoblastic leukemia
TCR  T-cell receptor
TCRA/B/G/D gene for T-cell receptor α/β/γ/δ
TdT  Terminal deoxynucleotidyl Transferase
TEA  T-early alpha
TEC  thymic epithelial cell
Tcf  T-cell factor
UCB  umbilical cord blood
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SUMMARY 
All cells of the immune system are derived from hematopoietic stem cells (HSCs) 
located in the bone marrow (BM). While all other hematopoietic lineages develop in 
the BM, this is not the case for T cells. For the complicated differentiation events that 
comprise T-cell development, such as rearrangements of the T-cell receptor (TCR) 
genes, positive and negative selection events and effector cell differentiation, a 
specialized environment is required: the thymus. 
Precursor cells from the BM seed the thymus and start developing into T cells. 
The various steps of thymocyte differentiation are guided by proteins produced by the 
thymic stroma. Many aspects about the consecutive stages of T-cell development and 
the proteins involved are still incompletely understood. Better understanding of these 
processes will contribute to the improvement of diagnostics and therapies for diseases 
in which T-cell development is affected, such as T-cell acute lymphoblastic leukemia 
and SCID. 
In Chapter 2 of this thesis, we determined the numbers and relative contributions 
of the different thymocyte subpopulations in the human thymus and how these values 
change as children age. The thymus appeared to be most active in children 6 to 9 
months of age. In addition, we demonstrated that B-cell development takes place in 
normal human thymus. 
To gain more insight into the regulation of TCR gene rearrangement processes, 
we studied the several thymocyte subpopulations in more detail in Chapter 3. In each 
subpopulation, we quantitatively determined the amount of rearranged alleles of each 
TCR locus. Furthermore we used DNA microarray to study up- and downregulation of 
genes in each subset, in relationship to the TCR gene rearrangements. 
It remains elusive which progenitor cells from the BM seed the thymus. Are these cells 
already committed to the lymphoid or T-cell lineage? Or do these cells retain potential to 
develop into any hematopoietic cell type and do they develop into T cells only because of 
signals emanating from the thymic stroma, which induce T-cell development? In Chapter 
4 we attempted to resolve this issue by studying the most immature populations in the 
thymus. Using several culture systems, we investigated whether these thymocytes are 
able to develop into different hematopoietic lineages. We conclude that the thymus-
seeding cells are very immature and possibly are true HSCs. 
Two signal transduction pathways that are considered to be crucial for T-cell 
development were studied in Chapters 5 to 8: the Wnt and the Notch cascade. Both 
signal transduction routes are activated by extracellular molecules: the Wnt pathway 
by proteins of the Wnt family that are secreted by the thymic stroma as well as by 
thymocytes themselves and the Notch pathway by Delta and Jagged proteins that are 
expressed on the cell membrane of stroma cells. 
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In Chapter 5 we demonstrate that Wnt signaling predominantly occurs in the most 
immature thymocyte subpopulations. This is not determined by membrane proximal 
factors, as Wnt proteins are mainly produced by the more mature thymocytes, while 
Wnt receptors are expressed at equal levels in all subsets. Whether cells are able to 
respond to a Wnt signal appears to be determined by the presence of activating factors 
and the absence of inhibiting factors in a cell. 
Which genes are induced or repressed after a thymocyte receives a Wnt signal? 
This question was answered in Chapter 6, using three different methods to induce Wnt 
signaling in combination with DNA microarrays. Most of the identified genes appeared 
to be involved in proliferation and in adhesion to the thymic stroma. 
To investigate the function of a specific Wnt gene during T-cell development and 
hematopoiesis in general, we studied mice deficient for Wnt3a in Chapter 7. This 
mutation is embryonically lethal, which complicates experimental approaches. By 
culturing fetal thymi and hematopoietic progenitor cells from fetal liver in vitro and by 
transplantations into irradiated mice, we were able to study the immune system of these 
mice. From our results we can conclude that Wnt3a plays a role in T-cell but not B-cell 
development and is critical for HSC maintenance. 
Chapter 8 focuses on the Notch signal transduction pathway. Similar to the 
experiments described in Chapter 6 for the Wnt pathway, we here investigated which 
genes are induced or repressed by a Notch signal. For this purpose, we activated Notch 
signaling in progenitor cells from human umbilical cord blood. Although Notch signaling 
is essential for the development of T cells from multipotent precursors, we did not find 
upregulation of T-cell specific genes. Apparently Notch signaling does not directly induce 
a T-cell program in progenitor cells. We identified a number of novel Notch target genes, 
which may be important for T-cell development. 
Finally, the results of the different chapters are integrated in Chapter 9, with emphasis 
on T-cell commitment. I suggest that alternative lineages are not actively repressed 
during T-cell development, as the thymus provides an excellent microenvironment for 
the preferential development of T cells. 
Why is the thymic microenvironment so special that T cells develop only in this 
organ? The thymic stroma provides many signals that promote T-cell development, 
such as cytokines, adhesion molecules, Wnt proteins and Notch ligands. However, 
neither Wnt nor Notch signaling directly induces a T-cell program. My hypothesis is that 
Wnt and Notch signals cooperate to induce massive proliferation of the thymus-seeding 
cells. Only when enough thymocytes have been generated, a subsequent Notch signal 
is able to effectively initiate T-cell differentiation. 
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SAMENVATTING VOOR NIET-IMMUNOLOGEN
Het immuunsysteem zorgt voor de afweer tegen ziekteverwekkers (bijvoorbeeld 
virussen en bacteriën) die het lichaam binnendringen. Een belangrijke rol in het 
immuunsysteem wordt vervuld door T-cellen. Dit zijn afweercellen die circuleren door 
het bloed en de lymfeklieren, op zoek naar geïnfecteerde cellen, met als doel deze 
te doden. Bovendien kunnen ze andere afweercellen aanzetten tot een adequate 
afweerreactie. T-cellen zijn dus zeer gespecialiseerde cellen.
T-cellen dragen op hun celoppervlak zogenaamde T-celreceptoren, moleculen 
waarmee ze andere lichaamscellen aftasten. Iedere T-cel draagt één type T-celreceptor. 
Omdat een mens miljarden T-cellen heeft, kunnen alle T-cellen van een mens tezamen 
in principe iedere vreemde indringer herkennen. Al die miljarden verschillende T-
celreceptoren worden gevormd door het willekeurig aan elkaar plakken (‘recombineren’) 
van verschillende gensegmenten die coderen voor delen van de T-celreceptoren. De 
aldus ontstane T-celreceptoren worden uitgebreid getest: ze moeten goed in elkaar 
zitten, maar ze mogen geen lichaamseigen structuren herkennen. Alleen cellen die er 
in slagen om een goede T-celreceptor te produceren, mogen uitgroeien tot volwassen 
(‘rijpe’) T-cellen.
Alle afweercellen in het lichaam ontstaan uit bloedstamcellen die zich bevinden in 
het beenmerg. Ook de ontwikkeling van bloedstamcellen tot rijpe afweercellen vindt 
plaats in het beenmerg. Dit geldt echter niet voor T-cellen! Het recombineren van 
de T-celreceptor gensegmenten, het testen van de T-celreceptoren en het uitrijpen 
tot gespecialiseerde T-cellen zijn ingewikkelde processen, die in principe alleen 
plaatsvinden in de thymus (zwezerik). 
Voorlopercellen uit het beenmerg reizen naar de thymus en beginnen daar aan hun 
ontwikkeling tot T-cel. De zich ontwikkelende cellen in de thymus worden thymocyten 
genoemd. De thymusomgeving (het ‘stroma’) maakt signaalstoffen die ervoor zorgen 
dat de thymocyten de verschillende ontwikkelingsstappen doormaken. Bepaalde 
signaalstoffen zetten thymocyten aan tot celdeling, andere zorgen bijvoorbeeld dat de 
recombinatie van de T-celreceptor gensegmenten begint. Er is nog veel onduidelijk over 
de opeenvolgende ontwikkelingsstappen die plaatsvinden in de thymus en de precieze 
rol van verschillende signaalstoffen daarbij. Een beter begrip van deze verschillende 
processen zal bijdragen aan de verbetering van diagnostiek en therapie voor ziekten 
waarbij de T-celontwikkeling is aangedaan, bijvoorbeeld T-cel leukemie en aangeboren 
immuundeficiënties. 
De verschillende ontwikkelingsstadia van thymocyten (‘subpopulaties’) zijn te 
onderscheiden door thymocyten te kleuren met fluorescerende markers. In Hoofdstuk 2 
van dit proefschrift onderzochten wij in welke aantallen en verhoudingen de verschillende 
subpopulaties aanwezig zijn in de humane thymus, en hoe deze waarden veranderen 
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naarmate kinderen ouder worden. De thymus blijkt het meest actief in baby’s van 6 
tot 9 maanden oud. Ook tonen wij in Hoofdstuk 2 aan dat een kleine populatie van B-
cellen, afweercellen die normaalgesproken uitrijpen in het beenmerg, zich ontwikkelt in 
de thymus. 
Om meer inzicht te krijgen in de regulatie van de T-celreceptor recombinatieprocessen, 
kijken wij in Hoofdstuk 3 nog gedetailleerder naar de verschillende populaties van 
thymocyten. Wij bestudeerden in welke subpopulaties de recombinaties van de 
verschillende T-celreceptor gensegmenten plaatsvinden en welke genen hierbij ‘aan’ 
en ‘uit’ gezet worden.
Het is onduidelijk welk type voorlopercellen uit het beenmerg naar de thymus 
reizen. Zijn deze cellen voorbestemd om T-cel te worden? Of zijn het cellen die nog 
alle kanten op kunnen, maar die zich louter tot T-cel zullen ontwikkelen omdat ze in 
een thymusomgeving terechtkomen en signalen krijgen die hen tot T-celontwikkeling 
aanzetten? In Hoofdstuk 4 proberen wij deze vraag te beantwoorden door de meest 
onrijpe subpopulaties in de thymus uitgebreid te bestuderen. Wij onderzochten met 
behulp van verschillende kweeksystemen of deze thymocyten nog in staat zijn zich te 
ontwikkelen tot andere afweercellen dan T-cellen. Dit blijkt het geval te zijn, waardoor 
wij kunnen concluderen dat de cellen die binnenkomen in de thymus zeer onrijp en 
mogelijk zelfs echte bloedstamcellen zijn. 
De signaalstoffen die worden geproduceerd door het thymusstroma binden aan 
receptoren op het celoppervlak van de thymocyten. Hiermee zetten ze in de thymocyten 
een reeks van gebeurtenissen in gang (een ‘signaaltransductiecascade’) die uiteindelijk 
leidt tot het ‘aan’ en ‘uit’ zetten van bepaalde genen, bijvoorbeeld genen die zorgen voor 
celdeling of voor recombinatie van gensegmenten. Twee signaaltransductiecascades 
worden bestudeerd in de Hoofdstukken 5 t/m 8: de Wnt-cascade en de Notch-cascade. 
De Wnt-cascade wordt aangezet door signaalstoffen van de Wnt-familie, die worden 
uitgescheiden door het thymusstroma en de thymocyten zelf; de Notch-cascade wordt 
aangezet door de signaalstoffen Delta en Jagged, die op het celoppervlak van de 
stromacellen zitten.
In Hoofdstuk 5 bestudeerden wij in welke subpopulaties van thymocyten de Wnt-
cascade actief is en tonen aan dat dit voornamelijk in de meest onrijpe populaties is. 
Wnt-eiwitten blijken echter vooral te worden geproduceerd door de rijpere thymocyten 
en Wnt-receptoren zijn in gelijke mate aanwezig in alle subpopulaties. Of cellen in staat 
zijn te reageren op een Wnt-signaal, blijkt te worden bepaald door de aanwezigheid 
van factoren in de cel die de Wnt-cascade stimuleren en de afwezigheid van remmende 
factoren.
Welke genen ‘aan’ en ‘uit’ worden gezet nadat een thymocyt een Wnt-signaal heeft 
gekregen, hebben wij onderzocht in Hoofdstuk 6. Wij vonden voornamelijk genen die 
zorgen voor celdeling en voor het plakken (‘adhesie’) van de thymocyten aan het stroma.
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De Wnt-cascade is actief in sommige subpopulaties van thymocyten en zet bepaalde 
genen ‘aan’. Maar zijn Wnt-eiwitten werkelijk onmisbaar voor T-celontwikkeling? In 
Hoofdstuk 7 bestuderen wij muizen die een specifiek Wnt-eiwit, Wnt3a, missen. Omdat 
Wnt-eiwitten belangrijk zijn tijdens de foetale ontwikkeling, gaan Wnt3a knock-out 
muizen als embryo dood, hetgeen experimenten bemoeilijkt. Door foetale thymocyten 
en bloedstamcellen uit de foetale lever in kweekschaaltjes te laten uitrijpen, kunnen 
wij toch het afweersysteem bestuderen. Uit onze resultaten kunnen wij concluderen 
dat Wnt3a een rol speelt in T-celontwikkeling maar niet in B-celontwikkeling, en vooral 
belangrijk is voor bloedstamcellen.
De Notch-signaaltransductiecascade staat centraal in Hoofdstuk 8. Net als in 
Hoofdstuk 6 voor de Wnt-cascade, wordt hier gekeken welke genen ‘aan’ en ‘uit’ 
worden gezet door een Notch-signaal. Hier hebben wij een kunstmatig Notch-signaal 
gegeven aan bloedstamcellen uit humaan navelstrengbloed. Hoewel Notch-signalen 
onontbeerlijk zijn voor een bloedstamcel om zich te ontwikkelen tot T-cel, werden er 
geen genen actief die specifiek zijn voor T-cellen. Wel vonden wij een aantal nieuwe 
Notch-gereguleerde genen, die mogelijk belangrijk zijn voor T-celontwikkeling.
De resultaten uit de voorgaande hoofdstukken worden in een breder verband 
beschouwd in Hoofdstuk 9, waarbij de nadruk ligt op T-cel ‘commitment’, het proces dat 
zorgt dat een cel op een bepaald moment alleen nog T-cel kan worden en niets anders. 
Ik suggereer dat de thymus een zo gunstige omgeving vormt voor T-celontwikkeling, 
dat het actief remmen van andere mogelijke lotsbestemmingen onnodig is.
Wat maakt de thymusomgeving zo speciaal, dat T-cellen zich alleen daar ontwikkelen? 
Het thymusstroma produceert grote hoeveelheden signaalstoffen, bijvoorbeeld Wnt- 
en Notch-signalen, die T-celontwikkeling bevorderen. Maar Wnt- noch Notch-signalen 
zetten direct T-celgenen ‘aan’. Mijn hypothese is dat Wnt- en Notch-signalen samen 
zorgen voor een enorm aantal celdelingen in de meest onrijpe thymocyten. Pas als er 
voldoende thymocyten zijn gegenereerd, kan een volgend Notch-signaal ervoor zorgen 
dat de T-celontwikkeling werkelijk in gang wordt gezet.
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